
<html lang="en"     class="pb-page"  data-request-id="c8fc1f34-2fbc-4f5e-9635-37e3036592ce"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2013.56.issue-9;ctype:string:Journal Content;article:article:10.1021/jm400351a;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of Selective and Potent Inhibitors of Fibroblast Activation Protein and Prolyl Oligopeptidase" /></meta><meta name="dc.Creator" content="Sarah E.  Poplawski" /></meta><meta name="dc.Creator" content="Jack H.  Lai" /></meta><meta name="dc.Creator" content="Youhua  Li" /></meta><meta name="dc.Creator" content="Zhiping  Jin" /></meta><meta name="dc.Creator" content="Yuxin  Liu" /></meta><meta name="dc.Creator" content="Wengen  Wu" /></meta><meta name="dc.Creator" content="Yong  Wu" /></meta><meta name="dc.Creator" content="Yuhong  Zhou" /></meta><meta name="dc.Creator" content="James L.  Sudmeier" /></meta><meta name="dc.Creator" content="David G.  Sanford" /></meta><meta name="dc.Creator" content="William W.  Bachovchin" /></meta><meta name="dc.Description" content="Fibroblast activation protein (FAP) is a serine protease selectively expressed on reactive stromal fibroblasts of epithelial carcinomas. It is widely believed to play a role in tumor invasion and m..." /></meta><meta name="Description" content="Fibroblast activation protein (FAP) is a serine protease selectively expressed on reactive stromal fibroblasts of epithelial carcinomas. It is widely believed to play a role in tumor invasion and m..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 29, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400351a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400351a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400351a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400351a" /></link>
        
    
    

<title>Identification of Selective and Potent Inhibitors of Fibroblast Activation Protein and Prolyl Oligopeptidase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400351a" /></meta><meta property="og:title" content="Identification of Selective and Potent Inhibitors of Fibroblast Activation Protein and Prolyl Oligopeptidase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0017.jpeg" /></meta><meta property="og:description" content="Fibroblast activation protein (FAP) is a serine protease selectively expressed on reactive stromal fibroblasts of epithelial carcinomas. It is widely believed to play a role in tumor invasion and metastasis and therefore to represent a potential new drug target for cancer. Investigation into its biological function, however, has been hampered by the current unavailability of selective inhibitors. The challenge has been in identifying inhibitors that are selective for FAP over both the dipeptidyl peptidases (DPPs), with which it shares exopeptidase specificity, and prolyl oligopeptidase (PREP), with which it shares endopeptidase specificity. Here, we report the first potent FAP inhibitor with selectivity over both the DPPs and PREP, N-(pyridine-4-carbonyl)-d-Ala-boroPro (ARI-3099, 6). We also report a similarly potent and selective PREP inhibitor, N-(pyridine-3-carbonyl)-Val-boroPro (ARI-3531, 22). Both are boronic acid based inhibitors, demonstrating that high selectivity can be achieved using this electrophile. The inhibitors are stable, easy to synthesize, and should prove to be useful in helping to elucidate the biological functions of these two unique and interesting enzymes, as well as their potential as drug targets." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400351a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400351a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400351a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400351a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400351a&amp;href=/doi/10.1021/jm400351a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3467-3477</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4002692" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301734g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Selective and Potent Inhibitors of Fibroblast Activation Protein and Prolyl Oligopeptidase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+E.++Poplawski">Sarah E. Poplawski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jack+H.++Lai">Jack H. Lai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Youhua++Li">Youhua Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhiping++Jin">Zhiping Jin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuxin++Liu">Yuxin Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wengen++Wu">Wengen Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Wu">Yong Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuhong++Zhou">Yuhong Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+L.++Sudmeier">James L. Sudmeier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+G.++Sanford">David G. Sanford</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+W.++Bachovchin">William W. Bachovchin</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Arisaph Pharmaceuticals, Inc., 100 High Street, Suite 1202, Boston, Massachusetts 02110, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-636-6881. E-mail: <a href="/cdn-cgi/l/email-protection#681f010404010905460a090b00071e0b000106281c1d0e1c1b460d0c1d"><span class="__cf_email__" data-cfemail="fb8c929797929a96d5999a9893948d98939295bb8f8e9d8f88d59e9f8e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400351a&amp;href=/doi/10.1021%2Fjm400351a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3467–3477</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 17, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 October 2012</li><li><span class="item_label"><b>Published</b> online</span>29 April 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 May 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400351a" title="DOI URL">https://doi.org/10.1021/jm400351a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3467%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSarah%2BE.%2BPoplawski%252C%2BJack%2BH.%2BLai%252C%2BYouhua%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D9%26contentID%3Djm400351a%26title%3DIdentification%2Bof%2BSelective%2Band%2BPotent%2BInhibitors%2Bof%2BFibroblast%2BActivation%2BProtein%2Band%2BProlyl%2BOligopeptidase%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3477%26publicationDate%3DMay%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400351a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2496</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">47</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400351a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Selective and Potent Inhibitors of Fibroblast Activation Protein and Prolyl Oligopeptidase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;E. Poplawski&quot;},{&quot;first_name&quot;:&quot;Jack&quot;,&quot;last_name&quot;:&quot;H. Lai&quot;},{&quot;first_name&quot;:&quot;Youhua&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Zhiping&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Yuxin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Wengen&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Yuhong&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;L. Sudmeier&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;G. Sanford&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;W. Bachovchin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;3467-3477&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400351a&quot;},&quot;abstract&quot;:&quot;Fibroblast activation protein (FAP) is a serine protease selectively expressed on reactive stromal fibroblasts of epithelial carcinomas. It is widely believed to play a role in tumor invasion and metastasis and therefore to represent a potential new drug target for cancer. Investigation into its biological function, however, has been hampered by the current unavailability of selective inhibitors. The challenge has been in identifying inhibitors that are selective for FAP over both the dipeptidyl peptidases (DPPs), with which it shares exopeptidase specificity, and prolyl oligopeptidase (PREP), with which it shares endopeptidase specificity. Here, we report the first potent FAP inhibitor with selectivity over both the DPPs and PREP, N-(pyridine-4-carbonyl)-d-Ala-boroPro (ARI-3099, 6). We also report a similarly potent and selective PREP inhibitor, N-(pyridine-3-carbonyl)-Val-boroPro (ARI-3531, 22). Both are boronic acid based inhibitors, demonstrating that high selectivity can be achieved using this electrophi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400351a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400351a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400351a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400351a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400351a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400351a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400351a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400351a&amp;href=/doi/10.1021/jm400351a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400351a" /></input><a href="/doi/pdf/10.1021/jm400351a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400351a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400351a%26sid%3Dliteratum%253Aachs%26pmid%3D23594271%26genre%3Darticle%26aulast%3DPoplawski%26date%3D2013%26atitle%3DIdentification%2Bof%2BSelective%2Band%2BPotent%2BInhibitors%2Bof%2BFibroblast%2BActivation%2BProtein%2Band%2BProlyl%2BOligopeptidase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D9%26spage%3D3467%26epage%3D3477%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291831" title="Chemical specificity">Chemical specificity</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jmcmar.2013.56.issue-9/production/jmcmar.2013.56.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Fibroblast activation protein (FAP) is a serine protease selectively expressed on reactive stromal fibroblasts of epithelial carcinomas. It is widely believed to play a role in tumor invasion and metastasis and therefore to represent a potential new drug target for cancer. Investigation into its biological function, however, has been hampered by the current unavailability of selective inhibitors. The challenge has been in identifying inhibitors that are selective for FAP over both the dipeptidyl peptidases (DPPs), with which it shares exopeptidase specificity, and prolyl oligopeptidase (PREP), with which it shares endopeptidase specificity. Here, we report the first potent FAP inhibitor with selectivity over both the DPPs and PREP, <i>N</i>-(pyridine-4-carbonyl)-<span class="smallcaps smallerCapital">d</span>-Ala-boroPro (ARI-3099, <b>6</b>). We also report a similarly potent and selective PREP inhibitor, <i>N</i>-(pyridine-3-carbonyl)-Val-boroPro (ARI-3531, <b>22</b>). Both are boronic acid based inhibitors, demonstrating that high selectivity can be achieved using this electrophile. The inhibitors are stable, easy to synthesize, and should prove to be useful in helping to elucidate the biological functions of these two unique and interesting enzymes, as well as their potential as drug targets.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73724" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73724" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fibroblast activation protein (FAP) is a type II, membrane-bound serine protease highly expressed on activated stromal fibroblasts of essentially all epithelial cell carcinomas but not on the cancer cells themselves, normal fibroblasts, or normal tissues.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> FAP is most closely related to dipeptidyl peptidase IV (DPPIV, EC 3.4.14.5), with which it shares 54% sequence homology, membership in protease clan SC subfamily S9B, and the relatively rare ability to cleave peptides after proline residues. Other human enzymes with post-proline cleaving activity include dipeptidyl peptidase 8 (DPP8), dipeptidyl peptidase 9 (DPP9), dipeptidyl peptidase II (DPPII, EC 3.4.14.2), and prolyl oligopeptidase (PREP, EC 3.4.21.26).<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> The dipeptidyl peptidases (DPPs) are exclusively exopeptidases, whereas PREP is exclusively an endopeptidase. FAP is unique in having both exo- and endopeptidase activities.<a onclick="showRef(event, 'ref4 ref8'); return false;" href="javascript:void(0);" class="ref ref4 ref8">(4, 8)</a></div><div class="NLM_p">Post-proline cleaving enzymes are expected to have important biological functions in part because of the unique structure of proline but also because many bioactive peptides contain conserved proline residues at sites that appear to serve as key recognition elements for proteolytic processing.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Of the human post-proline cleaving enzymes, only the biological function of DPPIV has thus far been discovered and described. DPPIV regulates the incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) and, as a result, is now a validated target for the treatment of type 2 diabetes.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a></div><div class="NLM_p">The unique expression profile of FAP, coupled with studies indicating that it plays an important role in supporting tumor growth and metastasis, has generated interest in FAP as a therapeutic target.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> Tumors have been reported to grow more slowly in FAP knockout mice and more rapidly when transfected with FAP.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Kramen et al. have reported that genetic depletion of FAP-positive fibroblasts in a mouse lung cancer model results in hypoxic necrosis of tumor and stromal cells via elicitation of an immune response mediated by TNF-α and IFN-γ.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This is especially exciting, as it indicates that FAP may promote tumor growth, at least in part, by helping to hold the host’s antitumor immune response at bay and therefore suggests that FAP targeted therapies may help to turn on antitumor immunity. The mechanisms through which FAP mediates the above effects, however, are essentially unknown. It is not even clear whether or not its protease activity is involved, although inhibitors have been reported to have antitumor effects, including those mediated via enhancement of antitumor immunity.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> The inhibitors used in these experiments were not entirely specific for FAP, however, usually cross-reacting with the DPPs, PREP, or both, rendering the connection between the protease activity and tumor growth promoting activities of FAP less than certain.</div><div class="NLM_p">The current lack of specific FAP inhibitors is therefore an important factor hampering investigation of FAP’s biological functions and its potential as a new target for anticancer drugs. The problem stems from FAP’s dual function as both an exo- and endopeptidase. Identifying inhibitors that are specific for FAP over the DPPs, or for FAP over PREP, is relatively simple, and such inhibitors exist.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Identifying inhibitors that are specific for FAP over both the DPPs and PREP at the same time is more difficult.</div><div class="NLM_p">Tsai et al. have reported that several substituted 4-carboxymethylpyroglutamic acid diamides are selective inhibitors of FAP.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> While they screened these compounds against several of the DPPs, they did not screen against PREP, so it is not clear whether or not these inhibitors are truly specific and to what degree. Ryabtsova et al. described the design of a series of acylated Gly-(2-cyano)pyrrolidines to specifically address FAP selectivity versus PREP.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The bulk of the inhibitors described were not particularly potent, however, and they ultimately concluded that “selectivity toward the endopeptidase PREP was found to be less evident” in comparison to the other dipeptidyl peptidases. Thus, no FAP inhibitors thus far claimed to be specific for FAP have been demonstrated to be selective over PREP. PREP, like DPPIV and FAP, belongs to protease clan SC but to a different subfamily, S9A. Also similar to FAP, it has both soluble and membrane-bound forms, although the soluble form of PREP is generally localized the cytosol, whereas the soluble form of FAP is in the plasma.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> PREP is highly conserved in mammals and widely distributed in cells and tissues, with especially high concentrations found in the brain.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a></div><div class="NLM_p">Small molecule inhibitors of serine proteases are often divided into two categories, covalent and noncovalent. Covalent inhibitors are those that incorporate functional groups designed to be attacked by, and to form a covalent bond with, the active site serine. Such functional groups have been called transition-state analogues, serine traps, or electrophiles. Covalent inhibitors can be reversible or irreversible. Examples of reversible covalent inhibitors include those incorporating aldehyde, nitrile, boronic acid, or α-ketoamide functional groups. Examples of irreversible covalent inhibitors include those incorporating chloromethyl ketone, phosphorofluoridate, or phosphonate ester groups. At the present time, conventional wisdom still appears to strongly prefer noncovalent over covalent inhibitors, whether reversible or not, for use as drugs.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> There are several reasons for this, but the most important is a belief that covalent inhibitors are too reactive to yield inhibitors specific enough to be safe for use in humans.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Thus, statements can be found in the literature prior to 2000 to the effect that covalent inhibitors, including those incorporating any of the electrophiles mentioned above would be too reactive to be sufficiently specific to ever yield a marketed drug.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> As of 2011, however, there are at least 39 examples of covalent inhibitors approved by the FDA. Of the 15 drugs on the market that target serine or threonine proteases, seven, or nearly half, contain an electrophile. These include one boronic acid, two α-ketoamides, and two nitriles.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">Here we report the design and characterization of boronic acid based inhibitors for FAP and PREP that combine low nanomolar potency with high selectivity. <i>N</i>-(Pyridine-4-carbonyl)-<span class="smallcaps smallerCapital">d</span>-Ala-boroPro (ARI-3099, <b>6</b>) is more than 350-fold selective for FAP over PREP, with negligible potency against the DPPs, while <i>N</i>-(pyridine-3-carbonyl)-Val-boroPro (ARI-3531, <b>22</b>) displays even greater selectivity for PREP over FAP (77 000-fold) while also not inhibiting the DPPs.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0015.gif" alt="" id="fx1" /></img><div class="NLM_p last">The fact that boronic acid-based compounds can discriminate between enzymes with specificities as closely overlapping as the post-proline cleaving enzymes demonstrates the high selectivity that can be achieved with this electrophile.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> P<sub>1</sub> and P<sub>2</sub> Substrate Specificity of FAP</h3><div class="NLM_p">Specificity profiling demonstrates that FAP, like all members of this family, strongly prefers cleaving after proline residues. This applies to both its exo- and endopeptidase activities (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, top). The P<sub>2</sub> specificity, however, is quite different for the exo- and endopeptidase activities (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, bottom). As an exopeptidase, FAP accepts essentially all residues at P<sub>2</sub> with proline, large, hydrophobic, aromatic, and positively charged residues preferred most and negatively charged side chains preferred least. As an endopeptidase, FAP exhibits an absolute requirement for glycine at P<sub>2</sub>; no other naturally occurring amino acid is accepted. This agrees with previous FAP specificity studies and explains why many FAP inhibitors are based upon an X-Gly-Pro sequence.<a onclick="showRef(event, 'ref21 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref21 ref34 ref35">(21, 34, 35)</a> While this structural motif confers specificity against DPPs, it generally does not prevent cross-reactivity with PREP.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. P<sub>1</sub> and P<sub>2</sub> specificity of FAP. Percentage of intact peptide remaining following a 24 h incubation at 37 °C of FAP with either the GXYSWS-NH<sub>2</sub> or Ac-GXYSWS-NH<sub>2</sub> peptide library for P<sub>1</sub> analysis or the XPYSWS-NH<sub>2</sub> or Ac-XPYSWS-NH<sub>2</sub> peptide library for P<sub>2</sub> analysis. The dark columns represent the peptide libraries with a free N-terminus, while the light columns represent the acetyl blocked libraries. Error bars show the mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Selective Inhibitors of FAP</h3><div class="NLM_p">A recent review cited Tran et al. as having reported that a nonpeptidic boroproline inhibitor, 1-(2-(1-oxoisoindolin-2-acetyl)-boroPro (<b>4</b>), is approximately 400-fold selective for FAP over PREP.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Tran et al. actually reported that <b>4</b> is only 3-fold selective for PREP over FAP,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> a finding with which our results essentially agree (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Furthermore, Tran et al. reported that a P<sub>2</sub><span class="smallcaps smallerCapital">d</span>-alanine-containing inhibitor, <i>N</i>-acetyl-<span class="smallcaps smallerCapital">d</span>-Ala-boroPro (<b>3</b>), exhibits modest potency (<i>K</i><sub>i</sub> of 350 nM) and specificity (7.7-fold) for FAP over PREP. Our results agree that <b>3</b> inhibits FAP with modest potency but disagree that it is selective for FAP over PREP; we find instead that <b>3</b> is modestly selective for PREP over FAP. Nevertheless, both results suggest that FAP is capable of tolerating a P<sub>2</sub><span class="smallcaps smallerCapital">d</span>-alanine in the context of an X-boroPro-based inhibitor.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. FAP Selectivity of Compounds <b>1</b>–<b>6</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0006.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0007.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">The FAP selectivity is equal to IC<sub>50</sub>(PREP)/IC<sub>50</sub>(FAP). IC<sub>50</sub> values are expressed with ±SEM.</p></div></div><div></div></div><div class="NLM_p last">Of the compounds reported here, Gly-boroPro (<b>1</b>) demonstrates the greatest degree of selectivity for FAP over PREP (900-fold). Because of the presence of the free N-terminal amino group, however, <b>1</b> exhibits essentially no selectivity for FAP over the DPPs. Addition of various N-terminal blocking groups to <b>1</b>, as shown with <b>2</b> and <b>5</b>, provides increased potency against FAP, elimination of cross-reactivity with the DPPs, but little to no selectivity for FAP over PREP. Replacement of the P<sub>2</sub> glycine of <b>5</b> with a <span class="smallcaps smallerCapital">d</span>-alanine (<b>6</b>) provides 360-fold selectivity for FAP over PREP while retaining FAP potency in the low nanomolar range.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Optimization of the N-Terminal Blocking Group</h3><div class="NLM_p">A number of variations of the X-<span class="smallcaps smallerCapital">d</span>-Ala-boroPro scaffold were assessed, with <b>6</b> possessing the most optimal combination of potency and selectivity. Both the presence of the nitrogen and its position in the pyridine ring proved to be important. The former provides selectivity for FAP, while the latter provides additional potency, as is evident in comparing <b>6</b> with <b>7</b> and <b>8</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The nitrogen atom at the 4- or para position appears optimal. Without a solved structure of FAP complexed to <b>6</b>, we cannot be certain why this is the case. However, through molecular modeling beginning with the existing homologous X-ray crystal structure of the DPPIV tetrahedral intermediate complexed with diprotinA, as performed by previous researchers,<a onclick="showRef(event, 'ref21 ref34'); return false;" href="javascript:void(0);" class="ref ref21 ref34">(21, 34)</a> we discovered a reasonable hypothesis for the role of the pyridine group. Positioning the -boroPro moiety into the hydrophobic S<sub>1</sub> pocket of FAP in a manner consistent with the diprotinA structure, the P<sub>2</sub><span class="smallcaps smallerCapital">d</span>-alanyl and 4-pyridylcarbonyl groups are oriented for an optimal fit. The resulting model strongly suggests that a protonated pyridine nitrogen atom in the 4-position could form a hydrogen bond with the backbone carbonyl oxygen of Glu<sup>204</sup>. The pyridyl nitrogen should have a p<i>K</i><sub>a</sub> of approximately 5.5, so it would not be unreasonable for it to be protonated in the complex. PREP does not have a corresponding carbonyl oxygen or any other functional group that could act as a hydrogen bond acceptor in this position.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of FAP vs PREP against a Panel of N-Substituted <span class="smallcaps smallerCapital">d</span>-Ala-boroPro-Based Inhibitors<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0008.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0009.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">The FAP selectivity is equal to IC<sub>50</sub>(PREP)/IC<sub>50</sub>(FAP). IC<sub>50</sub> values are expressed with ±SEM.</p></div></div><div></div></div><div class="NLM_p last">Addition of halo substituents (F and Cl) to the pyridine ring also appears to further improve potency against FAP but with a 2- to 3-fold loss in selectivity over PREP (<b>9</b>–<b>12</b>). There are several possible explanations for this. The electron withdrawing effect of fluorine and chlorine would be expected to reduce the p<i>K</i><sub>a</sub> of the pyridyl nitrogen, making it a stronger acid. Although this would reduce the fraction of protonated inhibitor in solution, it would make the pyridyl N–H a stronger hydrogen bond donor in the complex. Fluorine at this position enhances binding considerably less than chlorine, however, suggesting that the effect is more likely mediated by a steric or torsion angle change rather than an electronic effect. As torsion angle changes could have an effect on PREP binding as well, this may explain why these inhibitors are less selective for FAP over PREP in comparison to <b>6</b>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Effects of P<sub>2</sub><span class="smallcaps smallerCapital">d</span>-Amino Acid Variation on FAP and PREP Inhibition</h3><div class="NLM_p">The finding that a <span class="smallcaps smallerCapital">d</span>-alanine in P<sub>2</sub> provides significant selectivity for FAP over PREP prompted us to examine other <span class="smallcaps smallerCapital">d</span>-amino acids in this position (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). For this purpose we employed a dipeptide-boroPro scaffold with an <i>N</i>-(4-quinolinoyl) group substituted at the N-terminus. As before, placement of <span class="smallcaps smallerCapital">d</span>-alanine at the P<sub>2</sub> position in this scaffold yields a potent and highly selective FAP inhibitor (<b>13</b>). Increasing the size of the <span class="smallcaps smallerCapital">d</span>-amino acid at P<sub>2</sub> quickly leads to losses of both potency and FAP selectivity. In fact, the larger P<sub>2</sub> substitutions lead to such large and selective losses in potency toward FAP that the inhibitors become selective for PREP over FAP (<b>15</b>, <b>17</b>, <b>18</b>, and <b>19</b>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Comparison of FAP vs PREP against a Panel of P<sub>2</sub><span class="smallcaps smallerCapital">d</span>-Amino Acid Substituted Inhibitors<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0010.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0011.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>Table a</sup><p class="last">The FAP selectivity is equal to IC<sub>50</sub>(PREP)/IC<sub>50</sub>(FAP). IC<sub>50</sub> values are expressed with ±SEM.</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Selective Inhibitors of PREP</h3><div class="NLM_p">Identifying potent and selective inhibitors for PREP is a far more simple task than for FAP. N-Terminal substitution provides, at once, selectivity for PREP over all of the DPPs and over the exopeptidase activity of FAP. The problem then reduces to discriminating between the endopeptidase activities of PREP and FAP, which is relatively straightforward, as FAP’s endopeptidase activity has rather stringent requirements at P<sub>2</sub>, accepting so far only glycine or <span class="smallcaps smallerCapital">d</span>-alanine, whereas PREP is more promiscuous and will accept a variety of amino acids at this position.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Thus, blocking the N-terminus of Val-boroPro (<b>20</b>), which exhibits little to no selectivity against any of the post-proline cleaving enzymes, produces <b>22</b>, which combines 1 nM potency against PREP with greater than 77 000-fold selectivity over FAP, as well as the DPPs (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Substituting glycine for valine at P<sub>2</sub> in <b>22</b> produces a potent inhibitor (<b>21</b>) of both FAP and PREP, demonstrating that the P<sub>2</sub> valine provides selectivity for PREP over FAP.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PREP Selectivity of Compounds <b>20</b>–<b>22</b><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0012.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>Table a</sup><p class="last">The PREP selectivity is equal to IC<sub>50</sub>(FAP)/IC<sub>50</sub>(PREP). IC<sub>50</sub> values are expressed with ±SEM.</p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Determination of Competitive or Noncompetitive Inhibition</h3><div class="NLM_p">Given the structural similarities of <b>6</b> and <b>22</b> to the substrates used for IC<sub>50</sub> determinations, it was anticipated that they would be competitive inhibitors of FAP and PREP. This is in fact the case, as shown by the Lineweaver–Burk plots for <b>6</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. This kinetic analysis also provided <i>K</i><sub>i</sub> values for these two inhibitors (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The <i>K</i><sub>i</sub> values of <b>6</b> against FAP and PREP are lower than the IC<sub>50</sub> values, but the ratio of selectivity remains the same, as expected. As before, the selectivity of <b>22</b> for PREP over FAP could only be quantified as greater than 140 000-fold, as <b>22</b> does not inhibit FAP at the highest concentrations tested.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lineweaver–Burk plots for inhibition of FAP and PREP by <b>6</b>. FAP (A) and PREP (B) either alone (closed squares) or with inhibitor concentrations equal to 0.5 IC<sub>50</sub> (open squares), IC<sub>50</sub> (closed squares), or 2 IC<sub>50</sub> (open squares) were incubated with varying concentrations of Suc-GP-AMC ((0.1–5)<i>K</i><sub>m</sub>) at 37 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. <i>K</i><sub>i</sub> Values for <b>6</b> and <b>22</b> against FAP and PREP<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">inhibitor</th><th class="colsep0 rowsep0" align="center">FAP</th><th class="colsep0 rowsep0" align="center">PREP</th><th class="colsep0 rowsep0" align="center">FAP selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">9.0 ± 0.9</td><td class="colsep0 rowsep0" align="left">3100 ± 260</td><td class="colsep0 rowsep0" align="left">340</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.73 ± 0.15</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Values are expressed with ±SEM.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Inhibitor Selectivity in Vitro in Mock and mFAP Transfected Cells</h3><div class="NLM_p">Although <b>6</b> and <b>22</b> are here shown to be potent and selective inhibitors of FAP and PREP, one may question whether the selectivity can be demonstrated in a more biologically relevant milieu, such as in cell cultures. Therefore, HEK293 cells transfected with either murine FAP (mFAP) or a mock vector were incubated with 1 μM <b>2</b>, <b>6</b>, or <b>22</b>. Compound <b>2</b>, which is a relatively poor inhibitor of DPPIV, DPP8, and DPP9, but a potent inhibitor of both FAP and PREP, inhibited virtually all of the cellular prolyl endopeptidase activity in both cell lines (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The PREP specific inhibitor <b>22</b> inhibited all activity in the mock-transfected cells but only approximately 60% in the mFAP transfected cells. This demonstrates that all of the endogenous prolyl endopeptidase activity in the HEK293 cells can be attributed to PREP, in agreement with previously published results that showed that HEK293 cells do not express endogenous FAP.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Finally, the FAP specific inhibitor <b>6</b> reduced activity only in the mFAP transfected cells but not in mock transfected cells. Not only do these findings demonstrate specificity in a cell-culture-based setting, they also indicate that <b>6</b> inhibits mouse and human FAP.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of cellular prolyl endopeptidase activity in mock and murine FAP transfected HEK293 cells. Mock (dark columns) and mFAP transfected (light columns) HEK293 cells were incubated with cell culture medium alone or 1 μM <b>2</b>, <b>6</b>, or <b>22</b> for 15 min at 37 °C. The endopeptidase activity was assessed via cleavage of a Z-GP-AMC substrate: ∗∗∗, <i>P</i> < 0.0001 vs no inhibitor control. Error bars show the mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Effect of the Presence of PREP on the Selectivity of <b>6</b> toward FAP</h3><div class="NLM_p">Unlike the in vitro assays used to determine the previously reported IC<sub>50</sub> values, the cellular-based assay in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, as well as any future in vivo assays, involves a mixture of enzymes rather than a single purified enzyme. The chief competitor for a FAP inhibitor in vivo will likely be PREP. Therefore, the effect of varying concentrations of PREP on FAP inhibition by <b>6</b> was assessed (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of the presence of PREP on FAP inhibition by <b>6</b>. (A) Recombinant FAP (1 nM) was mixed with varying concentrations of recombinant PREP and assayed for FAP inhibition by 36 nM (IC<sub>50</sub>) or 1 μM <b>6</b>. (B) Standard curves were prepared for recombinant FAP (closed circles) and recombinant PREP (open circles) activity using 25 μM FAP specific substrate or Z-GP-AMC, respectively. FAP activity associated with 25 000 HEK-mFAP cells (red star) was measured using an FAP specific substrate and determined to be 2 nM. PREP activity associated with mock transfected HEK293 cells (blue star) was measured using Z-GP-AMC and determined to be 2.9 nM. This yields a cellular PREP to FAP ratio of 1:1.5. Error bars show the mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Focusing on 36 nM and 1 μM <b>6</b>, concentrations equal to the reported IC<sub>50</sub> and the amount used to assess cell-associated enzyme activity, it was shown that concentrations of PREP equal to 0.01- to 100-fold the concentration of FAP had no significant effect on the observed inhibition by <b>6</b>. In the case of PREP specific inhibition by <b>22</b>, similar results would be anticipated given that <b>22</b> is much more selective for PREP over FAP than <b>6</b> is for FAP over PREP.</div><div class="NLM_p last">In order to determine if this range covers the enzyme activities associated with the cells used for the experiment in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, their FAP and PREP activities were measured and the relative concentrations of each calculated using a standard curve prepared from purified enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). This yielded an FAP to PREP ratio of 1:1.5, well within the range tested in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A, further validating the cell-based results.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Cytotoxicity of <b>6</b> in mFAP Transfected Cells</h3><div class="NLM_p">Previously, it was discussed that inhibition of FAP activity in vivo has been associated with antitumor activity in a number of mouse tumor models.<a onclick="showRef(event, 'ref16 ref17 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref20">(16, 17, 20)</a> Consequently, the cytotoxicity of <b>6</b> in mFAP transfected HEK293 cells was assessed, as these cells are known to express FAP and to represent a cell line that has been shown to rely on FAP activity for maximal tumor growth in vivo<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). No cytotoxicity was observed in this assay. This does not necessarily prove that inhibition of FAP by <b>6</b> would not have an effect in vivo, however, as <b>20</b> has been shown to lack cytotoxicity against several tumor cell lines while still attenuating tumor growth in vivo in mice inoculated with those same cells.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In partial agreement with this, <b>20</b> was also shown here to lack cytotoxicity. Conversely, bortezomib, which represents a class of boronic acid inhibitors that target the proteasome, has been shown to be cytotoxic to cells in vitro and in vivo and was thus used here as a positive control.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> These results suggest that any reduction in tumor volume resulting from FAP inhibition in vivo must be mediated by more complex pathways than those that can be mimicked using a cell-based assay alone.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cytotoxicity of <b>6</b> in mFAP transfected HEK293 cells. Cells were treated with varying concentrations of <b>6</b> (light columns), <b>20</b> (dark columns), or bortezomib as a positive control (striped columns) for 48 h. Cytotoxicity was assessed using a CellTiter-Blue cell viability assay with calculation of percent cell viability based on vehicle treated control cells. Error bars show the mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Here we report the first FAP inhibitor, <b>6</b>, that combines low nanomolar potency with selectivity against both the DPPs and PREP, as well as <b>22</b>, a corresponding potent and specific inhibitor for PREP. Both are boronic acid based inhibitors, demonstrating that high selectivity can be achieved with the use of this electrophile, notwithstanding beliefs to the contrary. These inhibitors should prove to be useful in helping to elucidate the biological function of these important enzymes and to evaluate their potential as drug targets.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Inhibitor Synthesis</h3><div class="NLM_p last">Compound identities were confirmed via <sup>1</sup>H NMR and LC/MS, using the HPLC aspect of the latter to assess a level of relative purity of ≥95% for each inhibitor. Specifically, NMR spectra of the compounds in D<sub>2</sub>O were recorded on a Bruker Avance 300 MHz spectrometer with a 5 mm dual 1H/X probe. Chemical shifts were reported relative to DSS. Mass spectra and HPLC retention times were recorded on a Hewlett-Packard HP LC/MSD system with UV detector (monitoring at 215 and 254 nm), using a Discovery C18 569232-U RP-HPLC column (12.5 cm, 4.6 mm, 5 μm) with solvent gradient A (water, 0.1% TFA) and B (acetonitrile, 0.08% TFA) flowing at 0.5 mL/min. Unless otherwise noted, all HPLC retention times are given for an eluent gradient of 2% B for the first 5 min, 2–98% B over 10 min, and 98% B for the final 5 min.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Dipeptide Boronic Acid Synthesis</h3><div class="NLM_p last">Synthesis of the X-boroPro dipeptides (<b>1</b> and <b>20</b>) was performed essentially as described previously<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> except that the initial coupling step was performed with HATU/DIPEA rather than EDC/HOBt, and the N- and C-terminal protection groups of the <i>N</i>-Boc-(<i>S</i>)-X-(<i>R</i>)-boroPro-(1<i>S</i>,2<i>S</i>,3<i>R</i>,5<i>S</i>)-pinanediol ester products were removed simultaneously. For the latter, to a stirred solution of the protected product in CH<sub>2</sub>Cl<sub>2</sub> cooled to −78 °C, an equimolar amount of a 1.0 M solution of BCl<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub> was added. After 1 h, the product was extracted into water and purified on a Supelco Discovery-C18 column, eluting with water (0.1% TFA) and acetonitrile (0.08% TFA). Lyophilization yielded the free dipeptide boronic acids.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Glycinyl-(<i>R</i>)-boroproline (<b>1</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.69–2.07 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 3.03–3.05 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.36–3.50 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 3.88 (s, 2H, H<sub>2</sub>NC<i>H</i><sub>2</sub>CO). <sup>13</sup>C NMR (D<sub>2</sub>O) δ 29.13, 29.53, 42.89, 49.11, 50.12, 166.89. <sup>11</sup>B NMR (D<sub>2</sub>O) δ 11.03. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 309.2, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 155.2, [M – H<sub>2</sub>O + H<sup>+</sup>]. <i>t</i><sub>R</sub> = 5.2 min.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>S</i>)-Valinyl-(<i>R</i>)-boroproline (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 0.98 (d, <i>J</i> = 6.9 Hz, 3H, C<i>H</i><sub><i>3</i></sub>CHCH<sub>3</sub>), 1.08 (d, <i>J</i> = 6.9 Hz, 3H, CH<sub>3</sub>CHC<i>H</i><sub><i>3</i></sub>), 1.60–2.34 (m, 5H, CH<sub>3</sub>C<i>H</i>CH<sub>3</sub> and BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 3.03–3.09 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.43–3.75 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.12 (d, <i>J</i> = 6.3 Hz, 1H, H<sub>2</sub>NC<i>H</i>CO). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 393.3, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 197.1, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 11.1 min.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> N-Terminally Blocked Dipeptide Boronic Acids</h3><div class="NLM_p last">Synthesis of the N-terminally blocked X-boroPro dipeptides was similar to that of the dipeptide boronic acids but fell under two synthetic schemes, specifically, those that coupled the N-terminal blocking group to the P<sub>2</sub> residue first (<b>2</b>, <b>16</b>, and <b>19</b>) and those that coupled the P<sub>1</sub> and P<sub>2</sub> residues in the initial step, followed by the addition of the N-terminal blocking group (<b>5</b>–<b>15</b>, <b>17</b>, <b>18</b>, and <b>22</b>). The coupling methods for the blocking group additions, as well as descriptions of the specific chemical building blocks, are highlighted in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. In the cases of <b>3</b>, <b>4</b>, and <b>21</b>, the P<sub>2</sub> residues with the desired N-terminal blocking group were commercially available, and these were coupled directly to the pinanediol protected P<sub>1</sub> boroproline residue.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-(1-Naphthalenecarbonyl)glycinyl-(<i>R</i>)-boroproline (<b>2</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.73–2.13 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 3.08–3.14 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.55–3.74 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.25–4.39 (d, <i>J</i> = 15.2 Hz, 2H, HNC<i>H</i><sub>2</sub>CO), 7.59–7.76 (m, 4H, aromatic H), 8.00–8.18 (m, 3H, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 617.3, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 309.2, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 14.4 min.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-Acetyl-(<i>R</i>)-alaninyl-(<i>R</i>)-boroproline (<b>3</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.30–1.32 (d, <i>J</i> = 7.0 Hz, 3H, HNCHC<i>H</i><sub>3</sub>), 1.56–2.09 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.96–2.97 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.58–3.63 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.25–4.39 (q, <i>J</i> = 7.0 Hz, 3H, <i>H</i><sub>3</sub>CO). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 421.2, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 251.3, [M + Na<sup>+</sup>]; 211.3, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 12.2 min.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-(2-(1-Oxoisoindolin-2-acetyl)-(<i>R</i>)-boroproline (<b>4</b>)</h3><div class="NLM_p"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.67–2.07 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.99–3.04 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.47–3.62 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.41 (s, 2H, CC<i>H</i><sub>2</sub>N), 4.51 (s, 2H, HNC<i>H</i><sub>2</sub>CO), 7.49–7.76 (m, 4H, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 541.4, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 271.1, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 8.4 min.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Chemical Building Blocks Utilized for the Synthesis of the N-Terminally Blocked X-boroPro Dipeptides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0014.gif" alt="" id="fx9" /></img><div></div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-(Pyridine-4-carbonyl)glycinyl-(<i>R</i>)-boroproline (<b>5</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.52–2.13 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.91–3.02 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.36–3.64 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.23 (s, 2H, HNC<i>H</i><sub>2</sub>CO), 8.33–8.35 (d, <i>J</i> = 5.4 Hz, 2H, aromatic H), 8.91–8.93 (d, <i>J</i> = 5.4 Hz, 2H, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 519.2, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 260.1, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 11.9 min.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(Pyridine-4-carbonyl)-(<i>R</i>)-alaninyl-(<i>R</i>)-boroproline (<b>6</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.45–1.47 (d, 3H, HNCHC<i>H</i><sub>3</sub>), 1.68–2.16 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.98–3.04 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.66–3.71 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.83–4.86 (m, 1H, HNC<i>H</i>CO), 8.36–8.38 (d, 2H, aromatic H), 8.94–8.96 (d, 2H, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 547.2, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 274.1, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 12.0 min.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(Benzoyl)-(<i>R</i>)-alaninyl-(<i>R</i>)-boroproline (<b>7</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.38–1.51 (d, 3H, HNCHC<i>H</i><sub>3</sub>), 1.60–2.24 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.93–3.08 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.62–3.77 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.70–4.85 (m, 1H, HNC<i>H</i>CO), 7.49–7.82 (m, 5H, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 545.3, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 273.1, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 13.9 min.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(Pyridine-3-carbonyl)-(<i>R</i>)-alaninyl-(<i>R</i>)-boroproline (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.38–1.51 (d, 3H, HNCHC<i>H</i><sub>3</sub>), 1.58–2.20 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.79–3.05 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.59–3.74 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.72–4.87 (m, 1H, HNC<i>H</i>CO), 8.12–8.23 (m, 1H, aromatic H), 8.94–9.03 (m, 2H, aromatic H), 9.18–9.21 (s, 1H, aromatic H). The HPLC retention time is for an eluent gradient of 2% B for the first 3 min, 2–98% B over 6 min, and 98% B for the final 4 min. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 547.2, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 274.1, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 7.3 min.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(Pyridine-3-fluoro-4-carbonyl)-(<i>R</i>)-alaninyl-(<i>R</i>)-boroproline (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.41–1.50 (d, 3H, HNCHC<i>H</i><sub>3</sub>), 1.61–2.22 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.89–3.04 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.59–3.74 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.79–4.84 (m, 1H, HNC<i>H</i>CO), 8.02–8.09 (m, 1H, aromatic H), 8.69–8.74 (d, 1H, aromatic H), 8.80–8.84 (d, 1H, aromatic H). The HPLC retention time is for an eluent gradient of 2% B for the first 3 min, 2–98% B over 3 min, and 98% B for the final 5 min. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 583.2, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 292.0, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 7.2 min.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(Pyridine-3-chloro-4-carbonyl)-(<i>R</i>)-alaninyl-(<i>R</i>)-boroproline (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.34–1.46 (d, 3H, HNCHC<i>H</i><sub>3</sub>), 1.62–2.21 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.91–3.04 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.62–3.74 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.77–4.82 (m, 1H, HNC<i>H</i>CO), 7.89–7.93 (d, 1H, aromatic H), 8.71–8.76 (d, 1H, aromatic H), 8.81–8.85 (s, 1H, aromatic H). The HPLC retention time is for an eluent gradient of 2% B for the first 3 min, 2–98% B over 3 min, and 98% B for the final 5 min. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 615.2, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 308.0, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 7.6 min.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(Pyridine-2-fluoro-4-carbonyl)-(<i>R</i>)-alaninyl-(<i>R</i>)-boroproline (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.37–1.49 (d, 3H, HNCHC<i>H</i><sub>3</sub>), 1.61–2.21 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.93–3.03 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.62–3.69 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.61–4.80 (m, 1H, HNC<i>H</i>CO), 7.31–7.82 (m, 2H, aromatic H), 8.26–8.33 (d, 1H, aromatic H), 8.81–8.85 (s, 1H, aromatic H). The HPLC retention time is for an eluent gradient of 2% B for the first 3 min, 2–98% B over 3 min, and 98% B for the final 5 min. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 583.3, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 292.2, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 7.1 min.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(Pyridine-2-chloro-4-carbonyl)-(<i>R</i>)-alaninyl-(<i>R</i>)-boroproline (<b>12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.36–1.47 (d, 3H, HNCHC<i>H</i><sub>3</sub>), 1.59–2.11 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.88–3.01 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.62–3.71 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.66–4.79 (m, 1H, HNC<i>H</i>CO), 7.66–7.71 (d, 1H, aromatic H), 7.76–7.80 (s, 1H, aromatic H), 8.44–8.49 (d, 1H, aromatic H). The HPLC retention time is for an eluent gradient of 2% B for the first 3 min, 2–98% B over 3 min, and 98% B for the final 5 min. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 615.1, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 308.0, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 7.7 min.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(Quinoline-4-carbonyl)-(<i>R</i>)-alaninyl-(<i>R</i>)-boroproline (<b>13</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.45–1.48 (d, J = 6.9 Hz, 3H, HNCHC<i>H</i><sub>3</sub>), 1.70 – 2.13 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 3.02–3.07 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.72–3.77 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.88–4.97 (m, 1H, HNC<i>H</i>CO), 7.97–8.33 (m, 5H, aromatic H), 9.18–9.20 (d, 1H, NC<i>H</i>CH, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 647.3, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 324.3, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 12.8 min.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(Quinoline-4-carbonyl)-(<i>R</i>)-serinyl-(<i>R</i>)-boroproline (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.75–2.20 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 3.05–3.11 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.78–3.82 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 3.87–4.03 (m, 2H, CHC<i>H</i><sub>2</sub>OH), 5.13–5.17 (m, 1H, HNC<i>H</i>CO), 8.01–8.36 (m, 5H, aromatic H), 9.21–9.23 (d, 1H, NC<i>H</i>CH, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 679.3, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 340.2, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 12.4 min.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(Quinoline-4-carbonyl)-(<i>R</i>)-methioninyl-(<i>R</i>)-boroproline (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.74–2.22 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.04–2.22 (m, 5H, CHC<i>H</i><sub>2</sub>CH<sub>2</sub>SC<i>H</i><sub>3</sub>), 2.67–2.75 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 2.67–3.10 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 3.79–3.83 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>S), 5.14–5.19 (m, 1H, HNC<i>H</i>CO), 8.01–8.32 (m, 5H, aromatic H), 9.21–9.23 (d, 1H, NC<i>H</i>CH, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 767.3, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 384.5, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 12.9 min.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(Quinoline-4-carbonyl)-(<i>R</i>)-ethyl(glycinyl)-(<i>R</i>)-boroproline (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.02–1.07 (m, 3H, CHCH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.72–1.91 (m, 2H, CHC<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.72–2.16 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 3.03–3.08 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.76–3.81 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.84–4.89 (m, 1H, HNC<i>H</i>CO), 7.99–8.32 (m, 5H, aromatic H), 9.20–9.21 (d, 1H, NC<i>H</i>CH, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 675.3, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 338.4, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 13.2 min.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-(Quinoline-4-carbonyl)-(<i>R</i>)-propyl(glycinyl)-(<i>R</i>)-boroproline (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 0.93–0.98 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i>3), 1.45–1.52 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.73–1.84 (m, 2H, CHC<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.73–2.14 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 3.01–3.07 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.75–3.80 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.91–4.96 (m, 1H, HNC<i>H</i>CO), 7.99–8.30 (m, 5H, aromatic H), 9.20–9.21 (d, 1H, NC<i>H</i>CH, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 703.5, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 352.3, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 13.7 min.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(Quinoline-4-carbonyl)-(<i>R</i>)-butyl(glycinyl)-(<i>R</i>)-boroproline (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 0.86–0.91 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>C<i>H</i>3), 1.34–1.45 (m, 4H, CH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.81–1.85, (m, 2H, CHC<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.81–2.14 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 3.01–3.07 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.74–3.81 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.89–4.94 (m, 1H, HNC<i>H</i>CO), 7.99–8.30 (m, 5H, aromatic H), 9.19–9.21 (d, 1H, NC<i>H</i>CH, aromatic H). The HPLC retention time is for an eluent gradient 2% B for the first 3 min, 2–98% B over 6 min and 98%B for the final 4 min. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 365.7, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 8.5 min.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(Quinoline-4-carbonyl)-(<i>R</i>)-phenyl(glycinyl)-(<i>R</i>)-boroproline (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.70–1.72 (m, 2H, BCHC<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.73–2.00 (m, 2H, BCHCH<sub>2</sub>C<i>H</i><sub>2</sub>), 2.99–3.06 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.26–3.68 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 6.00 (s, 1H, HNC<i>H</i>CO), 7.42–7.46 (m, 5H, phenyl H), 7.93–8.31 (m, 5H, aromatic H), 9.13–9.15 (d, 1H, NC<i>H</i>CH, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 386.1, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 14.1 min.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(Pyridine-3-carbonyl)glycinyl-(<i>R</i>)-boroproline (<b>21</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 1.68–2.10 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 3.02–3.08 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.47–3.69 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.29 (s, 2H, HNC<i>H</i><sub>2</sub>CO), 8.18–8.22 (m, 1H, NCHC<i>H</i>CH, aromatic H), 8.94–8.96 (m, 2H, NC<i>H</i>CHC<i>H</i>, aromatic H), 9.22 (s, 1H, NC<i>H</i>CCO, aromatic H). LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 519.2, [2 × (M – H<sub>2</sub>O) + H<sup>+</sup>]; 260.1, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 11.5 min.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(Pyridine-3-carbonyl)-(<i>R</i>)-valinyl-(<i>R</i>)-boroproline (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (D<sub>2</sub>O) δ 0.96–1.03 (m, 6H, CHCH(C<i>H</i><sub>3</sub>)<sub>2</sub>), 1.69–2.15 (m, 4H, BCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>), 2.15–2.22 (m, 1H, CHC<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 2.95–2.99 (m, 1H, CH<sub>2</sub>C<i>H</i>B), 3.57–4.01 (m, 2H, CH<sub>2</sub>C<i>H</i><sub>2</sub>N), 4.61–4.63 (m, 1H, HNC<i>H</i>CO), 8.16–8.21 (m, 1H, NCHC<i>H</i>CH, aromatic H), 8.92–8.95 (m, 2H, NC<i>H</i>CHC<i>H</i>, aromatic H), 9.16 (s, 1H, NC<i>H</i>CCO, aromatic H). The HPLC retention time is for an eluent gradient 2% B for the first 3 min, 2–98% B over 6 min, and 98% B for the final 4 min. LC–MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> (rel intensity): 602.4, [2 × (M – H<sub>2</sub>O)]; 302.2, [M – H<sub>2</sub>O + H<sup>+</sup>], <i>t</i><sub>R</sub> = 6.7 min.</div></div><div id="sec4_23_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Synthesis of Bortezomib</h3><div class="NLM_p last">Bortezomib was synthesized as described previously.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Biological Materials</h3><div class="NLM_p last">The peptide libraries XPYSWS-NH<sub>2</sub>, Ac-XPYSWS-NH<sub>2</sub>, GXYSWS-NH<sub>2</sub>, and Ac-GXYSWS-NH<sub>2</sub>, where X represents all natural amino acids except cysteine were synthesized by the Tufts University Core Facility. The DPPIV enzyme used for the specificity studies was previously purified by our laboratory at Tufts University from human placenta, and the purified human FAP enzyme used for these studies was kindly provided by Syrxx, Inc. For the in vitro IC<sub>50</sub> determination assays, recombinant human DPPIV, DPP9, FAP, and PREP were purchased from R&D Systems, and DPP8 was from Biomol International. Buffer systems used were A (25 mM Tris, pH 8.0), B (50 mM Tris, pH 7.5), C (50 mM Tris, 140 mM NaCl, pH 7.5), D (25 mM Tris, 250 mM NaCl, pH 7.5), and E (20 mM Tris, 20 mM KCl, pH 7.4). Fluorogenic substrates were Gly-Pro-AMC, Z-Gly-Pro-AMC, or Suc-Gly-Pro-AMC purchased from Bachem or an N-terminally blocked FAP specific substrate.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The cell culture medium was RPMI 1640 without phenol red and supplemented with 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 4500 mg/L glucose, 100 IU/mL penicillin, and 100 μg/mL streptomycin.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Substrate Specificity Assay</h3><div class="NLM_p last">Peptide libraries (0.21 mM) were incubated for 24 h with 1 nM FAP in buffer E at 37 °C. The reaction was quenched by the addition of 1.2 N HCl. The samples were analyzed by reverse-phase HPLC–MS on a Thermo Finnigan LCQ Duo, quantifying the peaks in the resulting base peak chromatograms. Relative cleavage values were determined by comparing the postquench abundance of intact peptides to those in the initial library.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> In Vitro Enzyme IC<sub>50</sub> Assays</h3><div class="NLM_p">Enzymatic activity of DPPIV, DPP8, DPP9, FAP, and PREP was measured at 25 °C on a Molecular Devices M2<sup>e</sup> multidetection microtiter plate reader, monitoring the fluorescence at an excitation wavelength of 380 nm and an emission wavelength of 460 nm. The substrate was either H-Gly-Pro-AMC for the DPPIV, DPP8, and DPP9 assays or Z-Gly-Pro-AMC for the FAP and PREP assays. The reaction mixture contained 25 μM substrate, enzyme, buffer A (DPPIV and DPP9), buffer B (DPP8), buffer C (FAP), or buffer D (PREP) and a suitable amount of inhibitor (ranging between 10<sup>–4</sup> and 10<sup>–11</sup> M) in a total volume of 210 μL. The final enzyme concentrations were 0.1, 0.8, 0.4, 1.2, and 0.6 nM for DPPIV, DPP8, DPP9, FAP, and PREP, respectively. The IC<sub>50</sub> value is defined as the concentration of inhibitor required to reduce the enzyme activity by 50% after a 10 min preincubation with the enzyme at 25 °C prior to addition of the substrate.</div><div class="NLM_p last">Inhibitor stock solutions (100 mM) were prepared in either a pH 2.0 HCl solution for compounds <b>1</b> and <b>20</b> or DMSO. Those prepared in pH 2.0 solution were preincubated at 25 °C for 4 h prior to dilution. Immediately prior to the commencement of the experiment, the 100 mM stocks were further diluted to 10<sup>–3</sup> M in the appropriate assay buffer, from which 1:10 serial dilutions were prepared. All inhibitors were tested in triplicate.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Molecular Modeling of <b>6</b> Bound to FAP</h3><div class="NLM_p last">Using Insight II (version 2005.03) and beginning with the homologous X-ray crystallographic structure of the DPPIV tetrahedral intermediate complexed with diprotinA (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NU8">1NU8</a>), the -boroPro moiety of <b>6</b> was positioned in the similarly shaped hydrophobic S<sub>1</sub> pocket of FAP (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z68">1Z68</a>). The boron was placed at nearly the same distance, 1.6 Ǻ, from the Ser<sup>624</sup> oxygen as previously reported B–O bonds. Tetrahedral angles for boron were maintained as closely as possible, utilizing the free rotation of ligand C<sub>α</sub>–B and enzyme Ser<sup>624</sup> C<sub>α</sub>–C<sub>β</sub> single bonds. The ligand <b>6</b> dihedral angles were varied sequentially from ψ<sub>2</sub> to ϕ<sub>2</sub> of the <span class="smallcaps smallerCapital">d</span>-alanyl group to ψ<sub>3</sub> of the 4-pyridylcarbonyl group to optimize possible hydrogen bond receptors for the pyridinium N–H<sup>+</sup> group (ψ<sub>3</sub> = −160°, ω<sub>3</sub> = −177°, ϕ<sub>2</sub> = 94°, ψ<sub>2</sub> = 65°, ω<sub>2</sub> = −177°, ϕ<sub>1</sub> = −73°). This placed the pyridinium N–H<sup>+</sup> proton in position for hydrogen bonding to the backbone carbonyl oxygen atom of Glu<sup>204</sup>, with an H–O distance of 1.87 Ǻ and an N–H<sup>...</sup>O angle of 121°.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Characterization of Competitive/Noncompetitive Inhibition</h3><div class="NLM_p last">The enzyme kinetics for FAP or PREP with or without varying concentrations ((0.5–2)IC<sub>50</sub>) of <b>6</b> or <b>22</b> were measured in the appropriate assay buffer at 37 °C, using Suc-GP-AMC at concentrations equivalent to (0.1–5)× its respective <i>K</i><sub>m</sub> values for these enzymes. The enzyme concentration was 5 nM. <b>6</b> was added concurrent with the substrate and enzyme, while <b>22</b> was allowed to preincubate with the enzyme for 10 min prior to the addition of the substrate due to observed slow binding kinetics. The fluorescence was continuously monitored at excitation and emission wavelengths of 380 and 460 nm, respectively. Standard curves for 7-amino-4 methylcoumarin (Aldrich) were used to convert the fluorescence units into the concentration of the released fluorophore. From this, the slope of [AMC] versus time yielded the reaction rate for each condition. The resulting Lineweaver–Burk plots were prepared by plotting 1/<i>V</i>, where <i>V</i> was equal to the reaction rate calculated above, versus 1/[S] and were analyzed with a linear regression analysis, using GraphPad software. <i>K</i><sub>i</sub> values were also determined using GraphPad software, fitting the <i>V</i> vs [S] results to a competitive inhibition analysis.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Inhibition of Cellular Enzyme Activity in HEK293 Cells</h3><div class="NLM_p last">Mock or murine FAP (mFAP) transfected HEK293 cells were kindly provided by Jonathan Cheng from the Fox Chase Cancer Center. The cells were equilibrated in RPMI 1640 at a density of 25 000 cells/well, treated with 1 μM <b>2</b>, <b>6</b>, <b>22</b>, or RPMI 1640 alone, and allowed to incubate for 15 min at 37 °C. The substrate was 25 μM Z-Gly-Pro-AMC. The fluorescence was measured at 37 °C, monitoring an excitation wavelength of 380 nm and an emission wavelength of 460 nm. The percent activity was determined versus the RPMI 1640 control.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> In Vitro Mixed FAP and PREP Inhibition Assay</h3><div class="NLM_p last">Enzymatic activity of 1 nM FAP combined with 0.01–100 nM PREP was measured at 25 °C, monitoring the fluorescence at an excitation wavelength of 380 nm and an emission wavelength of 460 nm. The substrate was the N-terminally blocked FAP specific substrate, so as to be able to differentiate FAP activity in the presence of PREP. The final reaction mixture contained 25 μM substrate, enzyme, a 1:1 mixture of buffer C and buffer D, and either 36 nM or 1 μM <b>6</b> in a total volume of 210 μL. The enzymes were allowed to preincubate with the inhibitor for 10 min at room temperature prior to addition of the substrate. The percent of FAP activity was determined based on a simultaneously run control for each condition, which lacked treatment with the inhibitor.</div></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Measurement of FAP and PREP Activity in HEK293 Cells</h3><div class="NLM_p last">Both mock and mFAP transfected HEK293 cells were equilibrated in RPMI 1640 at a density of 25 000 cells/well. The mock transfected cells were treated with 25 μM Z-GP-AMC, and the mFAP transfected cells were treated with 50 μM N-terminally blocked FAP specific inhibitor in a total volume of 200 μL/well. The fluorescence was measured at 37 °C, monitoring an excitation wavelength of 380 nm and an emission wavelength of 460 nm. To calculate the relative cellular PREP and FAP concentrations, standard activity curves were prepared for each using varying concentrations of purified enzyme and Z-GP-AMC for PREP and the N-terminally blocked FAP specific substrate for FAP. The relative concentration of active enzyme associated with the cells was calculated via interpolation from the standard curves and the measured cellular activity.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Cell Viability Assay</h3><div class="NLM_p last">mFAP transfected HEK293 cells were equilibrated in RPMI 1640 at a density of 25 000 cells/well. Cells were treated with RPMI 1640 alone or varying concentrations of <b>6</b>, <b>20</b>, or bortezomib (ranging between 10<sup>–3</sup> and 10<sup>–11</sup> M) in a final assay volume of 100 μL. Following a 48 h incubation at 37 °C, all wells were treated with CellTiter-Blue reagent from Promega and incubated an additional 2 h at 37 °C and the fluorescence was measured, monitoring an excitation wavelength of 560 nm and an emission wavelength of 590 nm. Percent cell viability relating to the inhibitors was determined versus the cells treated with RPMI 1640 alone.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm400351a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William W. Bachovchin</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Arisaph Pharmaceuticals,
Inc., 100 High Street, Suite 1202, Boston, Massachusetts
02110, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f98e909595909894d79b989a91968f9a919097b98d8c9f8d8ad79c9d8c"><span class="__cf_email__" data-cfemail="22554b4e4e4b434f0c4043414a4d54414a4b4c6256574456510c474657">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah E. Poplawski</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Arisaph Pharmaceuticals,
Inc., 100 High Street, Suite 1202, Boston, Massachusetts
02110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jack H. Lai</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Arisaph Pharmaceuticals,
Inc., 100 High Street, Suite 1202, Boston, Massachusetts
02110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youhua Li</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiping Jin</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuxin Liu</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wengen Wu</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Wu</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuhong Zhou</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James L. Sudmeier</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David G. Sanford</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, Tufts University Sackler School of Biomedical Sciences, 136 Harrison Avenue, Boston, Massachusetts 02111, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Arisaph Pharmaceuticals,
Inc., 100 High Street, Suite 1202, Boston, Massachusetts
02110, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d115e3406-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Arisaph Pharmaceuticals, Inc.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> Abbreviations Used</h2><tr><td class="NLM_term">FAP</td><td class="NLM_def"><p class="first last">fibroblast activation protein</p></td></tr><tr><td class="NLM_term">PREP</td><td class="NLM_def"><p class="first last">prolyl oligopeptidase</p></td></tr><tr><td class="NLM_term">DPPIV</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase IV</p></td></tr><tr><td class="NLM_term">DPPII</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase II</p></td></tr><tr><td class="NLM_term">DPP8</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase 8</p></td></tr><tr><td class="NLM_term">DPP9</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase 9</p></td></tr><tr><td class="NLM_term">GLP-1</td><td class="NLM_def"><p class="first last">glucagon-like peptide 1</p></td></tr><tr><td class="NLM_term">GIP</td><td class="NLM_def"><p class="first last">glucose-dependent insulinotropic peptide</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">inhibition constant</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">median inhibition concentration</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">7235</span><span class="NLM_x">–</span> <span class="NLM_lpage">7239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=7235-7239&author=P.+Garin-Chesaauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Cell+surface+glycoprotein+of+reactive+stromal+fibroblasts+as+a+potential+antibody+target+in+human+epithelial+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DCell%2520surface%2520glycoprotein%2520of%2520reactive%2520stromal%2520fibroblasts%2520as%2520a%2520potential%2520antibody%2520target%2520in%2520human%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1990%26volume%3D87%26spage%3D7235%26epage%3D7239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozer, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albino, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span> </span><span class="NLM_article-title">Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3327</span><span class="NLM_x">–</span> <span class="NLM_lpage">3335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=3327-3335&author=W.+J.+Rettigauthor=P.+Garin-Chesaauthor=J.+H.+Healeyauthor=S.+L.+Suauthor=H.+L.+Ozerauthor=M.+Schwabauthor=A.+P.+Albinoauthor=L.+J.+Old&title=Regulation+and+heteromeric+structure+of+the+fibroblast+activation+protein+in+normal+and+transformed+cells+of+mesenchymal+and+neuroectodermal+origin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DSu%26aufirst%3DS.%2BL.%26aulast%3DOzer%26aufirst%3DH.%2BL.%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DAlbino%26aufirst%3DA.%2BP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26atitle%3DRegulation%2520and%2520heteromeric%2520structure%2520of%2520the%2520fibroblast%2520activation%2520protein%2520in%2520normal%2520and%2520transformed%2520cells%2520of%2520mesenchymal%2520and%2520neuroectodermal%2520origin%26jtitle%3DCancer%2520Res.%26date%3D1993%26volume%3D53%26spage%3D3327%26epage%3D3335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortunato, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanlan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: purification, epitope mapping and induction by growth factors</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1002%2Fijc.2910580314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=7519584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1994&pages=385-392&author=W.+J.+Rettigauthor=S.+L.+Suauthor=S.+R.+Fortunatoauthor=M.+J.+Scanlanauthor=B.+K.+Rajauthor=P.+Garin-Chesaauthor=J.+H.+Healeyauthor=L.+J.+Old&title=Fibroblast+activation+protein%3A+purification%2C+epitope+mapping+and+induction+by+growth+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein: purification, epitope mapping and induction by growth factors</span></div><div class="casAuthors">Rettig, Wolfgang J.; Su, Sai L.; Fortunato, Sheila R.; Scanlan, Matthew J.; Raj, B. K. Mohan; Garin-Chesa, Pilar; Healey, John H.; Old, Lloyd J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">385-92</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The human fibroblast activation protein (FAP) defined by monoclonal antibody (MAb) F19 is a cell surface antigen expressed in reactive stromal fibroblasts of breast, colorectal, lung and other epithelial cancers.  In contrast to its stroma-specific localization in epithelial neoplasms, FAP is expressed in the malignant mesenchymal cells of bone and soft tissue sarcomas.  FAP is transiently expressed in some fetal mesenchymal tissues but is absent or expressed at low levels in most adult tissues.  FAP is induced in cultured fibroblasts and, in these cells, consists of a Mr 95,000 subunit (FAPα) carrying the F19 epitope and a noncovalently bound Mr 105,000 subunit (FAPβ) lacking the F19 epitope.  Using MAb F19 and 5 newly derived MAbs, the authors identify 3 distinct epitopes on FAPα and tentatively assign one epitope to FAPβ.  Anal. of detergent exts. of a FAPαhighβ- sarcoma cell line by size exclusion-high performance liq. chromatog. (HPLC) revealed that FAPα does not elute as a Mr 95,000 species but as part of a high-mol. wt. complex (Mr > 400,000) that dissocs. into Mr 95,000 subunits in SDS gels.  Immunoaffinity purifn. of FAPα followed by tryptic digestion, reversed-phase HPLC and microsequencing identified 3 unique FAPα peptides, with 2 showing sequence similarity (23/38 identical amino acids) to segments of CD26, a T-cell activation antigen.  CD26 is a membrane-bound enzyme (dipeptidyl aminopeptidase IV), but immunopurified FAPα has little if any dipeptidase activity with typical CD26 substrates.  Finally, studies with FAPlow leptomeningeal fibroblasts revealed that transforming growth factor-β, 12-O-tetradecanoylphorbol-13-acetate and retinoids can upregulate FAP expression, whereas serum and several other factors had no or little effect on FAP levels.  FAP and CD26 may belong to a family of structurally related but functionally distinct activation proteins that are expressed on different cell types and show unique modes of regulation in normal and malignant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhaRLD8KLeb7Vg90H21EOLACvtfcHk0lhsDW2pAZYQwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKgtL8%253D&md5=06ccffd843a71e7ea2047ea775451a14</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910580314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910580314%26sid%3Dliteratum%253Aachs%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DSu%26aufirst%3DS.%2BL.%26aulast%3DFortunato%26aufirst%3DS.%2BR.%26aulast%3DScanlan%26aufirst%3DM.%2BJ.%26aulast%3DRaj%26aufirst%3DB.%2BK.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520purification%252C%2520epitope%2520mapping%2520and%2520induction%2520by%2520growth%2520factors%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1994%26volume%3D58%26spage%3D385%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">36505</span><span class="NLM_x">–</span> <span class="NLM_lpage">36512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=36505-36512&author=J.+E.+Parkauthor=M.+C.+Lenterauthor=R.+N.+Zimmermannauthor=P.+Garin-Chesaauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Fibroblast+activation+protein%2C+a+dual+specificity+serine+protease+expressed+in+reactive+human+tumor+stromal+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DLenter%26aufirst%3DM.%2BC.%26aulast%3DZimmermann%26aufirst%3DR.%2BN.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DFibroblast%2520activation%2520protein%252C%2520a%2520dual%2520specificity%2520serine%2520protease%2520expressed%2520in%2520reactive%2520human%2520tumor%2520stromal%2520fibroblasts%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D36505%26epage%3D36512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Connolly, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanford, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiluwal, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healey, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimare, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maw, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudmeier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span> </span><span class="NLM_article-title">Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6005</span><span class="NLM_x">–</span> <span class="NLM_lpage">6013</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800390n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6005-6013&author=B.+A.+Connollyauthor=D.+G.+Sanfordauthor=A.+K.+Chiluwalauthor=S.+E.+Healeyauthor=D.+E.+Petersauthor=M.+T.+Dimareauthor=W.+Wuauthor=Y.+Liuauthor=H.+Mawauthor=Y.+Zhouauthor=Y.+Liauthor=Z.+Jinauthor=J.+L.+Sudmeierauthor=J.+H.+Laiauthor=W.+W.+Bachovchin&title=Dipeptide+boronic+acid+inhibitors+of+dipeptidyl+peptidase+IV%3A+determinants+of+potency+and+in+vivo+efficacy+and+safety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm800390n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800390n%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DB.%2BA.%26aulast%3DSanford%26aufirst%3DD.%2BG.%26aulast%3DChiluwal%26aufirst%3DA.%2BK.%26aulast%3DHealey%26aufirst%3DS.%2BE.%26aulast%3DPeters%26aufirst%3DD.%2BE.%26aulast%3DDimare%26aufirst%3DM.%2BT.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMaw%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DSudmeier%26aufirst%3DJ.%2BL.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DDipeptide%2520boronic%2520acid%2520inhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV%253A%2520determinants%2520of%2520potency%2520and%2520in%2520vivo%2520efficacy%2520and%2520safety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6005%26epage%3D6013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Maes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilany, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpé, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span> </span><span class="NLM_article-title">Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivitives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2005&pages=315-324&author=M.+Maesauthor=A.+Lambeirauthor=K.+Gilanyauthor=K.+Sentenauthor=P.+Van+der+Vekenauthor=B.+Leitingauthor=K.+Augustynsauthor=S.+Scharp%C3%A9author=I.+De+Meester&title=Kinetic+investigation+of+human+dipeptidyl+peptidase+II+%28DPPII%29-mediated+hydrolysis+of+dipeptide+derivitives+and+its+identification+as+quiescent+cell+proline+dipeptidase+%28QPP%29%2Fdipeptidyl+peptidase+7+%28DPP7%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaes%26aufirst%3DM.%26aulast%3DLambeir%26aufirst%3DA.%26aulast%3DGilany%26aufirst%3DK.%26aulast%3DSenten%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DScharp%25C3%25A9%26aufirst%3DS.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DKinetic%2520investigation%2520of%2520human%2520dipeptidyl%2520peptidase%2520II%2520%2528DPPII%2529-mediated%2520hydrolysis%2520of%2520dipeptide%2520derivitives%2520and%2520its%2520identification%2520as%2520quiescent%2520cell%2520proline%2520dipeptidase%2520%2528QPP%2529%252Fdipeptidyl%2520peptidase%25207%2520%2528DPP7%2529%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D386%26spage%3D315%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Yoshimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R.</span><span> </span><span class="NLM_article-title">Post-proline cleaving enzyme and post-proline dipeptidyl aminopeptidase. Comparison of two peptidases with high specificity for proline residues</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">3708</span><span class="NLM_x">–</span> <span class="NLM_lpage">3716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1978&pages=3708-3716&author=T.+Yoshimotoauthor=M.+Fischlauthor=R.+C.+Orlowskiauthor=R.+Walter&title=Post-proline+cleaving+enzyme+and+post-proline+dipeptidyl+aminopeptidase.+Comparison+of+two+peptidases+with+high+specificity+for+proline+residues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimoto%26aufirst%3DT.%26aulast%3DFischl%26aufirst%3DM.%26aulast%3DOrlowski%26aufirst%3DR.%2BC.%26aulast%3DWalter%26aufirst%3DR.%26atitle%3DPost-proline%2520cleaving%2520enzyme%2520and%2520post-proline%2520dipeptidyl%2520aminopeptidase.%2520Comparison%2520of%2520two%2520peptidases%2520with%2520high%2520specificity%2520for%2520proline%2520residues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1978%26volume%3D253%26spage%3D3708%26epage%3D3716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Levy, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodeling interface in human cirrhosis</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1768</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1999&pages=1768-1778&author=M.+T.+Levyauthor=G.+W.+McCaughanauthor=C.+A.+Abbottauthor=J.+E.+Parkauthor=A.+M.+Cunninghamauthor=E.+Mullerauthor=W.+J.+Rettigauthor=M.+D.+Gorrell&title=Fibroblast+activation+protein%3A+a+cell+surface+dipeptidyl+peptidase+and+gelatinase+expressed+by+stellate+cells+at+the+tissue+remodeling+interface+in+human+cirrhosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DM.%2BT.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DCunningham%26aufirst%3DA.%2BM.%26aulast%3DMuller%26aufirst%3DE.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520a%2520cell%2520surface%2520dipeptidyl%2520peptidase%2520and%2520gelatinase%2520expressed%2520by%2520stellate%2520cells%2520at%2520the%2520tissue%2520remodeling%2520interface%2520in%2520human%2520cirrhosis%26jtitle%3DHepatology%26date%3D1999%26volume%3D29%26spage%3D1768%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Vanhoof, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendriks, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpé, S.</span><span> </span><span class="NLM_article-title">Proline motifs in peptides and their biological processing</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1096%2Ffasebj.9.9.7601338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=7601338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADyaK2MXmvFCltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=736-744&author=G.+Vanhoofauthor=F.+Goossensauthor=I.+De+Meesterauthor=D.+Hendriksauthor=S.+Scharp%C3%A9&title=Proline+motifs+in+peptides+and+their+biological+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proline motifs in peptides and their biological processing</span></div><div class="casAuthors">Vanhoof, Greet; Goossens, Filip; De Meester, Ingrid; Hendriks, Dirk; Scharpe, Simon</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">736-44</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review, with 68 refs.  Many biol. important peptide sequences contain proline.  It confers unique conformational constraints on the peptide chain in that the side-chain is cyclized back onto the backbone amide position.  Inside an α-helix the possibility of making hydrogen bonds to the preceding turn is lost and a kink will be introduced.  The conformational restrictions imposed by proline motifs in a peptide chain appear to imply important structural or biol. functions as can be deduced from their often remarkably high degree of conservation as found in many proteins and peptides, esp. cytokines, growth factors, G-protein-coupled receptors, V3 loops of the HIV envelope glycoprotein gp120, and neuro- and vasoactive peptides.  Only a limited no. of peptidases are known to be able to hydrolyze proline adjacent bonds.  Their activity is influenced by the isomeric state (cis-trans) as well as the position of proline in the peptide chain.  The three proline specific metallo-peptidases (aminopeptidase P, carboxypeptidase P and prolidase) are activated by Mn2+, whereas the three serine type peptidases cleaving a post proline bond (prolyl oligopeptidase, dipeptidyl peptidase IV, and prolylcarboxypeptidase) share the sequential order of the catalytic Ser-Asp-His triad, which differentiates them from the chymotrypsin (His-Asp-Ser) and subtilisin (Asp-His-Ser) families.  An endo or C terminal Pro-Pro bond and an endo pre-Pro peptide bond possess a high degree of resistance to any mammalian proteolytic enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz_jJTdKPvebVg90H21EOLACvtfcHk0lhXK3YMrWG5NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvFCltbo%253D&md5=c7f0cca49b831f369a7cc252ffe75d5f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.9.9.7601338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.9.9.7601338%26sid%3Dliteratum%253Aachs%26aulast%3DVanhoof%26aufirst%3DG.%26aulast%3DGoossens%26aufirst%3DF.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DHendriks%26aufirst%3DD.%26aulast%3DScharp%25C3%25A9%26aufirst%3DS.%26atitle%3DProline%2520motifs%2520in%2520peptides%2520and%2520their%2520biological%2520processing%26jtitle%3DFASEB%2520J.%26date%3D1995%26volume%3D9%26spage%3D736%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Mentlein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallwitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, W. E.</span><span> </span><span class="NLM_article-title">Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">214</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1111%2Fj.1432-1033.1993.tb17986.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=8100523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADyaK3sXks1elsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1993&pages=829-835&author=R.+Mentleinauthor=B.+Gallwitzauthor=W.+E.+Schmidt&title=Dipeptidyl-peptidase+IV+hydrolyses+gastric+inhibitory+polypeptide%2C+glucagon-like+peptide-1%287-36%29amide%2C+peptide+histidine+methionine+and+is+responsible+for+their+degradation+in+human+serum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl-peptidase IV hydrolyzes gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum</span></div><div class="casAuthors">Mentlein, Rolf; Gallwitz, Baptist; Schmidt, Wolfgang E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">829-35</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Peptides of the glucagon/VIP family share a considerable sequence similarity at their N-terminus.  They either start with Tyr-Ala, His-Ala or His-Ser which might be in part potential targets for dipeptidyl-peptidase IV, a highly specialized aminopeptidase removing dipeptides only from peptides with N-terminal penultimate proline or alanine.  GH-releasing factor(1-29)amide and gastric inhibitory peptide/glucose-dependent insulinotropic peptide (GIP) with terminal Tyr-Ala as well as glucagon-like peptide-1(7-36)amide/insulinotropin [GLP-1(7-36)amide] and peptide histidine methionine (PHM) with terminal His-Ala were hydrolyzed to their des-Xaa-Ala derivs. by dipeptidyl-peptidase IV purified from human placenta.  VIP with terminal His-Ser was not degraded by the peptidase.  The kinetics of the hydrolysis of GIP, GLP-1(7-36)amide and PHM were analyzed in detail.  For these peptides Km values of 4-34 μM and Vmax values of 0.6-3.8 μmol/min/mg protein were detd. for the purified peptidase which should allow their enzymic degrdn. also at physiol., nanomolar concns.  When human serum was incubated with GIP or GLP-1(7-36)amide the same fragments as with the purified dipeptidyl-peptidase IV, namely the des-Xaa-Ala peptides and Tyr-Ala in the case of GIP or His-Ala in the case of GLP-1(7-36)amide, were identified as the main degrdn. products of these peptide hormones.  Incorporation of inhibitors specific for dipeptidyl-peptidase IV, 1 mM Lys-pyrrolidide or 0.1 mM diprotin A (Ile-Pro-Ile), completely abolished the prodn. of these fragments by serum.  It is concluded that dipeptidyl-peptidase IV initiates the metab. of GIP and GLP-1(7-36)amide in human serum.  Since an intact N-terminus is obligate for the biol. activity of the members of the glucagon/VIP peptide family [e.g., GIP(3-42) is known to be inactive to release insulin in the presence of glucose as is intact GIP], dipeptidyl-peptidase-IV action inactivates these peptide hormones.  The relevance of this finding for their inactivation and their detn. by immunoassays is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaIzMbUUoh9LVg90H21EOLACvtfcHk0lidSyuqKNKBag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1elsLs%253D&md5=dd06411585d4e8bb42d5b093e895b900</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1993.tb17986.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1993.tb17986.x%26sid%3Dliteratum%253Aachs%26aulast%3DMentlein%26aufirst%3DR.%26aulast%3DGallwitz%26aufirst%3DB.%26aulast%3DSchmidt%26aufirst%3DW.%2BE.%26atitle%3DDipeptidyl-peptidase%2520IV%2520hydrolyses%2520gastric%2520inhibitory%2520polypeptide%252C%2520glucagon-like%2520peptide-1%25287-36%2529amide%252C%2520peptide%2520histidine%2520methionine%2520and%2520is%2520responsible%2520for%2520their%2520degradation%2520in%2520human%2520serum%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1993%26volume%3D214%26spage%3D829%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kieffer, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pederson, R. A.</span><span> </span><span class="NLM_article-title">Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">3585</span><span class="NLM_x">–</span> <span class="NLM_lpage">3596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1995&pages=3585-3596&author=T.+J.+Kiefferauthor=C.+H.+McIntoshauthor=R.+A.+Pederson&title=Degradation+of+glucose-dependent+insulinotropic+polypeptide+and+truncated+glucagon-like+peptide+1+in+vitro+and+in+vivo+by+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKieffer%26aufirst%3DT.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DC.%2BH.%26aulast%3DPederson%26aufirst%3DR.%2BA.%26atitle%3DDegradation%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide%2520and%2520truncated%2520glucagon-like%2520peptide%25201%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DEndocrinology%26date%3D1995%26volume%3D136%26spage%3D3585%26epage%3D3596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Choy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, S.</span><span> </span><span class="NLM_article-title">Sitagliptin: a novel drug for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Cardiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">264</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1097%2FCRD.0b013e318123f771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=17700385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A280%3ADC%252BD2svovFensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=264-271&author=M.+Choyauthor=S.+Lam&title=Sitagliptin%3A+a+novel+drug+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Sitagliptin: a novel drug for the treatment of type 2 diabetes</span></div><div class="casAuthors">Choy Mary; Lam Sum</div><div class="citationInfo"><span class="NLM_cas:title">Cardiology in review</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">264-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Type 2 diabetes mellitus is a common chronic disease that causes significant morbidity and mortality worldwide.  The primary goal of treatment is to target glycemic control by maintaining the glycosylated hemoglobin level near 6-7% without predisposing patients to hypoglycemia.  Diabetes results from a combination of increased hepatic glucose production, decreased insulin secretion from beta cells, and insulin resistance in the peripheral tissues.  Currently available antidiabetic agents work by different mechanisms to lower blood glucose levels.  Unfortunately, each of them has its tolerability and safety concerns that limit its use and dose titration.  Sitagliptin is the first antidiabetic agent from the class of dipeptidyl peptidase-4 enzyme inhibitors.  It increases the amount of circulating incretins, which stimulate insulin secretion and inhibit glucose production.  Sitagliptin was approved by the US Food and Drug Administration (FDA) for use with diet and exercise to improve glycemic control in adult patients with type 2 diabetes.  It can be used alone or in combination with metformin or a thiazolidinedione (pioglitazone or rosiglitazone) when treatment with either drug alone provides inadequate glucose control.  The usual adult dose is 100 mg once daily.  A dose of 25-50 mg once daily is recommended for patients with moderate-to-severe renal impairment.  In randomized, placebo-controlled trials that lasted for up to 6 months, sitagliptin lowered glycosylated hemoglobin levels by 0.5-0.8%.  In a 52-week clinical trial, sitagliptin was shown to be noninferior to glipizide as an add-on agent in patients inadequately controlled on metformin alone.  Sitagliptin was well tolerated with the most common side effects being gastrointestinal complaints (up to 16%), including abdominal pain, nausea and diarrhea; hypoglycemia and body weight gain occurred at similar rates compared with placebo.  Overall, sitagliptin provides a treatment option for patients with type 2 diabetes as a monotherapy, or as an adjunct to metformin or a thiazolidinedione when patients achieve inadequate glycemic control while on either of the agents.  It is also an alternative therapy for those patients who have contraindications or intolerability to other antidiabetic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQE6VB-Pf2cTq91pGlMMoT5fW6udTcc2ea4m8cKFszHwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svovFensw%253D%253D&md5=f4f20ba2241dacf7e55c26d3c5cec66c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1097%2FCRD.0b013e318123f771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCRD.0b013e318123f771%26sid%3Dliteratum%253Aachs%26aulast%3DChoy%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DS.%26atitle%3DSitagliptin%253A%2520a%2520novel%2520drug%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DCardiol.%2520Rev.%26date%3D2007%26volume%3D15%26spage%3D264%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbrack, R. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valianou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogatko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alpaugh, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span> </span><span class="NLM_article-title">Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4767</span><span class="NLM_x">–</span> <span class="NLM_lpage">4772</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4767-4772&author=J.+D.+Chengauthor=R.+L.+Dunbrackauthor=M.+Valianouauthor=A.+Rogatkoauthor=R.+K.+Alpaughauthor=L.+M.+Weiner&title=Promotion+of+tumor+growth+by+murine+fibroblast+activation+protein%2C+a+serine+protease%2C+in+an+animal+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DDunbrack%26aufirst%3DR.%2BL.%26aulast%3DValianou%26aufirst%3DM.%26aulast%3DRogatko%26aufirst%3DA.%26aulast%3DAlpaugh%26aufirst%3DR.%2BK.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26atitle%3DPromotion%2520of%2520tumor%2520growth%2520by%2520murine%2520fibroblast%2520activation%2520protein%252C%2520a%2520serine%2520protease%252C%2520in%2520an%2520animal%2520model%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4767%26epage%3D4772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Scott, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiseman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divgi, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gansen, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanswell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bette, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amelsberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlock, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span> </span><span class="NLM_article-title">A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1639</span><span class="NLM_x">–</span> <span class="NLM_lpage">1647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=12738716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFeisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1639-1647&author=A.+M.+Scottauthor=G.+Wisemanauthor=S.+Weltauthor=A.+Adjeiauthor=F.+T.+Leeauthor=W.+Hopkinsauthor=C.+R.+Divgiauthor=L.+H.+Hansonauthor=P.+Mitchellauthor=D.+N.+Gansenauthor=S.+M.+Larsonauthor=J.+N.+Ingleauthor=E.+W.+Hoffmanauthor=P.+Tanswellauthor=G.+Ritterauthor=L.+S.+Cohenauthor=P.+Betteauthor=L.+Arvayauthor=A.+Amelsbergauthor=D.+Vlockauthor=W.+J.+Rettigauthor=L.+J.+Old&title=A+phase+I+dose-escalation+study+of+sibrotuzumab+in+patients+with+advanced+or+metastatic+fibroblast+activation+protein-positive+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer</span></div><div class="casAuthors">Scott, Andrew M.; Wiseman, Greg; Welt, Sydney; Adjei, Alex; Lee, Fook-Thean; Hopkins, Wendie; Divgi, Chaitan R.; Hanson, Lorelei H.; Mitchell, Paul; Gansen, Denise N.; Larson, Steven M.; Ingle, James N.; Hoffman, Eric W.; Tanswell, Paul; Ritter, Gerd; Cohen, Leonard S.; Bette, Peter; Arvay, Lisa; Amelsberg, Andree; Vlock, Dan; Rettig, Wolfgang J.; Old, Lloyd J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1639-1647</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The purpose of this research was to det. the safety, immunogenicity, pharmacokinetics, biodistribution, and tumor uptake of repeat infusions of a complementarity-detg. region grafted humanized antibody (sibrotuzumab) directed against human fibroblast activation protein (FAP).  Exptl. Design: A Phase I open-label dose escalation study was conducted in patients with cancers epidemiol. known to be FAP pos.  Patients were entered into one of four dosage tiers of 5, 10, 25, or 50 mg/m2 sibrotuzumab, administered weekly for 12 wk, with trace labeling with 8-10 mCi of 131I in weeks 1, 5, and 9.  RESULTS: A total of 26 patients were entered into the trial (15 males and 11 females; mean age, 59.9 yr; age range, 41-81 yr).  Twenty patients had colorectal carcinoma, and 6 patients had non-small cell lung cancer.  A total of 218 infusions of sibrotuzumab were administered during the first 12 wk of the study, with 24 patients being evaluable.  One patient received an addnl. 96 infusions on continued-use phase for a total of 108 infusions over a 2-yr period, and 1 patient received an addnl. 6 infusions on continued use.  There were no objective tumor responses.  Only one episode of dose-limiting toxicity was obsd.  Therefore, a max. tolerated dose was not reached.  Treatment-related adverse events were obsd. in 6 patients during the infusional monitoring period.  Four of the 6 patients, 3 of whom had assocd. pos. serum human antihuman antibody, were removed from the study because of clin. immune responses.  Gamma camera images of [131I]sibrotuzumab demonstrated no normal organ uptake of sibrotuzumab, with tumor uptake evident within 24-48 h after infusion.  Anal. of pharmacokinetics demonstrated a similar mean terminal t1/2 of 1.4-2.6 days at the 5, 10, and 25 mg/m2 dose levels, and with a longer mean t1/2 of 4.9 days at the 50 mg/m2 dose level.  CONCLUSION: Repeat infusions of the humanized anti-FAP antibody sibrotuzumab can be administered safely to patients with advanced FAP-pos. cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCBq6WNJIOsrVg90H21EOLACvtfcHk0lidSyuqKNKBag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFeisbc%253D&md5=b0a39685070fb41ec2309ac5cc2027d8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DA.%2BM.%26aulast%3DWiseman%26aufirst%3DG.%26aulast%3DWelt%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DF.%2BT.%26aulast%3DHopkins%26aufirst%3DW.%26aulast%3DDivgi%26aufirst%3DC.%2BR.%26aulast%3DHanson%26aufirst%3DL.%2BH.%26aulast%3DMitchell%26aufirst%3DP.%26aulast%3DGansen%26aufirst%3DD.%2BN.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DIngle%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DE.%2BW.%26aulast%3DTanswell%26aufirst%3DP.%26aulast%3DRitter%26aufirst%3DG.%26aulast%3DCohen%26aufirst%3DL.%2BS.%26aulast%3DBette%26aufirst%3DP.%26aulast%3DArvay%26aufirst%3DL.%26aulast%3DAmelsberg%26aufirst%3DA.%26aulast%3DVlock%26aufirst%3DD.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26atitle%3DA%2520phase%2520I%2520dose-escalation%2520study%2520of%2520sibrotuzumab%2520in%2520patients%2520with%2520advanced%2520or%2520metastatic%2520fibroblast%2520activation%2520protein-positive%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D1639%26epage%3D1647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Puré, E.</span><span> </span><span class="NLM_article-title">The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1517%2F14728220903103841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=19606930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Sku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=967-973&author=E.+Pur%C3%A9&title=The+road+to+integrative+cancer+therapies%3A+emergence+of+a+tumor-associated+fibroblast+protease+as+a+potential+therapeutic+target+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer</span></div><div class="casAuthors">Pure, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">967-973</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Great inroads have been made in defining the oncogenic pathways intrinsic to neoplastic cells and the mechanisms by which they are activated in tumors.  Knowledge of these pathways provides numerous opportunities that are actively being pursued to develop targeted therapies for cancer.  Complementary studies, focused on the non-transformed components of the tumor microenvironment (TME), have revealed that the extrinsic cues provided by the TME are also essential for tumor cells to manifest a fully transformed phenotype, angiogenesis and metastasis.  Delineation of these cues and their underlying cellular and mol. pathways will thus lead to a new era of integrative cancer therapy based on combinatorial drug regiments that act synergistically to destroy the neoplastic cells by targeting both the intrinsic and extrinsic pro-oncogenic pathways.  Tumor-assocd. fibroblasts (TAFs) and proteases are two of the key regulators of epithelial-derived tumors that represent potential targets of such integrative therapies.  Herein, we consider the potential therapeutic benefit of inhibiting the function of fibroblast activation protein (FAP), a cell surface serine protease with dipeptidyl peptidase and endopeptidase activity that is expressed on TAFs and pericytes, in an integrative approach to treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppEDzBKqL3Y7Vg90H21EOLACvtfcHk0lh5iAKfN5dkmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Sku7w%253D&md5=ec455a687909d70185c196d879bd99bc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F14728220903103841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220903103841%26sid%3Dliteratum%253Aachs%26aulast%3DPur%25C3%25A9%26aufirst%3DE.%26atitle%3DThe%2520road%2520to%2520integrative%2520cancer%2520therapies%253A%2520emergence%2520of%2520a%2520tumor-associated%2520fibroblast%2520protease%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D967%26epage%3D973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Santos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aziz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissil, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puré, E.</span><span> </span><span class="NLM_article-title">Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3613</span><span class="NLM_x">–</span> <span class="NLM_lpage">3625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1172%2FJCI38988" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=19920354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCit7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=3613-3625&author=A.+M.+Santosauthor=J.+Jungauthor=N.+Azizauthor=J.+L.+Kissilauthor=E.+Pur%C3%A9&title=Targeting+fibroblast+activation+protein+inhibits+tumor+stromagenesis+and+growth+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice</span></div><div class="casAuthors">Santos, Angelica M.; Jung, Jason; Aziz, Nazneen; Kissil, Joseph L.; Pure, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3613-3625</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Membrane-bound proteases have recently emerged as crit. mediators of tumorigenesis, angiogenesis, and metastasis.  However, the mechanisms by which they regulate these processes remain unknown.  As the cell surface serine protease fibroblast activation protein (FAP) is selectively expressed on tumor-assocd. fibroblasts and pericytes in epithelial tumors, we set out to investigate the role of FAP in mouse models of epithelial-derived solid tumors.  In this study, we demonstrate that genetic deletion and pharmacol. inhibition of FAP inhibited tumor growth in both an endogenous mouse model of lung cancer driven by the K-rasG12D mutant and a mouse model of colon cancer, in which CT26 mouse colon cancer cells were transplanted into immune competent syngeneic mice.  Interestingly, growth of only the K-rasG12D-driven lung tumors was also attenuated by inhibition of the closely related protease dipeptidyl peptidase IV (DPPIV).  Our results indicate that FAP depletion inhibits tumor cell proliferation indirectly, increases accumulation of collagen, decreases myofibroblast content, and decreases blood vessel d. in tumors.  These data provide proof of principle that targeting stromal cell-mediated modifications of the tumor microenvironment may be an effective approach to treating epithelial-derived solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY1-xywXMGHrVg90H21EOLACvtfcHk0lh5iAKfN5dkmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCit7jK&md5=20f20b9dbbcbe1f72a06d37f6ee19cde</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1172%2FJCI38988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI38988%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DA.%2BM.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DAziz%26aufirst%3DN.%26aulast%3DKissil%26aufirst%3DJ.%2BL.%26aulast%3DPur%25C3%25A9%26aufirst%3DE.%26atitle%3DTargeting%2520fibroblast%2520activation%2520protein%2520inhibits%2520tumor%2520stromagenesis%2520and%2520growth%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D3613%26epage%3D3625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valianou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canutescu, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span> </span><span class="NLM_article-title">Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1158%2F1535-7163.MCT-05-0128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=15767544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Kgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=351-360&author=J.+D.+Chengauthor=M.+Valianouauthor=A.+A.+Canutescuauthor=E.+K.+Jaffeauthor=H.+O.+Leeauthor=H.+Wangauthor=J.+H.+Laiauthor=W.+W.+Bachovchinauthor=L.+M.+Weiner&title=Abrogation+of+fibroblast+activation+protein+enzymatic+activity+attenuates+tumor+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth</span></div><div class="casAuthors">Cheng, Jonathan D.; Valianou, Matthildi; Canutescu, Adrian A.; Jaffe, Eileen K.; Lee, Hyung-Ok; Wang, Hao; Lai, Jack H.; Bachovchin, William W.; Weiner, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">351-360</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tumor-assocd. fibroblasts are functionally and phenotypically distinct from normal fibroblasts that are not in the tumor microenvironment.  Fibroblast activation protein is a 95 kDa cell surface glycoprotein expressed by tumor stromal fibroblasts, and has been shown to have dipeptidyl peptidase and collagenase activity.  Site-directed mutagenesis at the catalytic site of fibroblast activation protein, Ser624 Ala624, resulted in an ∼100,000-fold loss of fibroblast activation protein dipeptidyl peptidase (DPP) activity.  HEK293 cells transfected with wild-type fibroblast activation protein, enzymic mutant (S624A) fibroblast activation protein, or vector alone, were inoculated s.c. into immunodeficient mouse to assess the contribution of fibroblast activation protein enzymic activity to tumor growth.  Overexpression of wild-type fibroblast activation protein showed growth potentiation and enhanced tumorigenicity compared with both fibroblast activation protein S624A and vector-transfected HEK293 xenografts.  HEK293 cells transfected with fibroblast activation protein S624A showed tumor growth rates and tumorigenicity potential similar only to vector-transfected HEK293.  In vivo assessment of fibroblast activation protein DPP activity of these tumors showed enhanced enzymic activity of wild-type fibroblast activation protein, with only baseline levels of fibroblast activation protein DPP activity in either fibroblast activation protein S624A or vector-only xenografts.  These results indicate that the enzymic activity of fibroblast activation protein is necessary for fibroblast activation protein-driven tumor growth in the HEK293 xenograft model system.  This establishes the proof-of-principle that the enzymic activity of fibroblast activation protein plays an important role in the promotion of tumor growth, and provides an attractive target for therapeutics designed to alter fibroblast activation protein-induced tumor growth by targeting its enzymic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJQ7ekEjT-O7Vg90H21EOLACvtfcHk0lh5iAKfN5dkmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Kgu7g%253D&md5=9ef5725b966bd47692ad130aecf56ba9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0128%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DValianou%26aufirst%3DM.%26aulast%3DCanutescu%26aufirst%3DA.%2BA.%26aulast%3DJaffe%26aufirst%3DE.%2BK.%26aulast%3DLee%26aufirst%3DH.%2BO.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26atitle%3DAbrogation%2520of%2520fibroblast%2520activation%2520protein%2520enzymatic%2520activity%2520attenuates%2520tumor%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D351%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kraman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambrough, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magiera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopinathan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fearon, D. T.</span><span> </span><span class="NLM_article-title">Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=827-830&author=M.+Kramanauthor=P.+J.+Bambroughauthor=J.+N.+Arnoldauthor=E.+W.+Robertsauthor=L.+Magieraauthor=J.+O.+Jonesauthor=A.+Gopinathanauthor=D.+A.+Tuvesonauthor=D.+T.+Fearon&title=Suppression+of+antitumor+immunity+by+stromal+cells+expressing+fibroblast+activation+protein-alpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKraman%26aufirst%3DM.%26aulast%3DBambrough%26aufirst%3DP.%2BJ.%26aulast%3DArnold%26aufirst%3DJ.%2BN.%26aulast%3DRoberts%26aufirst%3DE.%2BW.%26aulast%3DMagiera%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DJ.%2BO.%26aulast%3DGopinathan%26aufirst%3DA.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DFearon%26aufirst%3DD.%2BT.%26atitle%3DSuppression%2520of%2520antitumor%2520immunity%2520by%2520stromal%2520cells%2520expressing%2520fibroblast%2520activation%2520protein-alpha%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D827%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aziz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions</span> <span class="citation_source-journal">Clin. Exp. Metastasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">579</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1007%2Fs10585-011-9392-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=21604185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFCnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=567-579&author=Y.+Huangauthor=A.+E.+Simmsauthor=A.+Mazurauthor=S.+Wangauthor=N.+R.+Le%C3%B3nauthor=B.+Jonesauthor=N.+Azizauthor=T.+Kelly&title=Fibroblast+activation+protein-%CE%B1+promotes+tumor+growth+and+invasion+of+breast+cancer+cells+through+non-enzymatic+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions</span></div><div class="casAuthors">Huang, Yan; Simms, Avis E.; Mazur, Anna; Wang, Sophie; Leon, Noel R.; Jones, Barry; Aziz, Nazneen; Kelly, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Metastasis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">567-579</span>CODEN:
                <span class="NLM_cas:coden">CEXMD2</span>;
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Fibroblast activation protein-α (FAP) is a cell surface, serine protease of the post-prolyl peptidase family that is expressed in human breast cancer but not in normal tissues.  Previously, we showed that FAP expression increased tumor growth rates in a mouse model of human breast cancer.  Here the role of the proteolytic activities of FAP in promoting tumor growth, matrix degrdn. and invasion was investigated.  Mammary fat pads of female SCID mice were inoculated with breast cancer cells that express FAP and the mice treated with normal saline or Val-boroPro (talabostat); Glu-boroPro (PT-630); or 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine (LAF-237) that inhibit prolyl peptidases.  Other mice were injected with breast cancer cells expressing a catalytically inactive mutant of FAP and did not receive inhibitor treatment.  PT-630 and LAF-237 did not slow growth of tumors produced by any of the three cell lines expressing FAP.  Talabostat slightly decreased the growth rates of the FAP-expressing tumors but because PT-630 and LAF-237 did not, the growth retardation was likely not related to the inhibition of FAP or the related post-prolyl peptidase dipeptidyl peptidase IV.  Breast cancer cells expressing a catalytically inactive mutant of FAP (FAPS624A) also produced tumors that grew rapidly.  In vitro studies revealed that cells expressing wild type FAP or FAPS624A degrade extracellular matrix (ECM) more extensively, accumulate higher levels of matrix metalloproteinase-9 (MMP-9) in conditioned medium, are more invasive in type I collagen gels, and have altered signaling compared to control transfectants that do not express FAP and form slow growing tumors.  We conclude that the proteolytic activity of FAP participates in matrix degrdn., but other functions of the protein stimulate increased tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofYFS39K1wf7Vg90H21EOLACvtfcHk0lgCB719QfgWZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFCnurw%253D&md5=fe86072a63578490a9eadcacf0d979aa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs10585-011-9392-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10585-011-9392-x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSimms%26aufirst%3DA.%2BE.%26aulast%3DMazur%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLe%25C3%25B3n%26aufirst%3DN.%2BR.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DAziz%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DT.%26atitle%3DFibroblast%2520activation%2520protein-%25CE%25B1%2520promotes%2520tumor%2520growth%2520and%2520invasion%2520of%2520breast%2520cancer%2520cells%2520through%2520non-enzymatic%2520functions%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D2011%26volume%3D28%26spage%3D567%26epage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallner, B. P.</span><span> </span><span class="NLM_article-title">PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">5471</span><span class="NLM_x">–</span> <span class="NLM_lpage">5480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=5471-5480&author=S.+Adamsauthor=G.+T.+Millerauthor=M.+I.+Jessonauthor=T.+Watanabeauthor=B.+Jonesauthor=B.+P.+Wallner&title=PT-100%2C+a+small+molecule+dipeptidyl+peptidase+inhibitor%2C+has+potent+antitumor+effects+and+augments+antibody-mediated+cytotoxicity+via+a+novel+immune+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DG.%2BT.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DWallner%26aufirst%3DB.%2BP.%26atitle%3DPT-100%252C%2520a%2520small%2520molecule%2520dipeptidyl%2520peptidase%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520effects%2520and%2520augments%2520antibody-mediated%2520cytotoxicity%2520via%2520a%2520novel%2520immune%2520mechanism%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D5471%26epage%3D5480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Selective inhibition of fibroblast activation protein based on dipeptide substrate specificity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7437</span><span class="NLM_x">–</span> <span class="NLM_lpage">7444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7437-7444&author=C.+Y.+Edosadaauthor=C.+Quanauthor=C.+Wiesmannauthor=T.+Tranauthor=D.+Sutherlinauthor=M.+Reynoldsauthor=J.+M.+Elliottauthor=H.+Raabauthor=W.+Fairbrotherauthor=B.+B.+Wolf&title=Selective+inhibition+of+fibroblast+activation+protein+based+on+dipeptide+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DReynolds%26aufirst%3DM.%26aulast%3DElliott%26aufirst%3DJ.%2BM.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DFairbrother%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DSelective%2520inhibition%2520of%2520fibroblast%2520activation%2520protein%2520based%2520on%2520dipeptide%2520substrate%2520specificity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7437%26epage%3D7444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4 and POP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1438</span><span class="NLM_x">–</span> <span class="NLM_lpage">1442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1438-1442&author=T.+Tranauthor=C.+Quanauthor=C.+Y.+Edosadaauthor=M.+Mayedaauthor=C.+Wiesmannauthor=D.+Sutherlinauthor=B.+B.+Wolf&title=Synthesis+and+structure%E2%80%93activity+relationship+of+N-acyl-Gly-%2C+N-acyl-Sar-+and+N-blocked-boroPro+inhibitors+of+FAP%2C+DPP4+and+POP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DMayeda%26aufirst%3DM.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520N-acyl-Gly-%252C%2520N-acyl-Sar-%2520and%2520N-blocked-boroPro%2520inhibitors%2520of%2520FAP%252C%2520DPP4%2520and%2520POP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1438%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Tsai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiaang, W.</span><span> </span><span class="NLM_article-title">Substituted 4-caboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6572</span><span class="NLM_x">–</span> <span class="NLM_lpage">6583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1002556" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6572-6583&author=T.+Tsaiauthor=T.+Yehauthor=X.+Chenauthor=T.+Hsuauthor=Y.+Jaoauthor=C.+Huangauthor=J.+Songauthor=Y.+Huangauthor=C.+Chienauthor=J.+Chiuauthor=S.+Yenauthor=H.+Tangauthor=Y.+Chaoauthor=W.+Jiaang&title=Substituted+4-caboxymethylpyroglutamic+acid+diamides+as+potent+and+selective+inhibitors+of+fibroblast+activation+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm1002556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1002556%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DT.%26aulast%3DYeh%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DJao%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DChiu%26aufirst%3DJ.%26aulast%3DYen%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DChao%26aufirst%3DY.%26aulast%3DJiaang%26aufirst%3DW.%26atitle%3DSubstituted%25204-caboxymethylpyroglutamic%2520acid%2520diamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6572%26epage%3D6583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ryabtsova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issues of FAP/prolyl oligopeptidase (PREP)-selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3412</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3412-3417&author=O.+Ryabtsovaauthor=K.+Jansenauthor=S.+Van+Goethemauthor=J.+Joossensauthor=J.+D.+Chengauthor=A.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Acylated+Gly-%282-cyano%29pyrrolidines+as+inhibitors+of+fibroblast+activation+protein+%28FAP%29+and+the+issues+of+FAP%2Fprolyl+oligopeptidase+%28PREP%29-selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyabtsova%26aufirst%3DO.%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DLambeir%26aufirst%3DA.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DAcylated%2520Gly-%25282-cyano%2529pyrrolidines%2520as%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520and%2520the%2520issues%2520of%2520FAP%252Fprolyl%2520oligopeptidase%2520%2528PREP%2529-selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3412%26epage%3D3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=1397-1404&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=V.+J.+Christiansenauthor=C.+S.+Leeauthor=J.+G.+Chunauthor=P.+A.+McKee&title=Antiplasmin-cleaving+enzyme+is+a+soluble+form+of+fibroblast+activation+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DChun%26aufirst%3DJ.%2BG.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DAntiplasmin-cleaving%2520enzyme%2520is%2520a%2520soluble%2520form%2520of%2520fibroblast%2520activation%2520protein%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D1397%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Tenorio-Laranga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venäläinen, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Horsman, J. A.</span><span> </span><span class="NLM_article-title">Characterization of membrane-bound prolyl endopeptidase from brain</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">4415</span><span class="NLM_x">–</span> <span class="NLM_lpage">4427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2008&pages=4415-4427&author=J.+Tenorio-Larangaauthor=J.+I.+Ven%C3%A4l%C3%A4inenauthor=P.+T.+M%C3%A4nnist%C3%B6author=J.+A.+Garc%C3%ADa-Horsman&title=Characterization+of+membrane-bound+prolyl+endopeptidase+from+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTenorio-Laranga%26aufirst%3DJ.%26aulast%3DVen%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%2BI.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DGarc%25C3%25ADa-Horsman%26aufirst%3DJ.%2BA.%26atitle%3DCharacterization%2520of%2520membrane-bound%2520prolyl%2520endopeptidase%2520from%2520brain%26jtitle%3DFEBS%2520J.%26date%3D2008%26volume%3D275%26spage%3D4415%26epage%3D4427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Irazusta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrinaga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Maeso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meana, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casis, L.</span><span> </span><span class="NLM_article-title">Distribution of prolyl endopeptidase activities in rat and human brain</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1016%2FS0197-0186%2801%2900078-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=11792464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVOjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2002&pages=337-345&author=J.+Irazustaauthor=G.+Larrinagaauthor=J.+Gonz%C3%A1lez-Maesoauthor=J.+Gilauthor=J.+J.+Meanaauthor=L.+Casis&title=Distribution+of+prolyl+endopeptidase+activities+in+rat+and+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of prolyl endopeptidase activities in rat and human brain</span></div><div class="casAuthors">Irazusta, Jon; Larrinaga, Gorka; Gonzalez-Maeso, Javier; Gil, Javier; Meana, J. Javier; Casis, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-345</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Prolyl endopeptidase (I) is a proteolytic enzyme which could play a neuropeptide-catabolizing role in the central nervous system.  Although I has been described as a cytosolic enzyme, it has become clear that it can also be found in particulate form.  Here, the regional and subcellular distribution of I was evaluated in rat and human brain.  I activity was higher in the human than in the rat brain.  In the human brain, the activity levels of both sol. and particulate I were highest in the frontal, parietal, and occipital cortexes and lowest in the cerebellum.  In the rat brain, the regional distribution of I was more homogeneous.  I activity in all of the areas of the central nervous system was higher than in peripheral tissues.  The subcellular distribution of the enzyme in the brain indicated that I is higher in the cytosolic fraction than in the particulate fractions.  The particulate form was enriched in synaptosomal and myelin membranes.  The high activity of I in the human cortex suggests that it may play a role in the functions of this brain area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoULD-VZP08a7Vg90H21EOLACvtfcHk0ljDtRnzYSOhVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVOjtg%253D%253D&md5=36ade534063e5d762c2243f5c6572d6d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0197-0186%2801%2900078-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-0186%252801%252900078-X%26sid%3Dliteratum%253Aachs%26aulast%3DIrazusta%26aufirst%3DJ.%26aulast%3DLarrinaga%26aufirst%3DG.%26aulast%3DGonz%25C3%25A1lez-Maeso%26aufirst%3DJ.%26aulast%3DGil%26aufirst%3DJ.%26aulast%3DMeana%26aufirst%3DJ.%2BJ.%26aulast%3DCasis%26aufirst%3DL.%26atitle%3DDistribution%2520of%2520prolyl%2520endopeptidase%2520activities%2520in%2520rat%2520and%2520human%2520brain%26jtitle%3DNeurochem.%2520Int.%26date%3D2002%26volume%3D40%26spage%3D337%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Myöhänen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyykkö, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpen, O.</span><span> </span><span class="NLM_article-title">Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1369%2F0022155412453051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=22740343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A280%3ADC%252BC38jlsFSltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=706-715&author=T.+T.+My%C3%B6h%C3%A4nenauthor=E.+Pyykk%C3%B6author=P.+T.+M%C3%A4nnist%C3%B6author=O.+Carpen&title=Distribution+of+prolyl+oligopeptidase+in+human+peripheral+tissues+and+in+ovarian+and+colorectal+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors</span></div><div class="casAuthors">Myohanen Timo T; Pyykko Elisa; Mannisto Pekka T; Carpen Olli</div><div class="citationInfo"><span class="NLM_cas:title">The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">706-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Prolyl oligopeptidase (PREP) is a serine protease that hydrolyzes peptides shorter than 30-mer, and it has been connected with multiple physiological and pathological conditions.  PREP has been mostly studied in the brain, but significant PREP activities have been measured in peripheral tissues.  Moreover, increased PREP activities have been found in tumors.  In this study, the authors studied the immunohistochemical distribution of PREP protein in human peripheral tissues and in ovarian and colorectal tumors.  PREP was found to be widely distributed in human peripheral tissues and specifically in certain cells.  The most intense PREP expression was seen in the testis, ovaries, liver, and some parts of the skin.  At the cellular level, high PREP levels were seen as a rule in secreting epithelial cells and cells involved in reproduction.  Increased PREP expression was seen in most of the tumors studied.  PREP expression was higher in malignant than benign tumors, and in ovarian epithelial cancers, there was a trend for increased PREP staining with increased malignancy grade.  Results suggest that PREP may be associated with secretory processes as well as in reproduction.  A more abundant expression of PREP in malignant than benign tumors suggests that PREP may be associated with expansion and metastasis of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaIn2AZnomMEcLvDNbOD4DfW6udTcc2eY14FzqNAHOA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jlsFSltg%253D%253D&md5=39f1d2b6f803c150ca501148da7439ef</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1369%2F0022155412453051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252F0022155412453051%26sid%3Dliteratum%253Aachs%26aulast%3DMy%25C3%25B6h%25C3%25A4nen%26aufirst%3DT.%2BT.%26aulast%3DPyykk%25C3%25B6%26aufirst%3DE.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DCarpen%26aufirst%3DO.%26atitle%3DDistribution%2520of%2520prolyl%2520oligopeptidase%2520in%2520human%2520peripheral%2520tissues%2520and%2520in%2520ovarian%2520and%2520colorectal%2520tumors%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2012%26volume%3D60%26spage%3D706%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Targeting proteases: successes, failures and future prospects</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1038%2Fnrd2092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=16955069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=785-799&author=B.+Turk&title=Targeting+proteases%3A+successes%2C+failures+and+future+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting proteases: successes, failures and future prospects</span></div><div class="casAuthors">Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">785-799</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Until fairly recently, proteases were considered primarily to be protein-degrading enzymes.  However, this view has dramatically changed and proteases are now seen as extremely important signalling mols. that are involved in numerous vital processes.  Protease signalling pathways are strictly regulated, and the dysregulation of protease activity can lead to pathologies such as cardiovascular and inflammatory diseases, cancer, osteoporosis and neurol. disorders.  Several small-mol. drugs targeting proteases are already on the market and many more are in development.  The status of human protease research and prospects for future protease-targeted drugs are reviewed here, with ref. to some key examples where protease drugs have succeeded or failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa_X9u2oqlzrVg90H21EOLACvtfcHk0lh6z58XV20tfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltrs%253D&md5=00111ddbeafb283cbe88f7b0ee7bb404</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnrd2092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2092%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DTargeting%2520proteases%253A%2520successes%252C%2520failures%2520and%2520future%2520prospects%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D785%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DDrug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Strategies for discovering and derisking covalent, irreversible enzyme inhibitors</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">964</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.4155%2Ffmc.10.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=20640225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=949-964&author=D.+S.+Johnsonauthor=E.+Weerapanaauthor=B.+F.+Cravatt&title=Strategies+for+discovering+and+derisking+covalent%2C+irreversible+enzyme+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for discovering and derisking covalent, irreversible enzyme inhibitors</span></div><div class="casAuthors">Johnson, Douglas S.; Weerapana, Eranthie; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">949-964</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  This article presents several covalent inhibitors, including examples of successful drugs, as well as highly selective, irreversible inhibitors of emerging therapeutic targets, such as fatty acid amide hydolase.  Covalent inhibitors have many desirable features, including increased biochem. efficiency of target disruption, less sensitivity toward pharmacokinetic parameters and increased duration of action that outlasts the pharmacokinetics of the compd.  Safety concerns that must be mitigated include lack of specificity and the potential immunogenicity of protein-inhibitor adduct(s).  Particular attention will be given to recent technologies, such as activity-based protein profiling, which allow one to define the proteome-wide selectivity patterns for covalent inhibitors in vitro and in vivo.  For instance, any covalent inhibitor can, in principle, be modified with a 'clickable' tag to generate an activity probe that is almost indistinguishable from the original agent.  These probes can be applied to any living system across a broad dose range to fully inventory their on and off targets.  The substantial no. of drugs on the market today that act by a covalent mechanism belies historical prejudices against the development of irreversibly acting therapeutic small mols.  Emerging proteomic technologies offer a means to systematically discriminate safe (selective) vs. deleterious (nonselective) covalent inhibitors and thus should inspire their future design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqm0whEybB-LVg90H21EOLACvtfcHk0lhoX0N41xXLmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D&md5=07e1f89418b168798ae5c1a9fa43e9c1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.21%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStrategies%2520for%2520discovering%2520and%2520derisking%2520covalent%252C%2520irreversible%2520enzyme%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D949%26epage%3D964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Sanderson, P. E.</span><span> </span><span class="NLM_article-title">Small, noncovalent serine protease inhibitors</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1002%2F%28SICI%291098-1128%28199903%2919%3A2%3C179%3A%3AAID-MED4%3E3.0.CO%3B2-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=10189177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADyaK1MXhvF2htrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=179-197&author=P.+E.+Sanderson&title=Small%2C+noncovalent+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Small, noncovalent serine protease inhibitors</span></div><div class="casAuthors">Sanderson, Philip E. J.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-197</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 103 refs.  Thrombin and factor Xa (fXa) are the only serine proteases for which small, potent, selective, noncovalent inhibitors have been developed, which are ultimately intended as drug development candidates (in this case as anticoagulants).  Noncovalent inhibitors may be more selective and chem. and metabolically less reactive than covalent inhibitors.  In addn., noncovalent inhibitors are more likely to have fast-binding kinetics which is particularly important in the development of thrombin inhibitors.  TAME derived noncovalent thrombin inhibitors argatroban, napsagatran, and UK 156,406 have entered clin. trials as anticoagulants, the latter as an orally active agent.  Serine trap deletion from substrate-like peptides led to the development of inogatran and melagatran, both of which have entered clin. trials as i.v. agents.  The use of 3-aminopyridinone and pyrazinone acetamide peptidomimetic templates has resulted in the development of L-375,378 which has been chosen for clin. development as an orally active anticoagulant.  Recently, compds. which do not have the conventional hydrogen bonding capabilities of peptides have begun to appear in the thrombin literature.  Publications on noncovalent fXa inhibitors cover this type of peptidomimetic almost exclusively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1uE-zC5_v97Vg90H21EOLACvtfcHk0lhoX0N41xXLmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvF2htrw%253D&md5=b090ed0593d910f5fedeaae1d82e5634</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199903%2919%3A2%3C179%3A%3AAID-MED4%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199903%252919%253A2%253C179%253A%253AAID-MED4%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26atitle%3DSmall%252C%2520noncovalent%2520serine%2520protease%2520inhibitors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1999%26volume%3D19%26spage%3D179%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Bachovchin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">The pharmacological landscape and therapeutic potential of serine hydrolases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1038%2Fnrd3620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=22212679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=52-68&author=D.+A.+Bachovchinauthor=B.+F.+Cravatt&title=The+pharmacological+landscape+and+therapeutic+potential+of+serine+hydrolases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacological landscape and therapeutic potential of serine hydrolases</span></div><div class="casAuthors">Bachovchin, Daniel A.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-68</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Serine hydrolases perform crucial roles in many biol. processes, and several of these enzymes are targets of approved drugs for indications such as type 2 diabetes, Alzheimer's disease and infectious diseases.  Despite this, most of the human serine hydrolases (of which there are more than 200) remain poorly characterized with respect to their physiol. substrates and functions, and the vast majority lack selective, in vivo-active inhibitors.  Here, we review the current state of pharmacol. for mammalian serine hydrolases, including marketed drugs, compds. that are under clin. investigation and selective inhibitors emerging from academic probe development efforts.  We also highlight recent methodol. advances that have accelerated the rate of inhibitor discovery and optimization for serine hydrolases, which we anticipate will aid in their biol. characterization and, in some cases, therapeutic validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsWC4iV3Xc57Vg90H21EOLACvtfcHk0lhoX0N41xXLmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOktA%253D%253D&md5=4fde1e23117ad11848a9c2eef85376b7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrd3620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3620%26sid%3Dliteratum%253Aachs%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DThe%2520pharmacological%2520landscape%2520and%2520therapeutic%2520potential%2520of%2520serine%2520hydrolases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D52%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">580</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=580&publication_year=2006&pages=1581-1586&author=C.+Y.+Edosadaauthor=C.+Quanauthor=T.+Tranauthor=V.+Phamauthor=C.+Wiesmannauthor=W.+Fairbrotherauthor=B.+B.+Wolf&title=Peptide+substrate+profiling+defines+fibroblast+activation+protein+as+an+endopeptidase+of+strict+Gly%282%29-Pro%281%29-cleaving+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DPham%26aufirst%3DV.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DFairbrother%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DPeptide%2520substrate%2520profiling%2520defines%2520fibroblast%2520activation%2520protein%2520as%2520an%2520endopeptidase%2520of%2520strict%2520Gly%25282%2529-Pro%25281%2529-cleaving%2520specificity%26jtitle%3DFEBS%2520Lett.%26date%3D2006%26volume%3D580%26spage%3D1581%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Aggarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kole, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topaloglu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi701921b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1076-1086&author=S.+Aggarwalauthor=W.+N.+Brennenauthor=T.+P.+Koleauthor=E.+Schneiderauthor=O.+Topalogluauthor=M.+Yatesauthor=R.+J.+Cotterauthor=S.+R.+Denmeade&title=Fibroblast+activation+protein+peptide+substrates+identified+from+human+collagen+I+derived+gelatin+cleavage+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi701921b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi701921b%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DS.%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DKole%26aufirst%3DT.%2BP.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DTopaloglu%26aufirst%3DO.%26aulast%3DYates%26aufirst%3DM.%26aulast%3DCotter%26aufirst%3DR.%2BJ.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DFibroblast%2520activation%2520protein%2520peptide%2520substrates%2520identified%2520from%2520human%2520collagen%2520I%2520derived%2520gelatin%2520cleavage%2520sites%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D1076%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Wolf, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D.</span><span> </span><span class="NLM_article-title">On the edge of validation—cancer protease fibroblast activation protein</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=719-727&author=B.+B.+Wolfauthor=C.+Quanauthor=T.+Tranauthor=C.+Wiesmannauthor=D.+Sutherlin&title=On+the+edge+of+validation%E2%80%94cancer+protease+fibroblast+activation+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DB.%2BB.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DSutherlin%26aufirst%3DD.%26atitle%3DOn%2520the%2520edge%2520of%2520validation%25E2%2580%2594cancer%2520protease%2520fibroblast%2520activation%2520protein%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D719%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Fülöp, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böcskei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgár, L.</span><span> </span><span class="NLM_article-title">Prolyl oligopeptidase; an unusual beta-propeller domain regulates proteolysis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1998&pages=161-170&author=V.+F%C3%BCl%C3%B6pauthor=Z.+B%C3%B6cskeiauthor=L.+Polg%C3%A1r&title=Prolyl+oligopeptidase%3B+an+unusual+beta-propeller+domain+regulates+proteolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DV.%26aulast%3DB%25C3%25B6cskei%26aufirst%3DZ.%26aulast%3DPolg%25C3%25A1r%26aufirst%3DL.%26atitle%3DProlyl%2520oligopeptidase%253B%2520an%2520unusual%2520beta-propeller%2520domain%2520regulates%2520proteolysis%26jtitle%3DCell%26date%3D1998%26volume%3D94%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Wang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D. M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=935-945&author=X.+M.+Wangauthor=D.+M.+T.+Yuauthor=W.+McCaughanauthor=M.+D.+Gorrell&title=Fibroblast+activation+protein+increases+apoptosis%2C+cell+adhesion%2C+and+migration+by+the+LX-2+human+stellate+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BM.%26aulast%3DYu%26aufirst%3DD.%2BM.%2BT.%26aulast%3DMcCaughan%26aufirst%3DW.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DFibroblast%2520activation%2520protein%2520increases%2520apoptosis%252C%2520cell%2520adhesion%252C%2520and%2520migration%2520by%2520the%2520LX-2%2520human%2520stellate%2520cell%2520line%26jtitle%3DHepatology%26date%3D2005%26volume%3D42%26spage%3D935%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Sunwoo, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bancroft, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Waes, C.</span><span> </span><span class="NLM_article-title">Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κB cell survival, tumor growth, and angiogenesis in squamous cell carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=11350913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlels7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=1419-1428&author=J.+B.+Sunwooauthor=Z.+Chenauthor=G.+Dongauthor=N.+Yehauthor=C.+C.+Bancroftauthor=E.+Sausvilleauthor=J.+Adamsauthor=P.+Elliotauthor=C.+Van+Waes&title=Novel+proteasome+inhibitor+PS-341+inhibits+activation+of+nuclear+factor-%CE%BAB+cell+survival%2C+tumor+growth%2C+and+angiogenesis+in+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma</span></div><div class="casAuthors">Sunwoo, John B.; Chen, Zhong; Dong, Gang; Yeh, Ning; Bancroft, Caren Crowl; Sausville, Edward; Adams, Julian; Elliott, Peter; Van Waes, Carter</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1419-1428</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have shown that activation of nuclear factor-κB (NF-κB) promotes cell survival and expression of cytokines such as growth-regulated oncogene-α, which can modulate angiogenesis, growth, and metastasis of squamous cell carcinoma (SCC).  Activation of NF-κB and cytoprotective genes in cancer may result from signal-induced phosphorylation and proteasome-dependent degrdn. of inhibitor-κB.  In this study, we examd. the effects of the novel proteasome inhibitor PS-341 on activation of NF-κB and cell survival, growth, and angiogenesis in murine and human SCC cell lines.  PS-341 inhibited activation of NF-κB DNA binding and functional reporter activity at concns. between 10-8 and 10-7 M.  Cytotoxicity was obsd. at 10-7 M in four murine and two human SCC lines, and followed early cleavage of poly(ADP-ribose) polymerase, a marker of caspase-mediated apoptosis.  In vivo, PS-341 inhibited growth of murine and human SCC in mice at doses of 1-2 mg/kg given three times weekly, and dose-limiting toxicity was encountered at 2 mg/kg.  Tumor growth inhibition was assocd. with a marked decrease in vessel d.  PS-341 inhibited expression of the proangiogenic cytokines growth-regulated oncogene-α and vascular endothelial growth factor by SCC in the range at which PS-341 inhibits NF-κB.  We conclude that PS-341 inhibits activation of NF-κB pathway components related to cell survival, tumor growth, and angiogenesis in SCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEXkVYUm_8OrVg90H21EOLACvtfcHk0lju0enykd_GWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlels7k%253D&md5=f7299b6521b3d0a02437158154f52e89</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSunwoo%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DYeh%26aufirst%3DN.%26aulast%3DBancroft%26aufirst%3DC.%2BC.%26aulast%3DSausville%26aufirst%3DE.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DElliot%26aufirst%3DP.%26aulast%3DVan%2BWaes%26aufirst%3DC.%26atitle%3DNovel%2520proteasome%2520inhibitor%2520PS-341%2520inhibits%2520activation%2520of%2520nuclear%2520factor-%25CE%25BAB%2520cell%2520survival%252C%2520tumor%2520growth%252C%2520and%2520angiogenesis%2520in%2520squamous%2520cell%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D1419%26epage%3D1428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Coutts, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krolikowski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ksiazek, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2087</span><span class="NLM_x">–</span> <span class="NLM_lpage">2094</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950732f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=2087-2094&author=S.+J.+Couttsauthor=T.+A.+Kellyauthor=R.+J.+Snowauthor=C.+A.+Kennedyauthor=R.+W.+Bartonauthor=J.+Adamsauthor=D.+A.+Krolikowskiauthor=D.+M.+Freemanauthor=S.+J.+Campbellauthor=J.+F.+Ksiazekauthor=W.+W.+Bachovchin&title=Structure%E2%80%93activity+relationships+of+boronic+acid+inhibitors+of+dipeptidyl+peptidase+IV.+1.+Variation+of+the+P2+position+of+Xaa-boroPro+dipeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm950732f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950732f%26sid%3Dliteratum%253Aachs%26aulast%3DCoutts%26aufirst%3DS.%2BJ.%26aulast%3DKelly%26aufirst%3DT.%2BA.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DKennedy%26aufirst%3DC.%2BA.%26aulast%3DBarton%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DKrolikowski%26aufirst%3DD.%2BA.%26aulast%3DFreeman%26aufirst%3DD.%2BM.%26aulast%3DCampbell%26aufirst%3DS.%2BJ.%26aulast%3DKsiazek%26aufirst%3DJ.%2BF.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520boronic%2520acid%2520inhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV.%25201.%2520Variation%2520of%2520the%2520P2%2520position%2520of%2520Xaa-boroPro%2520dipeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D2087%26epage%3D2094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Milo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maw, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poplawski, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanford, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudmeier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span> </span><span class="NLM_article-title">Chemical and biological evaluation of dipeptidyl boronic acid proteasome inhibitors for use in prodrugs and pro-soft drugs targeting solid tumors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4365</span><span class="NLM_x">–</span> <span class="NLM_lpage">4377</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200460q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4365-4377&author=L.+J.+Miloauthor=J.+H.+Laiauthor=W.+Wuauthor=Y.+Liuauthor=H.+Mawauthor=Y.+Liauthor=Z.+Jinauthor=Y.+Shuauthor=S.+E.+Poplawskiauthor=Y.+Wuauthor=D.+G.+Sanfordauthor=J.+L.+Sudmeierauthor=W.+W.+Bachovchin&title=Chemical+and+biological+evaluation+of+dipeptidyl+boronic+acid+proteasome+inhibitors+for+use+in+prodrugs+and+pro-soft+drugs+targeting+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm200460q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200460q%26sid%3Dliteratum%253Aachs%26aulast%3DMilo%26aufirst%3DL.%2BJ.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMaw%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DPoplawski%26aufirst%3DS.%2BE.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSanford%26aufirst%3DD.%2BG.%26aulast%3DSudmeier%26aufirst%3DJ.%2BL.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DChemical%2520and%2520biological%2520evaluation%2520of%2520dipeptidyl%2520boronic%2520acid%2520proteasome%2520inhibitors%2520for%2520use%2520in%2520prodrugs%2520and%2520pro-soft%2520drugs%2520targeting%2520solid%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4365%26epage%3D4377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Poplawski, S. E.; Li, Y.; Shu, Y.; Zhang, M.; DiMare, M. T.; Sanford, D. G.; Lai, J. H.; Cheng, J. D.; Gorrell, M. D.; Bachovchin, W. W.</span> Unpublished data.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Poplawski%2C+S.+E.%3B+Li%2C+Y.%3B+Shu%2C+Y.%3B+Zhang%2C+M.%3B+DiMare%2C+M.+T.%3B+Sanford%2C+D.+G.%3B+Lai%2C+J.+H.%3B+Cheng%2C+J.+D.%3B+Gorrell%2C+M.+D.%3B+Bachovchin%2C+W.+W.+Unpublished+data."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPoplawski%26aufirst%3DS.%2BE." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 47 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yibo Zhou, Keyi Yin, Hao Dong, Sheng Yang, JunBin Li, Jinqiu Luo, Yi Li, <span class="NLM_string-name hlFld-ContribAuthor">Ronghua Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Long-Lasting Bioluminescence Imaging of the Fibroblast Activation Protein by an Amphiphilic Block Copolymer-Based Probe. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2021,</strong> <em>93 </em>
                                    (8)
                                     , 3726-3732. <a href="https://doi.org/10.1021/acs.analchem.0c03638" title="DOI URL">https://doi.org/10.1021/acs.analchem.0c03638</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.0c03638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.0c03638%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DLong-Lasting%252BBioluminescence%252BImaging%252Bof%252Bthe%252BFibroblast%252BActivation%252BProtein%252Bby%252Ban%252BAmphiphilic%252BBlock%252BCopolymer-Based%252BProbe%26aulast%3DZhou%26aufirst%3DYibo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26082020%26date%3D04022021%26date%3D18022021%26volume%3D93%26issue%3D8%26spage%3D3726%26epage%3D3732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dongyang Fan, Jian Zhang, Yanhua Hu, Zhenfeng Zhang, Ilya D. Gridnev, <span class="NLM_string-name hlFld-ContribAuthor">Wanbin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Hydrogenation of α-Boryl Enamides Enabled by Nonbonding Interactions. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (5)
                                     , 3232-3240. <a href="https://doi.org/10.1021/acscatal.9b04543" title="DOI URL">https://doi.org/10.1021/acscatal.9b04543</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b04543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b04543%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DAsymmetric%252BHydrogenation%252Bof%252B%2525CE%2525B1-Boryl%252BEnamides%252BEnabled%252Bby%252BNonbonding%252BInteractions%26aulast%3DFan%26aufirst%3DDongyang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D2020%26date%3D22102019%26date%3D05022020%26date%3D20022020%26date%3D10022020%26volume%3D10%26issue%3D5%26spage%3D3232%26epage%3D3240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">An De Decker, Gwendolyn Vliegen, Dries Van Rompaey, Anke Peeraer, An Bracke, Line Verckist, Koen Jansen, Ruth Geiss-Friedlander, Koen Augustyns, Hans De Winter, Ingrid De Meester, Anne-Marie Lambeir, <span class="NLM_string-name hlFld-ContribAuthor">Pieter Van der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 1173-1179. <a href="https://doi.org/10.1021/acsmedchemlett.9b00191" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BSmall%252BMolecule-Derived%25252C%252BHighly%252BSelective%252BSubstrates%252Bfor%252BFibroblast%252BActivation%252BProtein%252B%252528FAP%252529%26aulast%3DDe%2BDecker%26aufirst%3DAn%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25042019%26date%3D09072019%26date%3D10072019%26date%3D09072019%26volume%3D10%26issue%3D8%26spage%3D1173%26epage%3D1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koen  Jansen</span>, <span class="hlFld-ContribAuthor ">Leen  Heirbaut</span>, <span class="hlFld-ContribAuthor ">Robert  Verkerk</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Cheng</span>, <span class="hlFld-ContribAuthor ">Jurgen  Joossens</span>, <span class="hlFld-ContribAuthor ">Paul  Cos</span>, <span class="hlFld-ContribAuthor ">Louis  Maes</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, and <span class="hlFld-ContribAuthor ">Pieter  Van der Veken</span>  . </span><span class="cited-content_cbyCitation_article-title">Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (7)
                                     , 3053-3074. <a href="https://doi.org/10.1021/jm500031w" title="DOI URL">https://doi.org/10.1021/jm500031w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500031w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500031w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExtended%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Band%252BPharmacokinetic%252BInvestigation%252Bof%252B%2525284-Quinolinoyl%252529glycyl-2-cyanopyrrolidine%252BInhibitors%252Bof%252BFibroblast%252BActivation%252BProtein%252B%252528FAP%252529%26aulast%3DJansen%26aufirst%3DKoen%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08012014%26date%3D24032014%26date%3D10042014%26date%3D11032014%26volume%3D57%26issue%3D7%26spage%3D3053%26epage%3D3074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katharina  Dendl</span>, <span class="hlFld-ContribAuthor ">Joel  Schlittenhardt</span>, <span class="hlFld-ContribAuthor ">Fabian  Staudinger</span>, <span class="hlFld-ContribAuthor ">Clemens  Kratochwil</span>, <span class="hlFld-ContribAuthor ">Anette  Altmann</span>, <span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>, <span class="hlFld-ContribAuthor ">Frederik L.  Giesel</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Fibroblast Activation Protein Ligands in Oncologic PET Imaging. </span><span class="cited-content_cbyCitation_journal-name">PET Clinics</span><span> <strong>2021,</strong> <em>16 </em>
                                    (3)
                                     , 341-351. <a href="https://doi.org/10.1016/j.cpet.2021.03.012" title="DOI URL">https://doi.org/10.1016/j.cpet.2021.03.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cpet.2021.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cpet.2021.03.012%26sid%3Dliteratum%253Aachs%26jtitle%3DPET%2520Clinics%26atitle%3DThe%252BRole%252Bof%252BFibroblast%252BActivation%252BProtein%252BLigands%252Bin%252BOncologic%252BPET%252BImaging%26aulast%3DDendl%26aufirst%3DKatharina%26date%3D2021%26volume%3D16%26issue%3D3%26spage%3D341%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adéla  Šimková</span>, <span class="hlFld-ContribAuthor ">Tereza  Ormsby</span>, <span class="hlFld-ContribAuthor ">Natan  Sidej</span>, <span class="hlFld-ContribAuthor ">Lenka Poštová  Slavětínská</span>, <span class="hlFld-ContribAuthor ">Jiří  Brynda</span>, <span class="hlFld-ContribAuthor ">Jana  Beranová</span>, <span class="hlFld-ContribAuthor ">Pavel  Šácha</span>, <span class="hlFld-ContribAuthor ">Pavel  Majer</span>, <span class="hlFld-ContribAuthor ">Jan  Konvalinka</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship and biochemical evaluation of novel fibroblast activation protein and prolyl endopeptidase inhibitors with α-ketoamide warheads. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>23 </em>, 113717. <a href="https://doi.org/10.1016/j.ejmech.2021.113717" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113717</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113717%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Band%252Bbiochemical%252Bevaluation%252Bof%252Bnovel%252Bfibroblast%252Bactivation%252Bprotein%252Band%252Bprolyl%252Bendopeptidase%252Binhibitors%252Bwith%252B%2525CE%2525B1-ketoamide%252Bwarheads%26aulast%3D%25C5%25A0imkov%25C3%25A1%26aufirst%3DAd%25C3%25A9la%26date%3D2021%26volume%3D23%26spage%3D113717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cecy R.  Xi</span>, <span class="hlFld-ContribAuthor ">Arianna  Di Fazio</span>, <span class="hlFld-ContribAuthor ">Naveed Ahmed  Nadvi</span>, <span class="hlFld-ContribAuthor ">Michelle Sui Wen  Xiang</span>, <span class="hlFld-ContribAuthor ">Hui Emma  Zhang</span>, <span class="hlFld-ContribAuthor ">Chandrika  Deshpande</span>, <span class="hlFld-ContribAuthor ">Yiqian  Chen</span>, <span class="hlFld-ContribAuthor ">Mehdi Sharifi  Tabar</span>, <span class="hlFld-ContribAuthor ">Xin Maggie  Wang</span>, <span class="hlFld-ContribAuthor ">Charles G.  Bailey</span>, <span class="hlFld-ContribAuthor ">Geoffrey W.  McCaughan</span>, <span class="hlFld-ContribAuthor ">W. Bret  Church</span>, <span class="hlFld-ContribAuthor ">Mark D.  Gorrell</span>. </span><span class="cited-content_cbyCitation_article-title">An improved production and purification protocol for recombinant soluble human fibroblast activation protein alpha. </span><span class="cited-content_cbyCitation_journal-name">Protein Expression and Purification</span><span> <strong>2021,</strong> <em>181 </em>, 105833. <a href="https://doi.org/10.1016/j.pep.2021.105833" title="DOI URL">https://doi.org/10.1016/j.pep.2021.105833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pep.2021.105833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pep.2021.105833%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Expression%2520and%2520Purification%26atitle%3DAn%252Bimproved%252Bproduction%252Band%252Bpurification%252Bprotocol%252Bfor%252Brecombinant%252Bsoluble%252Bhuman%252Bfibroblast%252Bactivation%252Bprotein%252Balpha%26aulast%3DXi%26aufirst%3DCecy%2BR.%26date%3D2021%26volume%3D181%26spage%3D105833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yentl  Van Rymenant</span>, <span class="hlFld-ContribAuthor ">Muhammet  Tanc</span>, <span class="hlFld-ContribAuthor ">Roos  Van Elzen</span>, <span class="hlFld-ContribAuthor ">An  Bracke</span>, <span class="hlFld-ContribAuthor ">Olivier  De Wever</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>, <span class="hlFld-ContribAuthor ">Mark  Kockx</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.640566" title="DOI URL">https://doi.org/10.3389/fchem.2021.640566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.640566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.640566%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DIn%252BVitro%252Band%252BIn%252BSitu%252BActivity-Based%252BLabeling%252Bof%252BFibroblast%252BActivation%252BProtein%252Bwith%252BUAMC1110-Derived%252BProbes%26aulast%3DVan%2BRymenant%26aufirst%3DYentl%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui Jin  Jung</span>, <span class="hlFld-ContribAuthor ">Eun Hye  Nam</span>, <span class="hlFld-ContribAuthor ">Jin Young  Park</span>, <span class="hlFld-ContribAuthor ">Prithwish  Ghosh</span>, <span class="hlFld-ContribAuthor ">In Su  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>37 </em>, 127846. <a href="https://doi.org/10.1016/j.bmcl.2021.127846" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127846%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252BBR102910%252Bas%252Ba%252Bselective%252Bfibroblast%252Bactivation%252Bprotein%252B%252528FAP%252529%252Binhibitor%26aulast%3DJung%26aufirst%3DHui%2BJin%26date%3D2021%26volume%3D37%26spage%3D127846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James M.  Kelly</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Jeitner</span>, <span class="hlFld-ContribAuthor ">Shashikanth  Ponnala</span>, <span class="hlFld-ContribAuthor ">Clarence  Williams</span>, <span class="hlFld-ContribAuthor ">Anastasia  Nikolopoulou</span>, <span class="hlFld-ContribAuthor ">Stephen G.  DiMagno</span>, <span class="hlFld-ContribAuthor ">John W.  Babich</span>. </span><span class="cited-content_cbyCitation_article-title">A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα). </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2021,</strong> <em>7 </em><a href="https://doi.org/10.1007/s11307-021-01593-1" title="DOI URL">https://doi.org/10.1007/s11307-021-01593-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-021-01593-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-021-01593-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DA%252BTrifunctional%252BTheranostic%252BLigand%252BTargeting%252BFibroblast%252BActivation%252BProtein-%2525CE%2525B1%252B%252528FAP%2525CE%2525B1%252529%26aulast%3DKelly%26aufirst%3DJames%2BM.%26date%3D2021%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Euy Sung  Moon</span>, <span class="hlFld-ContribAuthor ">Filipe  Elvas</span>, <span class="hlFld-ContribAuthor ">Gwendolyn  Vliegen</span>, <span class="hlFld-ContribAuthor ">Stef  De Lombaerde</span>, <span class="hlFld-ContribAuthor ">Christel  Vangestel</span>, <span class="hlFld-ContribAuthor ">Sven  De Bruycker</span>, <span class="hlFld-ContribAuthor ">An  Bracke</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Eppard</span>, <span class="hlFld-ContribAuthor ">Lukas  Greifenstein</span>, <span class="hlFld-ContribAuthor ">Benedikt  Klasen</span>, <span class="hlFld-ContribAuthor ">Vasko  Kramer</span>, <span class="hlFld-ContribAuthor ">Steven  Staelens</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Pieter  Van der Veken</span>, <span class="hlFld-ContribAuthor ">Frank  Rösch</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Radiopharmacy and Chemistry</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41181-020-00102-z" title="DOI URL">https://doi.org/10.1186/s41181-020-00102-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41181-020-00102-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41181-020-00102-z%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Radiopharmacy%2520and%2520Chemistry%26atitle%3DTargeting%252Bfibroblast%252Bactivation%252Bprotein%252B%252528FAP%252529%25253A%252Bnext%252Bgeneration%252BPET%252Bradiotracers%252Busing%252Bsquaramide%252Bcoupled%252Bbifunctional%252BDOTA%252Band%252BDATA5m%252Bchelators%26aulast%3DMoon%26aufirst%3DEuy%2BSung%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Windisch</span>, <span class="hlFld-ContribAuthor ">Daniel R.  Zwahlen</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Koerber</span>, <span class="hlFld-ContribAuthor ">Frederik L.  Giesel</span>, <span class="hlFld-ContribAuthor ">Jürgen  Debus</span>, <span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>, <span class="hlFld-ContribAuthor ">Sebastian  Adeberg</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (9)
                                     , 2629. <a href="https://doi.org/10.3390/cancers12092629" title="DOI URL">https://doi.org/10.3390/cancers12092629</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12092629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12092629%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DClinical%252BResults%252Bof%252BFibroblast%252BActivation%252BProtein%252B%252528FAP%252529%252BSpecific%252BPET%252Band%252BImplications%252Bfor%252BRadiotherapy%252BPlanning%25253A%252BSystematic%252BReview%26aulast%3DWindisch%26aufirst%3DPaul%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D9%26spage%3D2629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adéla  Šimková</span>, <span class="hlFld-ContribAuthor ">Petr  Bušek</span>, <span class="hlFld-ContribAuthor ">Aleksi  Šedo</span>, <span class="hlFld-ContribAuthor ">Jan  Konvalinka</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2020,</strong> <em>1868 </em>
                                    (7)
                                     , 140409. <a href="https://doi.org/10.1016/j.bbapap.2020.140409" title="DOI URL">https://doi.org/10.1016/j.bbapap.2020.140409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2020.140409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2020.140409%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DMolecular%252Brecognition%252Bof%252Bfibroblast%252Bactivation%252Bprotein%252Bfor%252Bdiagnostic%252Band%252Btherapeutic%252Bapplications%26aulast%3D%25C5%25A0imkov%25C3%25A1%26aufirst%3DAd%25C3%25A9la%26date%3D2020%26volume%3D1868%26issue%3D7%26spage%3D140409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Plescia</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Design and discovery of boronic acid drugs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112270. <a href="https://doi.org/10.1016/j.ejmech.2020.112270" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112270%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bdiscovery%252Bof%252Bboronic%252Bacid%252Bdrugs%26aulast%3DPlescia%26aufirst%3DJessica%26date%3D2020%26volume%3D195%26spage%3D112270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel F.  Kawano</span>, <span class="hlFld-ContribAuthor ">Carlos H. T.  de Paula da Silva</span>, <span class="hlFld-ContribAuthor ">Carlton A.  Taft</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Inhibitors of the Human Fibroblast Activation Protein α as a Strategy to Hinder Metastasis and Angiogenesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 277-303. <a href="https://doi.org/10.1007/978-3-030-31403-3_11" title="DOI URL">https://doi.org/10.1007/978-3-030-31403-3_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-31403-3_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-31403-3_11%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BInhibitors%252Bof%252Bthe%252BHuman%252BFibroblast%252BActivation%252BProtein%252B%2525CE%2525B1%252Bas%252Ba%252BStrategy%252Bto%252BHinder%252BMetastasis%252Band%252BAngiogenesis%26aulast%3DKawano%26aufirst%3DDaniel%2BF.%26date%3D2020%26date%3D2020%26spage%3D277%26epage%3D303%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEmerging%252BResearch%252Bin%252BScience%252Band%252BEngineering%252BBased%252Bon%252BAdvanced%252BExperimental%252Band%252BComputational%252BStrategies%26aulast%3DLa%2BPorta%26aufirst%3DFelipe%2Bde%2BAlmeida%26date%3D2020%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Plescia</span>, <span class="hlFld-ContribAuthor ">Caroline  Dufresne</span>, <span class="hlFld-ContribAuthor ">Naëla  Janmamode</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Wahba</span>, <span class="hlFld-ContribAuthor ">Anthony K.  Mittermaier</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of covalent prolyl oligopeptidase boronic ester inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111783. <a href="https://doi.org/10.1016/j.ejmech.2019.111783" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111783%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bcovalent%252Bprolyl%252Boligopeptidase%252Bboronic%252Bester%252Binhibitors%26aulast%3DPlescia%26aufirst%3DJessica%26date%3D2020%26volume%3D185%26spage%3D111783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peio  Errarte</span>, <span class="hlFld-ContribAuthor ">Gorka  Larrinaga</span>, <span class="hlFld-ContribAuthor ">José I.  López</span>. </span><span class="cited-content_cbyCitation_article-title">The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Advanced Research</span><span> <strong>2020,</strong> <em>21 </em>, 103-108. <a href="https://doi.org/10.1016/j.jare.2019.09.004" title="DOI URL">https://doi.org/10.1016/j.jare.2019.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jare.2019.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jare.2019.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Advanced%2520Research%26atitle%3DThe%252Brole%252Bof%252Bcancer-associated%252Bfibroblasts%252Bin%252Brenal%252Bcell%252Bcarcinoma.%252BAn%252Bexample%252Bof%252Btumor%252Bmodulation%252Bthrough%252Btumor%25252Fnon-tumor%252Bcell%252Binteractions%26aulast%3DErrarte%26aufirst%3DPeio%26date%3D2020%26volume%3D21%26spage%3D103%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Lindner</span>, <span class="hlFld-ContribAuthor ">Anastasia  Loktev</span>, <span class="hlFld-ContribAuthor ">Frederik  Giesel</span>, <span class="hlFld-ContribAuthor ">Clemens  Kratochwil</span>, <span class="hlFld-ContribAuthor ">Annette  Altmann</span>, <span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting of activated fibroblasts for imaging and therapy. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Radiopharmacy and Chemistry</span><span> <strong>2019,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41181-019-0069-0" title="DOI URL">https://doi.org/10.1186/s41181-019-0069-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41181-019-0069-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41181-019-0069-0%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Radiopharmacy%2520and%2520Chemistry%26atitle%3DTargeting%252Bof%252Bactivated%252Bfibroblasts%252Bfor%252Bimaging%252Band%252Btherapy%26aulast%3DLindner%26aufirst%3DThomas%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raphaël  De Matos</span>, <span class="hlFld-ContribAuthor ">Jérémy  Vuilleumier</span>, <span class="hlFld-ContribAuthor ">Christophe  Mas</span>, <span class="hlFld-ContribAuthor ">Samuel  Constant</span>, <span class="hlFld-ContribAuthor ">Davide  Staedler</span>, <span class="hlFld-ContribAuthor ">Sandrine  Gerber-Lemaire</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor-conjugated harmonic nanoparticles targeting fibroblast activation protein. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (54)
                                     , 31659-31669. <a href="https://doi.org/10.1039/C9RA05299B" title="DOI URL">https://doi.org/10.1039/C9RA05299B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA05299B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA05299B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DInhibitor-conjugated%252Bharmonic%252Bnanoparticles%252Btargeting%252Bfibroblast%252Bactivation%252Bprotein%26aulast%3DDe%2BMatos%26aufirst%3DRapha%25C3%25ABl%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D54%26spage%3D31659%26epage%3D31669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shreyasi  Gupta</span>, <span class="hlFld-ContribAuthor ">Utpal  Sen</span>. </span><span class="cited-content_cbyCitation_article-title">More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>147 </em>, 104391. <a href="https://doi.org/10.1016/j.phrs.2019.104391" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104391%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DMore%252Bthan%252Bjust%252Ban%252Benzyme%25253A%252BDipeptidyl%252Bpeptidase-4%252B%252528DPP-4%252529%252Band%252Bits%252Bassociation%252Bwith%252Bdiabetic%252Bkidney%252Bremodelling%26aulast%3DGupta%26aufirst%3DShreyasi%26date%3D2019%26volume%3D147%26spage%3D104391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik L.  Giesel</span>, <span class="hlFld-ContribAuthor ">Clemens  Kratochwil</span>, <span class="hlFld-ContribAuthor ">Thomas  Lindner</span>, <span class="hlFld-ContribAuthor ">Manfred M.  Marschalek</span>, <span class="hlFld-ContribAuthor ">Anastasia  Loktev</span>, <span class="hlFld-ContribAuthor ">Wencke  Lehnert</span>, <span class="hlFld-ContribAuthor ">Jürgen  Debus</span>, <span class="hlFld-ContribAuthor ">Dirk  Jäger</span>, <span class="hlFld-ContribAuthor ">Paul  Flechsig</span>, <span class="hlFld-ContribAuthor ">Annette  Altmann</span>, <span class="hlFld-ContribAuthor ">Walter  Mier</span>, <span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>. </span><span class="cited-content_cbyCitation_article-title">68
              Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2019,</strong> <em>60 </em>
                                    (3)
                                     , 386-392. <a href="https://doi.org/10.2967/jnumed.118.215913" title="DOI URL">https://doi.org/10.2967/jnumed.118.215913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.215913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.215913%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3D68%252BGa-FAPI%252BPET%25252FCT%25253A%252BBiodistribution%252Band%252BPreliminary%252BDosimetry%252BEstimate%252Bof%252B2%252BDOTA-Containing%252BFAP-Targeting%252BAgents%252Bin%252BPatients%252Bwith%252BVarious%252BCancers%26aulast%3DGiesel%26aufirst%3DFrederik%2BL.%26date%3D2019%26date%3D2018%26volume%3D60%26issue%3D3%26spage%3D386%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui Emma  Zhang</span>, <span class="hlFld-ContribAuthor ">Elizabeth J.  Hamson</span>, <span class="hlFld-ContribAuthor ">Maria Magdalena  Koczorowska</span>, <span class="hlFld-ContribAuthor ">Stefan  Tholen</span>, <span class="hlFld-ContribAuthor ">Sumaiya  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Charles G.  Bailey</span>, <span class="hlFld-ContribAuthor ">Angelina J.  Lay</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Twigg</span>, <span class="hlFld-ContribAuthor ">Quintin  Lee</span>, <span class="hlFld-ContribAuthor ">Ben  Roediger</span>, <span class="hlFld-ContribAuthor ">Martin L.  Biniossek</span>, <span class="hlFld-ContribAuthor ">Matthew B.  O'Rourke</span>, <span class="hlFld-ContribAuthor ">Geoffrey W.  McCaughan</span>, <span class="hlFld-ContribAuthor ">Fiona M.  Keane</span>, <span class="hlFld-ContribAuthor ">Oliver  Schilling</span>, <span class="hlFld-ContribAuthor ">Mark D.  Gorrell</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics. </span><span class="cited-content_cbyCitation_journal-name">Molecular & Cellular Proteomics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (1)
                                     , 65-85. <a href="https://doi.org/10.1074/mcp.RA118.001046" title="DOI URL">https://doi.org/10.1074/mcp.RA118.001046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/mcp.RA118.001046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fmcp.RA118.001046%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520%2526%2520Cellular%2520Proteomics%26atitle%3DIdentification%252Bof%252BNovel%252BNatural%252BSubstrates%252Bof%252BFibroblast%252BActivation%252BProtein-alpha%252Bby%252BDifferential%252BDegradomics%252Band%252BProteomics%26aulast%3DZhang%26aufirst%3DHui%2BEmma%26date%3D2019%26volume%3D18%26issue%3D1%26spage%3D65%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jens T.  Siveke</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2018,</strong> <em>59 </em>
                                    (9)
                                     , 1412-1414. <a href="https://doi.org/10.2967/jnumed.118.214361" title="DOI URL">https://doi.org/10.2967/jnumed.118.214361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.214361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.214361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DFibroblast-Activating%252BProtein%25253A%252BTargeting%252Bthe%252BRoots%252Bof%252Bthe%252BTumor%252BMicroenvironment%26aulast%3DSiveke%26aufirst%3DJens%2BT.%26date%3D2018%26date%3D2018%26volume%3D59%26issue%3D9%26spage%3D1412%26epage%3D1414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salvador  Guardiola</span>, <span class="hlFld-ContribAuthor ">Roger  Prades</span>, <span class="hlFld-ContribAuthor ">Laura  Mendieta</span>, <span class="hlFld-ContribAuthor ">Arwin J.  Brouwer</span>, <span class="hlFld-ContribAuthor ">Jelle  Streefkerk</span>, <span class="hlFld-ContribAuthor ">Laura  Nevola</span>, <span class="hlFld-ContribAuthor ">Teresa  Tarragó</span>, <span class="hlFld-ContribAuthor ">Rob M.J.  Liskamp</span>, <span class="hlFld-ContribAuthor ">Ernest  Giralt</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2018,</strong> <em>25 </em>
                                    (8)
                                     , 1031-1037.e4. <a href="https://doi.org/10.1016/j.chembiol.2018.04.013" title="DOI URL">https://doi.org/10.1016/j.chembiol.2018.04.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2018.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2018.04.013%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DTargeted%252BCovalent%252BInhibition%252Bof%252BProlyl%252BOligopeptidase%252B%252528POP%252529%25253A%252BDiscovery%252Bof%252BSulfonylfluoride%252BPeptidomimetics%26aulast%3DGuardiola%26aufirst%3DSalvador%26date%3D2018%26volume%3D25%26issue%3D8%26spage%3D1031%26epage%3D1037.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marian C.  Okondo</span>, <span class="hlFld-ContribAuthor ">Sahana D.  Rao</span>, <span class="hlFld-ContribAuthor ">Cornelius Y.  Taabazuing</span>, <span class="hlFld-ContribAuthor ">Ashley J.  Chui</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Poplawski</span>, <span class="hlFld-ContribAuthor ">Darren C.  Johnson</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Bachovchin</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2018,</strong> <em>25 </em>
                                    (3)
                                     , 262-267.e5. <a href="https://doi.org/10.1016/j.chembiol.2017.12.013" title="DOI URL">https://doi.org/10.1016/j.chembiol.2017.12.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2017.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2017.12.013%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DInhibition%252Bof%252BDpp8%25252F9%252BActivates%252Bthe%252BNlrp1b%252BInflammasome%26aulast%3DOkondo%26aufirst%3DMarian%2BC.%26date%3D2018%26volume%3D25%26issue%3D3%26spage%3D262%26epage%3D267.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-ping  Chai</span>, <span class="hlFld-ContribAuthor ">Guang-long  Sun</span>, <span class="hlFld-ContribAuthor ">Yan-fen  Fang</span>, <span class="hlFld-ContribAuthor ">Li-hong  Hu</span>, <span class="hlFld-ContribAuthor ">Xuan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiong-wen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2018,</strong> <em>39 </em>
                                    (3)
                                     , 415-424. <a href="https://doi.org/10.1038/aps.2017.121" title="DOI URL">https://doi.org/10.1038/aps.2017.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2017.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2017.121%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DTumor-targeting%252Befficacy%252Bof%252Ba%252BBF211%252Bprodrug%252Bthrough%252Bhydrolysis%252Bby%252Bfibroblast%252Bactivation%252Bprotein-%2525CE%2525B1%26aulast%3DChai%26aufirst%3DXiao-ping%26date%3D2018%26date%3D2017%26volume%3D39%26issue%3D3%26spage%3D415%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Blake E.  Daniels</span>, <span class="hlFld-ContribAuthor ">Craig E.  Stivala</span>. </span><span class="cited-content_cbyCitation_article-title">A solid-phase approach for the synthesis of α-aminoboronic acid peptides. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (6)
                                     , 3343-3347. <a href="https://doi.org/10.1039/C7RA13479G" title="DOI URL">https://doi.org/10.1039/C7RA13479G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA13479G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA13479G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bsolid-phase%252Bapproach%252Bfor%252Bthe%252Bsynthesis%252Bof%252B%2525CE%2525B1-aminoboronic%252Bacid%252Bpeptides%26aulast%3DDaniels%26aufirst%3DBlake%2BE.%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D6%26spage%3D3343%26epage%3D3347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lili  Chen</span>, <span class="hlFld-ContribAuthor ">Jun-Jian  Shen</span>, <span class="hlFld-ContribAuthor ">Qian  Gao</span>, <span class="hlFld-ContribAuthor ">Senmiao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of cyclic chiral α-amino boronates by copper-catalyzed asymmetric dearomative borylation of indoles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2018,</strong> <em>9 </em>
                                    (26)
                                     , 5855-5859. <a href="https://doi.org/10.1039/C8SC01815D" title="DOI URL">https://doi.org/10.1039/C8SC01815D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8SC01815D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8SC01815D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DSynthesis%252Bof%252Bcyclic%252Bchiral%252B%2525CE%2525B1-amino%252Bboronates%252Bby%252Bcopper-catalyzed%252Basymmetric%252Bdearomative%252Bborylation%252Bof%252Bindoles%26aulast%3DChen%26aufirst%3DLili%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D26%26spage%3D5855%26epage%3D5859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Travis W.  Bainbridge</span>, <span class="hlFld-ContribAuthor ">Diana Ronai  Dunshee</span>, <span class="hlFld-ContribAuthor ">Noelyn M.  Kljavin</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Skelton</span>, <span class="hlFld-ContribAuthor ">Junichiro  Sonoda</span>, <span class="hlFld-ContribAuthor ">James A.  Ernst</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Homogeneous Assay for Circulating Endopeptidase Fibroblast Activation Protein (FAP). </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-12900-8" title="DOI URL">https://doi.org/10.1038/s41598-017-12900-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-12900-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-12900-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DSelective%252BHomogeneous%252BAssay%252Bfor%252BCirculating%252BEndopeptidase%252BFibroblast%252BActivation%252BProtein%252B%252528FAP%252529%26aulast%3DBainbridge%26aufirst%3DTravis%2BW.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucienne  Juillerat-Jeanneret</span>, <span class="hlFld-ContribAuthor ">Petra  Tafelmeyer</span>, <span class="hlFld-ContribAuthor ">Dela  Golshayan</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2017,</strong> <em>21 </em>
                                    (10)
                                     , 977-991. <a href="https://doi.org/10.1080/14728222.2017.1370455" title="DOI URL">https://doi.org/10.1080/14728222.2017.1370455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2017.1370455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2017.1370455%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DFibroblast%252Bactivation%252Bprotein-%2525CE%2525B1%252Bin%252Bfibrogenic%252Bdisorders%252Band%252Bcancer%25253A%252Bmore%252Bthan%252Ba%252Bprolyl-specific%252Bpeptidase%25253F%26aulast%3DJuillerat-Jeanneret%26aufirst%3DLucienne%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D10%26spage%3D977%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dean  Rea</span>, <span class="hlFld-ContribAuthor ">Roos  Van Elzen</span>, <span class="hlFld-ContribAuthor ">Hans  De Winter</span>, <span class="hlFld-ContribAuthor ">Sebastiaan  Van Goethem</span>, <span class="hlFld-ContribAuthor ">Bart  Landuyt</span>, <span class="hlFld-ContribAuthor ">Walter  Luyten</span>, <span class="hlFld-ContribAuthor ">Liliane  Schoofs</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Der Veken</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Vilmos  Fülöp</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 482-491. <a href="https://doi.org/10.1016/j.ejmech.2017.08.024" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCrystal%252Bstructure%252Bof%252BPorphyromonas%252Bgingivalis%252Bdipeptidyl%252Bpeptidase%252B4%252Band%252Bstructure-activity%252Brelationships%252Bbased%252Bon%252Binhibitor%252Bprofiling%26aulast%3DRea%26aufirst%3DDean%26date%3D2017%26volume%3D139%26spage%3D482%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minfeng  Chen</span>, <span class="hlFld-ContribAuthor ">Xueping  Lei</span>, <span class="hlFld-ContribAuthor ">Changzheng  Shi</span>, <span class="hlFld-ContribAuthor ">Maohua  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Li</span>, <span class="hlFld-ContribAuthor ">Baojian  Wu</span>, <span class="hlFld-ContribAuthor ">Zhengqiu  Li</span>, <span class="hlFld-ContribAuthor ">Weili  Han</span>, <span class="hlFld-ContribAuthor ">Bin  Du</span>, <span class="hlFld-ContribAuthor ">Jianyang  Hu</span>, <span class="hlFld-ContribAuthor ">Qiulin  Nie</span>, <span class="hlFld-ContribAuthor ">Weiqian  Mai</span>, <span class="hlFld-ContribAuthor ">Nan  Ma</span>, <span class="hlFld-ContribAuthor ">Nanhui  Xu</span>, <span class="hlFld-ContribAuthor ">Xinyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunlin  Fan</span>, <span class="hlFld-ContribAuthor ">Aihua  Hong</span>, <span class="hlFld-ContribAuthor ">Minghan  Xia</span>, <span class="hlFld-ContribAuthor ">Liangping  Luo</span>, <span class="hlFld-ContribAuthor ">Ande  Ma</span>, <span class="hlFld-ContribAuthor ">Hongsheng  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Yu</span>, <span class="hlFld-ContribAuthor ">Heru  Chen</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhang</span>, <span class="hlFld-ContribAuthor ">Wencai  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2017,</strong> <em>127 </em>
                                    (10)
                                     , 3689-3701. <a href="https://doi.org/10.1172/JCI94258" title="DOI URL">https://doi.org/10.1172/JCI94258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI94258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI94258%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DPericyte-targeting%252Bprodrug%252Bovercomes%252Btumor%252Bresistance%252Bto%252Bvascular%252Bdisrupting%252Bagents%26aulast%3DChen%26aufirst%3DMinfeng%26date%3D2017%26volume%3D127%26issue%3D10%26spage%3D3689%26epage%3D3701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liqiang  Han</span>, <span class="hlFld-ContribAuthor ">Yanzhao  Wen</span>, <span class="hlFld-ContribAuthor ">Ridong  Li</span>, <span class="hlFld-ContribAuthor ">Bo  Xu</span>, <span class="hlFld-ContribAuthor ">Zemei  Ge</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Tieming  Cheng</span>, <span class="hlFld-ContribAuthor ">Jingrong  Cui</span>, <span class="hlFld-ContribAuthor ">Runtao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (15)
                                     , 4031-4044. <a href="https://doi.org/10.1016/j.bmc.2017.05.049" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.05.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.05.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.05.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivity%252Bof%252Bpeptide%252Bproline-boronic%252Bacids%252Bas%252Bproteasome%252Binhibitors%26aulast%3DHan%26aufirst%3DLiqiang%26date%3D2017%26volume%3D25%26issue%3D15%26spage%3D4031%26epage%3D4044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katerina  Babkova</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Eugenie  Nepovimova</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>. </span><span class="cited-content_cbyCitation_article-title">Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (10)
                                     , 1015-1038. <a href="https://doi.org/10.4155/fmc-2017-0030" title="DOI URL">https://doi.org/10.4155/fmc-2017-0030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0030%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DProlyl%252Boligopeptidase%252Band%252Bits%252Brole%252Bin%252Bthe%252Borganism%25253A%252Battention%252Bto%252Bthe%252Bmost%252Bpromising%252Band%252Bclinically%252Brelevant%252Binhibitors%26aulast%3DBabkova%26aufirst%3DKaterina%26date%3D2017%26volume%3D9%26issue%3D10%26spage%3D1015%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Heterocycles with Applications in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 13-33. <a href="https://doi.org/10.1016/bs.aihch.2016.03.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.03.004%26sid%3Dliteratum%253Aachs%26atitle%3DSaturated%252BHeterocycles%252Bwith%252BApplications%252Bin%252BMedicinal%252BChemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2017%26spage%3D13%26epage%3D33%26pub%3DElsevier%26atitle%3DHeterocyclic%252BChemistry%252Bin%252Bthe%252B21st%252BCentury%252B-%252BA%252BTribute%252Bto%252BAlan%252BKatritzky%26date%3D2017%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marian C  Okondo</span>, <span class="hlFld-ContribAuthor ">Darren C  Johnson</span>, <span class="hlFld-ContribAuthor ">Ramya  Sridharan</span>, <span class="hlFld-ContribAuthor ">Eun Bin  Go</span>, <span class="hlFld-ContribAuthor ">Ashley J  Chui</span>, <span class="hlFld-ContribAuthor ">Mitchell S  Wang</span>, <span class="hlFld-ContribAuthor ">Sarah E  Poplawski</span>, <span class="hlFld-ContribAuthor ">Wengen  Wu</span>, <span class="hlFld-ContribAuthor ">Yuxin  Liu</span>, <span class="hlFld-ContribAuthor ">Jack H  Lai</span>, <span class="hlFld-ContribAuthor ">David G  Sanford</span>, <span class="hlFld-ContribAuthor ">Michael O  Arciprete</span>, <span class="hlFld-ContribAuthor ">Todd R  Golub</span>, <span class="hlFld-ContribAuthor ">William W  Bachovchin</span>, <span class="hlFld-ContribAuthor ">Daniel A  Bachovchin</span>. </span><span class="cited-content_cbyCitation_article-title">DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2017,</strong> <em>13 </em>
                                    (1)
                                     , 46-53. <a href="https://doi.org/10.1038/nchembio.2229" title="DOI URL">https://doi.org/10.1038/nchembio.2229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.2229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.2229%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DDPP8%252Band%252BDPP9%252Binhibition%252Binduces%252Bpro-caspase-1-dependent%252Bmonocyte%252Band%252Bmacrophage%252Bpyroptosis%26aulast%3DOkondo%26aufirst%3DMarian%2BC%26date%3D2017%26date%3D2016%26volume%3D13%26issue%3D1%26spage%3D46%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. V.  Pleshkan</span>, <span class="hlFld-ContribAuthor ">I. V.  Alekseenko</span>, <span class="hlFld-ContribAuthor ">D. V.  Tyulkina</span>, <span class="hlFld-ContribAuthor ">A. I.  Kyzmich</span>, <span class="hlFld-ContribAuthor ">M. V.  Zinovyeva</span>, <span class="hlFld-ContribAuthor ">E. D.  Sverdlov</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast activation protein (FAP) as a possible target of an antitumor strategy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Genetics, Microbiology and Virology</span><span> <strong>2016,</strong> <em>31 </em>
                                    (3)
                                     , 125-134. <a href="https://doi.org/10.3103/S0891416816030083" title="DOI URL">https://doi.org/10.3103/S0891416816030083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3103/S0891416816030083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3103%2FS0891416816030083%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Genetics%252C%2520Microbiology%2520and%2520Virology%26atitle%3DFibroblast%252Bactivation%252Bprotein%252B%252528FAP%252529%252Bas%252Ba%252Bpossible%252Btarget%252Bof%252Ban%252Bantitumor%252Bstrategy%26aulast%3DPleshkan%26aufirst%3DV.%2BV.%26date%3D2016%26date%3D2017%26volume%3D31%26issue%3D3%26spage%3D125%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew L.  Coppage</span>, <span class="hlFld-ContribAuthor ">Kathryn R.  Heard</span>, <span class="hlFld-ContribAuthor ">Matthew T.  DiMare</span>, <span class="hlFld-ContribAuthor ">Yuxin  Liu</span>, <span class="hlFld-ContribAuthor ">Wengen  Wu</span>, <span class="hlFld-ContribAuthor ">Jack H.  Lai</span>, <span class="hlFld-ContribAuthor ">William W.  Bachovchin</span>, . </span><span class="cited-content_cbyCitation_article-title">Human FGF-21 Is a Substrate of Fibroblast Activation Protein. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (3)
                                     , e0151269. <a href="https://doi.org/10.1371/journal.pone.0151269" title="DOI URL">https://doi.org/10.1371/journal.pone.0151269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0151269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0151269%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DHuman%252BFGF-21%252BIs%252Ba%252BSubstrate%252Bof%252BFibroblast%252BActivation%252BProtein%26aulast%3DCoppage%26aufirst%3DAndrew%2BL.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D3%26spage%3De0151269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pok Fai  Wong</span>, <span class="hlFld-ContribAuthor ">Margaret G.  Gall</span>, <span class="hlFld-ContribAuthor ">William W.  Bachovchin</span>, <span class="hlFld-ContribAuthor ">Geoffrey W.  McCaughan</span>, <span class="hlFld-ContribAuthor ">Fiona M.  Keane</span>, <span class="hlFld-ContribAuthor ">Mark D.  Gorrell</span>. </span><span class="cited-content_cbyCitation_article-title">Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Peptides</span><span> <strong>2016,</strong> <em>75 </em>, 80-95. <a href="https://doi.org/10.1016/j.peptides.2015.11.004" title="DOI URL">https://doi.org/10.1016/j.peptides.2015.11.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.peptides.2015.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.peptides.2015.11.004%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptides%26atitle%3DNeuropeptide%252BY%252Bis%252Ba%252Bphysiological%252Bsubstrate%252Bof%252Bfibroblast%252Bactivation%252Bprotein%25253A%252BEnzyme%252Bkinetics%252Bin%252Bblood%252Bplasma%252Band%252Bexpression%252Bof%252BY2R%252Band%252BY5R%252Bin%252Bhuman%252Bliver%252Bcirrhosis%252Band%252Bhepatocellular%252Bcarcinoma%26aulast%3DWong%26aufirst%3DPok%2BFai%26date%3D2016%26volume%3D75%26spage%3D80%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia  Andrés</span>, <span class="hlFld-ContribAuthor ">Gema  Ballano</span>, <span class="hlFld-ContribAuthor ">M. Isabel  Calaza</span>, <span class="hlFld-ContribAuthor ">Carlos  Cativiela</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of α-aminoboronic acids. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2016,</strong> <em>45 </em>
                                    (8)
                                     , 2291-2307. <a href="https://doi.org/10.1039/C5CS00886G" title="DOI URL">https://doi.org/10.1039/C5CS00886G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CS00886G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CS00886G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B1-aminoboronic%252Bacids%26aulast%3DAndr%25C3%25A9s%26aufirst%3DPatricia%26date%3D2016%26date%3D2016%26volume%3D45%26issue%3D8%26spage%3D2291%26epage%3D2307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. V.  Pleshkan</span>, <span class="hlFld-ContribAuthor ">I. V.  Alekseenko</span>, <span class="hlFld-ContribAuthor ">D. V.  Tyulkina</span>, <span class="hlFld-ContribAuthor ">A. I.  Kyzmich</span>, <span class="hlFld-ContribAuthor ">M. V.  Zinovyeva</span>, <span class="hlFld-ContribAuthor ">E. D.  Sverdlov</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast activation protein (FAP) as a possible target of the antitumor strategy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Genetics Microbiology and Virology (Russian version)</span><span> <strong>2016,</strong> <em>34 </em>
                                    (3)
                                     , 90. <a href="https://doi.org/10.18821/0208-0613-2016-34-3-90-97" title="DOI URL">https://doi.org/10.18821/0208-0613-2016-34-3-90-97</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18821/0208-0613-2016-34-3-90-97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18821%2F0208-0613-2016-34-3-90-97%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Genetics%2520Microbiology%2520and%2520Virology%2520%2528Russian%2520version%2529%26atitle%3DFibroblast%252Bactivation%252Bprotein%252B%252528FAP%252529%252Bas%252Ba%252Bpossible%252Btarget%252Bof%252Bthe%252Bantitumor%252Bstrategy%26aulast%3DPleshkan%26aufirst%3DV.%2BV.%26date%3D2016%26volume%3D34%26issue%3D3%26spage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Solène  Passemard</span>, <span class="hlFld-ContribAuthor ">Davide  Staedler</span>, <span class="hlFld-ContribAuthor ">Giona  Sonego</span>, <span class="hlFld-ContribAuthor ">Thibaud  Magouroux</span>, <span class="hlFld-ContribAuthor ">Guillaume Stéphane  Schneiter</span>, <span class="hlFld-ContribAuthor ">Lucienne  Juillerat-Jeanneret</span>, <span class="hlFld-ContribAuthor ">Luigi  Bonacina</span>, <span class="hlFld-ContribAuthor ">Sandrine  Gerber-Lemaire</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalized bismuth ferrite harmonic nanoparticles for cancer cells labeling and imaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nanoparticle Research</span><span> <strong>2015,</strong> <em>17 </em>
                                    (10)
                                     <a href="https://doi.org/10.1007/s11051-015-3218-8" title="DOI URL">https://doi.org/10.1007/s11051-015-3218-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11051-015-3218-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11051-015-3218-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nanoparticle%2520Research%26atitle%3DFunctionalized%252Bbismuth%252Bferrite%252Bharmonic%252Bnanoparticles%252Bfor%252Bcancer%252Bcells%252Blabeling%252Band%252Bimaging%26aulast%3DPassemard%26aufirst%3DSol%25C3%25A8ne%26date%3D2015%26date%3D2015%26volume%3D17%26issue%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yali  Han</span>, <span class="hlFld-ContribAuthor ">Yanwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Tanghong  Jia</span>, <span class="hlFld-ContribAuthor ">Yuping  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts. </span><span class="cited-content_cbyCitation_journal-name">Tumor Biology</span><span> <strong>2015,</strong> <em>36 </em>
                                    (3)
                                     , 1385-1394. <a href="https://doi.org/10.1007/s13277-015-3230-8" title="DOI URL">https://doi.org/10.1007/s13277-015-3230-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13277-015-3230-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13277-015-3230-8%26sid%3Dliteratum%253Aachs%26jtitle%3DTumor%2520Biology%26atitle%3DMolecular%252Bmechanism%252Bunderlying%252Bthe%252Btumor-promoting%252Bfunctions%252Bof%252Bcarcinoma-associated%252Bfibroblasts%26aulast%3DHan%26aufirst%3DYali%26date%3D2015%26date%3D2015%26volume%3D36%26issue%3D3%26spage%3D1385%26epage%3D1394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romana  Meletta</span>, <span class="hlFld-ContribAuthor ">Adrienne  Müller Herde</span>, <span class="hlFld-ContribAuthor ">Aristeidis  Chiotellis</span>, <span class="hlFld-ContribAuthor ">Malsor  Isa</span>, <span class="hlFld-ContribAuthor ">Zoran  Rancic</span>, <span class="hlFld-ContribAuthor ">Nicole  Borel</span>, <span class="hlFld-ContribAuthor ">Simon  Ametamey</span>, <span class="hlFld-ContribAuthor ">Stefanie  Krämer</span>, <span class="hlFld-ContribAuthor ">Roger  Schibli</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (2)
                                     , 2081-2099. <a href="https://doi.org/10.3390/molecules20022081" title="DOI URL">https://doi.org/10.3390/molecules20022081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules20022081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules20022081%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEvaluation%252Bof%252Bthe%252BRadiolabeled%252BBoronic%252BAcid-Based%252BFAP%252BInhibitor%252BMIP-1232%252Bfor%252BAtherosclerotic%252BPlaque%252BImaging%26aulast%3DMeletta%26aufirst%3DRomana%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D2%26spage%3D2081%26epage%3D2099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth J.  Hamson</span>, <span class="hlFld-ContribAuthor ">Fiona M.  Keane</span>, <span class="hlFld-ContribAuthor ">Stefan  Tholen</span>, <span class="hlFld-ContribAuthor ">Oliver  Schilling</span>, <span class="hlFld-ContribAuthor ">Mark D.  Gorrell</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">PROTEOMICS - Clinical Applications</span><span> <strong>2014,</strong> <em>8 </em>
                                    (5-6)
                                     , 454-463. <a href="https://doi.org/10.1002/prca.201300095" title="DOI URL">https://doi.org/10.1002/prca.201300095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prca.201300095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprca.201300095%26sid%3Dliteratum%253Aachs%26jtitle%3DPROTEOMICS%2520-%2520Clinical%2520Applications%26atitle%3DUnderstanding%252Bfibroblast%252Bactivation%252Bprotein%252B%252528FAP%252529%25253A%252BSubstrates%25252C%252Bactivities%25252C%252Bexpression%252Band%252Btargeting%252Bfor%252Bcancer%252Btherapy%26aulast%3DHamson%26aufirst%3DElizabeth%2BJ.%26date%3D2014%26date%3D2014%26volume%3D8%26issue%3D5-6%26spage%3D454%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuei-Min  Chung</span>, <span class="hlFld-ContribAuthor ">Shu-Ching  Hsu</span>, <span class="hlFld-ContribAuthor ">Yue-Ru  Chu</span>, <span class="hlFld-ContribAuthor ">Mei-Yao  Lin</span>, <span class="hlFld-ContribAuthor ">Weir-Tong  Jiaang</span>, <span class="hlFld-ContribAuthor ">Ruey-Hwa  Chen</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, . </span><span class="cited-content_cbyCitation_article-title">Fibroblast Activation Protein (FAP) Is Essential for the Migration of Bone Marrow Mesenchymal Stem Cells through RhoA Activation. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (2)
                                     , e88772. <a href="https://doi.org/10.1371/journal.pone.0088772" title="DOI URL">https://doi.org/10.1371/journal.pone.0088772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0088772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0088772%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DFibroblast%252BActivation%252BProtein%252B%252528FAP%252529%252BIs%252BEssential%252Bfor%252Bthe%252BMigration%252Bof%252BBone%252BMarrow%252BMesenchymal%252BStem%252BCells%252Bthrough%252BRhoA%252BActivation%26aulast%3DChung%26aufirst%3DKuei-Min%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3De88772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koen  Jansen</span>, <span class="hlFld-ContribAuthor ">Hans  De Winter</span>, <span class="hlFld-ContribAuthor ">Leen  Heirbaut</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Cheng</span>, <span class="hlFld-ContribAuthor ">Jurgen  Joossens</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Pieter  Van der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2014,</strong> <em>5 </em>
                                    (11)
                                     , 1700-1707. <a href="https://doi.org/10.1039/C4MD00167B" title="DOI URL">https://doi.org/10.1039/C4MD00167B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00167B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00167B%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DSelective%252Binhibitors%252Bof%252Bfibroblast%252Bactivation%252Bprotein%252B%252528FAP%252529%252Bwith%252Ba%252Bxanthine%252Bscaffold%26aulast%3DJansen%26aufirst%3DKoen%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D11%26spage%3D1700%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. P<sub>1</sub> and P<sub>2</sub> specificity of FAP. Percentage of intact peptide remaining following a 24 h incubation at 37 °C of FAP with either the GXYSWS-NH<sub>2</sub> or Ac-GXYSWS-NH<sub>2</sub> peptide library for P<sub>1</sub> analysis or the XPYSWS-NH<sub>2</sub> or Ac-XPYSWS-NH<sub>2</sub> peptide library for P<sub>2</sub> analysis. The dark columns represent the peptide libraries with a free N-terminus, while the light columns represent the acetyl blocked libraries. Error bars show the mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lineweaver–Burk plots for inhibition of FAP and PREP by <b>6</b>. FAP (A) and PREP (B) either alone (closed squares) or with inhibitor concentrations equal to 0.5 IC<sub>50</sub> (open squares), IC<sub>50</sub> (closed squares), or 2 IC<sub>50</sub> (open squares) were incubated with varying concentrations of Suc-GP-AMC ((0.1–5)<i>K</i><sub>m</sub>) at 37 °C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of cellular prolyl endopeptidase activity in mock and murine FAP transfected HEK293 cells. Mock (dark columns) and mFAP transfected (light columns) HEK293 cells were incubated with cell culture medium alone or 1 μM <b>2</b>, <b>6</b>, or <b>22</b> for 15 min at 37 °C. The endopeptidase activity was assessed via cleavage of a Z-GP-AMC substrate: ∗∗∗, <i>P</i> < 0.0001 vs no inhibitor control. Error bars show the mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of the presence of PREP on FAP inhibition by <b>6</b>. (A) Recombinant FAP (1 nM) was mixed with varying concentrations of recombinant PREP and assayed for FAP inhibition by 36 nM (IC<sub>50</sub>) or 1 μM <b>6</b>. (B) Standard curves were prepared for recombinant FAP (closed circles) and recombinant PREP (open circles) activity using 25 μM FAP specific substrate or Z-GP-AMC, respectively. FAP activity associated with 25 000 HEK-mFAP cells (red star) was measured using an FAP specific substrate and determined to be 2 nM. PREP activity associated with mock transfected HEK293 cells (blue star) was measured using Z-GP-AMC and determined to be 2.9 nM. This yields a cellular PREP to FAP ratio of 1:1.5. Error bars show the mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/medium/jm-2013-00351a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cytotoxicity of <b>6</b> in mFAP transfected HEK293 cells. Cells were treated with varying concentrations of <b>6</b> (light columns), <b>20</b> (dark columns), or bortezomib as a positive control (striped columns) for 48 h. Cytotoxicity was assessed using a CellTiter-Blue cell viability assay with calculation of percent cell viability based on vehicle treated control cells. Error bars show the mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-9/jm400351a/production/images/large/jm-2013-00351a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400351a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">7235</span><span class="NLM_x">–</span> <span class="NLM_lpage">7239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=7235-7239&author=P.+Garin-Chesaauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Cell+surface+glycoprotein+of+reactive+stromal+fibroblasts+as+a+potential+antibody+target+in+human+epithelial+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DCell%2520surface%2520glycoprotein%2520of%2520reactive%2520stromal%2520fibroblasts%2520as%2520a%2520potential%2520antibody%2520target%2520in%2520human%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1990%26volume%3D87%26spage%3D7235%26epage%3D7239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozer, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albino, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span> </span><span class="NLM_article-title">Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3327</span><span class="NLM_x">–</span> <span class="NLM_lpage">3335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=3327-3335&author=W.+J.+Rettigauthor=P.+Garin-Chesaauthor=J.+H.+Healeyauthor=S.+L.+Suauthor=H.+L.+Ozerauthor=M.+Schwabauthor=A.+P.+Albinoauthor=L.+J.+Old&title=Regulation+and+heteromeric+structure+of+the+fibroblast+activation+protein+in+normal+and+transformed+cells+of+mesenchymal+and+neuroectodermal+origin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DSu%26aufirst%3DS.%2BL.%26aulast%3DOzer%26aufirst%3DH.%2BL.%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DAlbino%26aufirst%3DA.%2BP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26atitle%3DRegulation%2520and%2520heteromeric%2520structure%2520of%2520the%2520fibroblast%2520activation%2520protein%2520in%2520normal%2520and%2520transformed%2520cells%2520of%2520mesenchymal%2520and%2520neuroectodermal%2520origin%26jtitle%3DCancer%2520Res.%26date%3D1993%26volume%3D53%26spage%3D3327%26epage%3D3335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortunato, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanlan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: purification, epitope mapping and induction by growth factors</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1002%2Fijc.2910580314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=7519584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1994&pages=385-392&author=W.+J.+Rettigauthor=S.+L.+Suauthor=S.+R.+Fortunatoauthor=M.+J.+Scanlanauthor=B.+K.+Rajauthor=P.+Garin-Chesaauthor=J.+H.+Healeyauthor=L.+J.+Old&title=Fibroblast+activation+protein%3A+purification%2C+epitope+mapping+and+induction+by+growth+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein: purification, epitope mapping and induction by growth factors</span></div><div class="casAuthors">Rettig, Wolfgang J.; Su, Sai L.; Fortunato, Sheila R.; Scanlan, Matthew J.; Raj, B. K. Mohan; Garin-Chesa, Pilar; Healey, John H.; Old, Lloyd J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">385-92</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The human fibroblast activation protein (FAP) defined by monoclonal antibody (MAb) F19 is a cell surface antigen expressed in reactive stromal fibroblasts of breast, colorectal, lung and other epithelial cancers.  In contrast to its stroma-specific localization in epithelial neoplasms, FAP is expressed in the malignant mesenchymal cells of bone and soft tissue sarcomas.  FAP is transiently expressed in some fetal mesenchymal tissues but is absent or expressed at low levels in most adult tissues.  FAP is induced in cultured fibroblasts and, in these cells, consists of a Mr 95,000 subunit (FAPα) carrying the F19 epitope and a noncovalently bound Mr 105,000 subunit (FAPβ) lacking the F19 epitope.  Using MAb F19 and 5 newly derived MAbs, the authors identify 3 distinct epitopes on FAPα and tentatively assign one epitope to FAPβ.  Anal. of detergent exts. of a FAPαhighβ- sarcoma cell line by size exclusion-high performance liq. chromatog. (HPLC) revealed that FAPα does not elute as a Mr 95,000 species but as part of a high-mol. wt. complex (Mr > 400,000) that dissocs. into Mr 95,000 subunits in SDS gels.  Immunoaffinity purifn. of FAPα followed by tryptic digestion, reversed-phase HPLC and microsequencing identified 3 unique FAPα peptides, with 2 showing sequence similarity (23/38 identical amino acids) to segments of CD26, a T-cell activation antigen.  CD26 is a membrane-bound enzyme (dipeptidyl aminopeptidase IV), but immunopurified FAPα has little if any dipeptidase activity with typical CD26 substrates.  Finally, studies with FAPlow leptomeningeal fibroblasts revealed that transforming growth factor-β, 12-O-tetradecanoylphorbol-13-acetate and retinoids can upregulate FAP expression, whereas serum and several other factors had no or little effect on FAP levels.  FAP and CD26 may belong to a family of structurally related but functionally distinct activation proteins that are expressed on different cell types and show unique modes of regulation in normal and malignant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhaRLD8KLeb7Vg90H21EOLACvtfcHk0lh4AzGStd9W8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKgtL8%253D&md5=06ccffd843a71e7ea2047ea775451a14</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910580314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910580314%26sid%3Dliteratum%253Aachs%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DSu%26aufirst%3DS.%2BL.%26aulast%3DFortunato%26aufirst%3DS.%2BR.%26aulast%3DScanlan%26aufirst%3DM.%2BJ.%26aulast%3DRaj%26aufirst%3DB.%2BK.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520purification%252C%2520epitope%2520mapping%2520and%2520induction%2520by%2520growth%2520factors%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1994%26volume%3D58%26spage%3D385%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">36505</span><span class="NLM_x">–</span> <span class="NLM_lpage">36512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=36505-36512&author=J.+E.+Parkauthor=M.+C.+Lenterauthor=R.+N.+Zimmermannauthor=P.+Garin-Chesaauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Fibroblast+activation+protein%2C+a+dual+specificity+serine+protease+expressed+in+reactive+human+tumor+stromal+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DLenter%26aufirst%3DM.%2BC.%26aulast%3DZimmermann%26aufirst%3DR.%2BN.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DFibroblast%2520activation%2520protein%252C%2520a%2520dual%2520specificity%2520serine%2520protease%2520expressed%2520in%2520reactive%2520human%2520tumor%2520stromal%2520fibroblasts%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D36505%26epage%3D36512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Connolly, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanford, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiluwal, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healey, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimare, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maw, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudmeier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span> </span><span class="NLM_article-title">Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6005</span><span class="NLM_x">–</span> <span class="NLM_lpage">6013</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800390n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6005-6013&author=B.+A.+Connollyauthor=D.+G.+Sanfordauthor=A.+K.+Chiluwalauthor=S.+E.+Healeyauthor=D.+E.+Petersauthor=M.+T.+Dimareauthor=W.+Wuauthor=Y.+Liuauthor=H.+Mawauthor=Y.+Zhouauthor=Y.+Liauthor=Z.+Jinauthor=J.+L.+Sudmeierauthor=J.+H.+Laiauthor=W.+W.+Bachovchin&title=Dipeptide+boronic+acid+inhibitors+of+dipeptidyl+peptidase+IV%3A+determinants+of+potency+and+in+vivo+efficacy+and+safety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm800390n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800390n%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DB.%2BA.%26aulast%3DSanford%26aufirst%3DD.%2BG.%26aulast%3DChiluwal%26aufirst%3DA.%2BK.%26aulast%3DHealey%26aufirst%3DS.%2BE.%26aulast%3DPeters%26aufirst%3DD.%2BE.%26aulast%3DDimare%26aufirst%3DM.%2BT.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMaw%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DSudmeier%26aufirst%3DJ.%2BL.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DDipeptide%2520boronic%2520acid%2520inhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV%253A%2520determinants%2520of%2520potency%2520and%2520in%2520vivo%2520efficacy%2520and%2520safety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6005%26epage%3D6013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Maes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilany, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpé, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span> </span><span class="NLM_article-title">Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivitives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2005&pages=315-324&author=M.+Maesauthor=A.+Lambeirauthor=K.+Gilanyauthor=K.+Sentenauthor=P.+Van+der+Vekenauthor=B.+Leitingauthor=K.+Augustynsauthor=S.+Scharp%C3%A9author=I.+De+Meester&title=Kinetic+investigation+of+human+dipeptidyl+peptidase+II+%28DPPII%29-mediated+hydrolysis+of+dipeptide+derivitives+and+its+identification+as+quiescent+cell+proline+dipeptidase+%28QPP%29%2Fdipeptidyl+peptidase+7+%28DPP7%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaes%26aufirst%3DM.%26aulast%3DLambeir%26aufirst%3DA.%26aulast%3DGilany%26aufirst%3DK.%26aulast%3DSenten%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DScharp%25C3%25A9%26aufirst%3DS.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DKinetic%2520investigation%2520of%2520human%2520dipeptidyl%2520peptidase%2520II%2520%2528DPPII%2529-mediated%2520hydrolysis%2520of%2520dipeptide%2520derivitives%2520and%2520its%2520identification%2520as%2520quiescent%2520cell%2520proline%2520dipeptidase%2520%2528QPP%2529%252Fdipeptidyl%2520peptidase%25207%2520%2528DPP7%2529%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D386%26spage%3D315%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Yoshimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R.</span><span> </span><span class="NLM_article-title">Post-proline cleaving enzyme and post-proline dipeptidyl aminopeptidase. Comparison of two peptidases with high specificity for proline residues</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">3708</span><span class="NLM_x">–</span> <span class="NLM_lpage">3716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1978&pages=3708-3716&author=T.+Yoshimotoauthor=M.+Fischlauthor=R.+C.+Orlowskiauthor=R.+Walter&title=Post-proline+cleaving+enzyme+and+post-proline+dipeptidyl+aminopeptidase.+Comparison+of+two+peptidases+with+high+specificity+for+proline+residues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimoto%26aufirst%3DT.%26aulast%3DFischl%26aufirst%3DM.%26aulast%3DOrlowski%26aufirst%3DR.%2BC.%26aulast%3DWalter%26aufirst%3DR.%26atitle%3DPost-proline%2520cleaving%2520enzyme%2520and%2520post-proline%2520dipeptidyl%2520aminopeptidase.%2520Comparison%2520of%2520two%2520peptidases%2520with%2520high%2520specificity%2520for%2520proline%2520residues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1978%26volume%3D253%26spage%3D3708%26epage%3D3716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Levy, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodeling interface in human cirrhosis</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1768</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1999&pages=1768-1778&author=M.+T.+Levyauthor=G.+W.+McCaughanauthor=C.+A.+Abbottauthor=J.+E.+Parkauthor=A.+M.+Cunninghamauthor=E.+Mullerauthor=W.+J.+Rettigauthor=M.+D.+Gorrell&title=Fibroblast+activation+protein%3A+a+cell+surface+dipeptidyl+peptidase+and+gelatinase+expressed+by+stellate+cells+at+the+tissue+remodeling+interface+in+human+cirrhosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DM.%2BT.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DCunningham%26aufirst%3DA.%2BM.%26aulast%3DMuller%26aufirst%3DE.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520a%2520cell%2520surface%2520dipeptidyl%2520peptidase%2520and%2520gelatinase%2520expressed%2520by%2520stellate%2520cells%2520at%2520the%2520tissue%2520remodeling%2520interface%2520in%2520human%2520cirrhosis%26jtitle%3DHepatology%26date%3D1999%26volume%3D29%26spage%3D1768%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Vanhoof, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goossens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendriks, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpé, S.</span><span> </span><span class="NLM_article-title">Proline motifs in peptides and their biological processing</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1096%2Ffasebj.9.9.7601338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=7601338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADyaK2MXmvFCltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=736-744&author=G.+Vanhoofauthor=F.+Goossensauthor=I.+De+Meesterauthor=D.+Hendriksauthor=S.+Scharp%C3%A9&title=Proline+motifs+in+peptides+and+their+biological+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proline motifs in peptides and their biological processing</span></div><div class="casAuthors">Vanhoof, Greet; Goossens, Filip; De Meester, Ingrid; Hendriks, Dirk; Scharpe, Simon</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">736-44</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review, with 68 refs.  Many biol. important peptide sequences contain proline.  It confers unique conformational constraints on the peptide chain in that the side-chain is cyclized back onto the backbone amide position.  Inside an α-helix the possibility of making hydrogen bonds to the preceding turn is lost and a kink will be introduced.  The conformational restrictions imposed by proline motifs in a peptide chain appear to imply important structural or biol. functions as can be deduced from their often remarkably high degree of conservation as found in many proteins and peptides, esp. cytokines, growth factors, G-protein-coupled receptors, V3 loops of the HIV envelope glycoprotein gp120, and neuro- and vasoactive peptides.  Only a limited no. of peptidases are known to be able to hydrolyze proline adjacent bonds.  Their activity is influenced by the isomeric state (cis-trans) as well as the position of proline in the peptide chain.  The three proline specific metallo-peptidases (aminopeptidase P, carboxypeptidase P and prolidase) are activated by Mn2+, whereas the three serine type peptidases cleaving a post proline bond (prolyl oligopeptidase, dipeptidyl peptidase IV, and prolylcarboxypeptidase) share the sequential order of the catalytic Ser-Asp-His triad, which differentiates them from the chymotrypsin (His-Asp-Ser) and subtilisin (Asp-His-Ser) families.  An endo or C terminal Pro-Pro bond and an endo pre-Pro peptide bond possess a high degree of resistance to any mammalian proteolytic enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz_jJTdKPvebVg90H21EOLACvtfcHk0li8woJCkLkCzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvFCltbo%253D&md5=c7f0cca49b831f369a7cc252ffe75d5f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.9.9.7601338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.9.9.7601338%26sid%3Dliteratum%253Aachs%26aulast%3DVanhoof%26aufirst%3DG.%26aulast%3DGoossens%26aufirst%3DF.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DHendriks%26aufirst%3DD.%26aulast%3DScharp%25C3%25A9%26aufirst%3DS.%26atitle%3DProline%2520motifs%2520in%2520peptides%2520and%2520their%2520biological%2520processing%26jtitle%3DFASEB%2520J.%26date%3D1995%26volume%3D9%26spage%3D736%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Mentlein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallwitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, W. E.</span><span> </span><span class="NLM_article-title">Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">214</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1111%2Fj.1432-1033.1993.tb17986.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=8100523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADyaK3sXks1elsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1993&pages=829-835&author=R.+Mentleinauthor=B.+Gallwitzauthor=W.+E.+Schmidt&title=Dipeptidyl-peptidase+IV+hydrolyses+gastric+inhibitory+polypeptide%2C+glucagon-like+peptide-1%287-36%29amide%2C+peptide+histidine+methionine+and+is+responsible+for+their+degradation+in+human+serum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl-peptidase IV hydrolyzes gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum</span></div><div class="casAuthors">Mentlein, Rolf; Gallwitz, Baptist; Schmidt, Wolfgang E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">829-35</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Peptides of the glucagon/VIP family share a considerable sequence similarity at their N-terminus.  They either start with Tyr-Ala, His-Ala or His-Ser which might be in part potential targets for dipeptidyl-peptidase IV, a highly specialized aminopeptidase removing dipeptides only from peptides with N-terminal penultimate proline or alanine.  GH-releasing factor(1-29)amide and gastric inhibitory peptide/glucose-dependent insulinotropic peptide (GIP) with terminal Tyr-Ala as well as glucagon-like peptide-1(7-36)amide/insulinotropin [GLP-1(7-36)amide] and peptide histidine methionine (PHM) with terminal His-Ala were hydrolyzed to their des-Xaa-Ala derivs. by dipeptidyl-peptidase IV purified from human placenta.  VIP with terminal His-Ser was not degraded by the peptidase.  The kinetics of the hydrolysis of GIP, GLP-1(7-36)amide and PHM were analyzed in detail.  For these peptides Km values of 4-34 μM and Vmax values of 0.6-3.8 μmol/min/mg protein were detd. for the purified peptidase which should allow their enzymic degrdn. also at physiol., nanomolar concns.  When human serum was incubated with GIP or GLP-1(7-36)amide the same fragments as with the purified dipeptidyl-peptidase IV, namely the des-Xaa-Ala peptides and Tyr-Ala in the case of GIP or His-Ala in the case of GLP-1(7-36)amide, were identified as the main degrdn. products of these peptide hormones.  Incorporation of inhibitors specific for dipeptidyl-peptidase IV, 1 mM Lys-pyrrolidide or 0.1 mM diprotin A (Ile-Pro-Ile), completely abolished the prodn. of these fragments by serum.  It is concluded that dipeptidyl-peptidase IV initiates the metab. of GIP and GLP-1(7-36)amide in human serum.  Since an intact N-terminus is obligate for the biol. activity of the members of the glucagon/VIP peptide family [e.g., GIP(3-42) is known to be inactive to release insulin in the presence of glucose as is intact GIP], dipeptidyl-peptidase-IV action inactivates these peptide hormones.  The relevance of this finding for their inactivation and their detn. by immunoassays is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaIzMbUUoh9LVg90H21EOLACvtfcHk0li8woJCkLkCzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1elsLs%253D&md5=dd06411585d4e8bb42d5b093e895b900</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1993.tb17986.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1993.tb17986.x%26sid%3Dliteratum%253Aachs%26aulast%3DMentlein%26aufirst%3DR.%26aulast%3DGallwitz%26aufirst%3DB.%26aulast%3DSchmidt%26aufirst%3DW.%2BE.%26atitle%3DDipeptidyl-peptidase%2520IV%2520hydrolyses%2520gastric%2520inhibitory%2520polypeptide%252C%2520glucagon-like%2520peptide-1%25287-36%2529amide%252C%2520peptide%2520histidine%2520methionine%2520and%2520is%2520responsible%2520for%2520their%2520degradation%2520in%2520human%2520serum%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1993%26volume%3D214%26spage%3D829%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kieffer, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pederson, R. A.</span><span> </span><span class="NLM_article-title">Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">3585</span><span class="NLM_x">–</span> <span class="NLM_lpage">3596</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1995&pages=3585-3596&author=T.+J.+Kiefferauthor=C.+H.+McIntoshauthor=R.+A.+Pederson&title=Degradation+of+glucose-dependent+insulinotropic+polypeptide+and+truncated+glucagon-like+peptide+1+in+vitro+and+in+vivo+by+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKieffer%26aufirst%3DT.%2BJ.%26aulast%3DMcIntosh%26aufirst%3DC.%2BH.%26aulast%3DPederson%26aufirst%3DR.%2BA.%26atitle%3DDegradation%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide%2520and%2520truncated%2520glucagon-like%2520peptide%25201%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DEndocrinology%26date%3D1995%26volume%3D136%26spage%3D3585%26epage%3D3596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Choy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, S.</span><span> </span><span class="NLM_article-title">Sitagliptin: a novel drug for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Cardiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">264</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1097%2FCRD.0b013e318123f771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=17700385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A280%3ADC%252BD2svovFensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=264-271&author=M.+Choyauthor=S.+Lam&title=Sitagliptin%3A+a+novel+drug+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Sitagliptin: a novel drug for the treatment of type 2 diabetes</span></div><div class="casAuthors">Choy Mary; Lam Sum</div><div class="citationInfo"><span class="NLM_cas:title">Cardiology in review</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">264-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Type 2 diabetes mellitus is a common chronic disease that causes significant morbidity and mortality worldwide.  The primary goal of treatment is to target glycemic control by maintaining the glycosylated hemoglobin level near 6-7% without predisposing patients to hypoglycemia.  Diabetes results from a combination of increased hepatic glucose production, decreased insulin secretion from beta cells, and insulin resistance in the peripheral tissues.  Currently available antidiabetic agents work by different mechanisms to lower blood glucose levels.  Unfortunately, each of them has its tolerability and safety concerns that limit its use and dose titration.  Sitagliptin is the first antidiabetic agent from the class of dipeptidyl peptidase-4 enzyme inhibitors.  It increases the amount of circulating incretins, which stimulate insulin secretion and inhibit glucose production.  Sitagliptin was approved by the US Food and Drug Administration (FDA) for use with diet and exercise to improve glycemic control in adult patients with type 2 diabetes.  It can be used alone or in combination with metformin or a thiazolidinedione (pioglitazone or rosiglitazone) when treatment with either drug alone provides inadequate glucose control.  The usual adult dose is 100 mg once daily.  A dose of 25-50 mg once daily is recommended for patients with moderate-to-severe renal impairment.  In randomized, placebo-controlled trials that lasted for up to 6 months, sitagliptin lowered glycosylated hemoglobin levels by 0.5-0.8%.  In a 52-week clinical trial, sitagliptin was shown to be noninferior to glipizide as an add-on agent in patients inadequately controlled on metformin alone.  Sitagliptin was well tolerated with the most common side effects being gastrointestinal complaints (up to 16%), including abdominal pain, nausea and diarrhea; hypoglycemia and body weight gain occurred at similar rates compared with placebo.  Overall, sitagliptin provides a treatment option for patients with type 2 diabetes as a monotherapy, or as an adjunct to metformin or a thiazolidinedione when patients achieve inadequate glycemic control while on either of the agents.  It is also an alternative therapy for those patients who have contraindications or intolerability to other antidiabetic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQE6VB-Pf2cTq91pGlMMoT5fW6udTcc2eYXvEIbzokt_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svovFensw%253D%253D&md5=f4f20ba2241dacf7e55c26d3c5cec66c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1097%2FCRD.0b013e318123f771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCRD.0b013e318123f771%26sid%3Dliteratum%253Aachs%26aulast%3DChoy%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DS.%26atitle%3DSitagliptin%253A%2520a%2520novel%2520drug%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DCardiol.%2520Rev.%26date%3D2007%26volume%3D15%26spage%3D264%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbrack, R. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valianou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogatko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alpaugh, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span> </span><span class="NLM_article-title">Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4767</span><span class="NLM_x">–</span> <span class="NLM_lpage">4772</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4767-4772&author=J.+D.+Chengauthor=R.+L.+Dunbrackauthor=M.+Valianouauthor=A.+Rogatkoauthor=R.+K.+Alpaughauthor=L.+M.+Weiner&title=Promotion+of+tumor+growth+by+murine+fibroblast+activation+protein%2C+a+serine+protease%2C+in+an+animal+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DDunbrack%26aufirst%3DR.%2BL.%26aulast%3DValianou%26aufirst%3DM.%26aulast%3DRogatko%26aufirst%3DA.%26aulast%3DAlpaugh%26aufirst%3DR.%2BK.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26atitle%3DPromotion%2520of%2520tumor%2520growth%2520by%2520murine%2520fibroblast%2520activation%2520protein%252C%2520a%2520serine%2520protease%252C%2520in%2520an%2520animal%2520model%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4767%26epage%3D4772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Scott, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiseman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divgi, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gansen, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanswell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bette, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amelsberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlock, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span> </span><span class="NLM_article-title">A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1639</span><span class="NLM_x">–</span> <span class="NLM_lpage">1647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=12738716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFeisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1639-1647&author=A.+M.+Scottauthor=G.+Wisemanauthor=S.+Weltauthor=A.+Adjeiauthor=F.+T.+Leeauthor=W.+Hopkinsauthor=C.+R.+Divgiauthor=L.+H.+Hansonauthor=P.+Mitchellauthor=D.+N.+Gansenauthor=S.+M.+Larsonauthor=J.+N.+Ingleauthor=E.+W.+Hoffmanauthor=P.+Tanswellauthor=G.+Ritterauthor=L.+S.+Cohenauthor=P.+Betteauthor=L.+Arvayauthor=A.+Amelsbergauthor=D.+Vlockauthor=W.+J.+Rettigauthor=L.+J.+Old&title=A+phase+I+dose-escalation+study+of+sibrotuzumab+in+patients+with+advanced+or+metastatic+fibroblast+activation+protein-positive+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer</span></div><div class="casAuthors">Scott, Andrew M.; Wiseman, Greg; Welt, Sydney; Adjei, Alex; Lee, Fook-Thean; Hopkins, Wendie; Divgi, Chaitan R.; Hanson, Lorelei H.; Mitchell, Paul; Gansen, Denise N.; Larson, Steven M.; Ingle, James N.; Hoffman, Eric W.; Tanswell, Paul; Ritter, Gerd; Cohen, Leonard S.; Bette, Peter; Arvay, Lisa; Amelsberg, Andree; Vlock, Dan; Rettig, Wolfgang J.; Old, Lloyd J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1639-1647</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The purpose of this research was to det. the safety, immunogenicity, pharmacokinetics, biodistribution, and tumor uptake of repeat infusions of a complementarity-detg. region grafted humanized antibody (sibrotuzumab) directed against human fibroblast activation protein (FAP).  Exptl. Design: A Phase I open-label dose escalation study was conducted in patients with cancers epidemiol. known to be FAP pos.  Patients were entered into one of four dosage tiers of 5, 10, 25, or 50 mg/m2 sibrotuzumab, administered weekly for 12 wk, with trace labeling with 8-10 mCi of 131I in weeks 1, 5, and 9.  RESULTS: A total of 26 patients were entered into the trial (15 males and 11 females; mean age, 59.9 yr; age range, 41-81 yr).  Twenty patients had colorectal carcinoma, and 6 patients had non-small cell lung cancer.  A total of 218 infusions of sibrotuzumab were administered during the first 12 wk of the study, with 24 patients being evaluable.  One patient received an addnl. 96 infusions on continued-use phase for a total of 108 infusions over a 2-yr period, and 1 patient received an addnl. 6 infusions on continued use.  There were no objective tumor responses.  Only one episode of dose-limiting toxicity was obsd.  Therefore, a max. tolerated dose was not reached.  Treatment-related adverse events were obsd. in 6 patients during the infusional monitoring period.  Four of the 6 patients, 3 of whom had assocd. pos. serum human antihuman antibody, were removed from the study because of clin. immune responses.  Gamma camera images of [131I]sibrotuzumab demonstrated no normal organ uptake of sibrotuzumab, with tumor uptake evident within 24-48 h after infusion.  Anal. of pharmacokinetics demonstrated a similar mean terminal t1/2 of 1.4-2.6 days at the 5, 10, and 25 mg/m2 dose levels, and with a longer mean t1/2 of 4.9 days at the 50 mg/m2 dose level.  CONCLUSION: Repeat infusions of the humanized anti-FAP antibody sibrotuzumab can be administered safely to patients with advanced FAP-pos. cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCBq6WNJIOsrVg90H21EOLACvtfcHk0ljwfKNBf-H-Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFeisbc%253D&md5=b0a39685070fb41ec2309ac5cc2027d8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DA.%2BM.%26aulast%3DWiseman%26aufirst%3DG.%26aulast%3DWelt%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DF.%2BT.%26aulast%3DHopkins%26aufirst%3DW.%26aulast%3DDivgi%26aufirst%3DC.%2BR.%26aulast%3DHanson%26aufirst%3DL.%2BH.%26aulast%3DMitchell%26aufirst%3DP.%26aulast%3DGansen%26aufirst%3DD.%2BN.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DIngle%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DE.%2BW.%26aulast%3DTanswell%26aufirst%3DP.%26aulast%3DRitter%26aufirst%3DG.%26aulast%3DCohen%26aufirst%3DL.%2BS.%26aulast%3DBette%26aufirst%3DP.%26aulast%3DArvay%26aufirst%3DL.%26aulast%3DAmelsberg%26aufirst%3DA.%26aulast%3DVlock%26aufirst%3DD.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26atitle%3DA%2520phase%2520I%2520dose-escalation%2520study%2520of%2520sibrotuzumab%2520in%2520patients%2520with%2520advanced%2520or%2520metastatic%2520fibroblast%2520activation%2520protein-positive%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D1639%26epage%3D1647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Puré, E.</span><span> </span><span class="NLM_article-title">The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1517%2F14728220903103841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=19606930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Sku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=967-973&author=E.+Pur%C3%A9&title=The+road+to+integrative+cancer+therapies%3A+emergence+of+a+tumor-associated+fibroblast+protease+as+a+potential+therapeutic+target+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The road to integrative cancer therapies: emergence of a tumor-associated fibroblast protease as a potential therapeutic target in cancer</span></div><div class="casAuthors">Pure, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">967-973</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Great inroads have been made in defining the oncogenic pathways intrinsic to neoplastic cells and the mechanisms by which they are activated in tumors.  Knowledge of these pathways provides numerous opportunities that are actively being pursued to develop targeted therapies for cancer.  Complementary studies, focused on the non-transformed components of the tumor microenvironment (TME), have revealed that the extrinsic cues provided by the TME are also essential for tumor cells to manifest a fully transformed phenotype, angiogenesis and metastasis.  Delineation of these cues and their underlying cellular and mol. pathways will thus lead to a new era of integrative cancer therapy based on combinatorial drug regiments that act synergistically to destroy the neoplastic cells by targeting both the intrinsic and extrinsic pro-oncogenic pathways.  Tumor-assocd. fibroblasts (TAFs) and proteases are two of the key regulators of epithelial-derived tumors that represent potential targets of such integrative therapies.  Herein, we consider the potential therapeutic benefit of inhibiting the function of fibroblast activation protein (FAP), a cell surface serine protease with dipeptidyl peptidase and endopeptidase activity that is expressed on TAFs and pericytes, in an integrative approach to treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppEDzBKqL3Y7Vg90H21EOLACvtfcHk0lgZPZsEXEDaqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Sku7w%253D&md5=ec455a687909d70185c196d879bd99bc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F14728220903103841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220903103841%26sid%3Dliteratum%253Aachs%26aulast%3DPur%25C3%25A9%26aufirst%3DE.%26atitle%3DThe%2520road%2520to%2520integrative%2520cancer%2520therapies%253A%2520emergence%2520of%2520a%2520tumor-associated%2520fibroblast%2520protease%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D967%26epage%3D973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Santos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aziz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissil, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puré, E.</span><span> </span><span class="NLM_article-title">Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3613</span><span class="NLM_x">–</span> <span class="NLM_lpage">3625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1172%2FJCI38988" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=19920354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCit7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=3613-3625&author=A.+M.+Santosauthor=J.+Jungauthor=N.+Azizauthor=J.+L.+Kissilauthor=E.+Pur%C3%A9&title=Targeting+fibroblast+activation+protein+inhibits+tumor+stromagenesis+and+growth+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice</span></div><div class="casAuthors">Santos, Angelica M.; Jung, Jason; Aziz, Nazneen; Kissil, Joseph L.; Pure, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3613-3625</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Membrane-bound proteases have recently emerged as crit. mediators of tumorigenesis, angiogenesis, and metastasis.  However, the mechanisms by which they regulate these processes remain unknown.  As the cell surface serine protease fibroblast activation protein (FAP) is selectively expressed on tumor-assocd. fibroblasts and pericytes in epithelial tumors, we set out to investigate the role of FAP in mouse models of epithelial-derived solid tumors.  In this study, we demonstrate that genetic deletion and pharmacol. inhibition of FAP inhibited tumor growth in both an endogenous mouse model of lung cancer driven by the K-rasG12D mutant and a mouse model of colon cancer, in which CT26 mouse colon cancer cells were transplanted into immune competent syngeneic mice.  Interestingly, growth of only the K-rasG12D-driven lung tumors was also attenuated by inhibition of the closely related protease dipeptidyl peptidase IV (DPPIV).  Our results indicate that FAP depletion inhibits tumor cell proliferation indirectly, increases accumulation of collagen, decreases myofibroblast content, and decreases blood vessel d. in tumors.  These data provide proof of principle that targeting stromal cell-mediated modifications of the tumor microenvironment may be an effective approach to treating epithelial-derived solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY1-xywXMGHrVg90H21EOLACvtfcHk0lgZPZsEXEDaqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCit7jK&md5=20f20b9dbbcbe1f72a06d37f6ee19cde</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1172%2FJCI38988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI38988%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DA.%2BM.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DAziz%26aufirst%3DN.%26aulast%3DKissil%26aufirst%3DJ.%2BL.%26aulast%3DPur%25C3%25A9%26aufirst%3DE.%26atitle%3DTargeting%2520fibroblast%2520activation%2520protein%2520inhibits%2520tumor%2520stromagenesis%2520and%2520growth%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D3613%26epage%3D3625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valianou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canutescu, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span> </span><span class="NLM_article-title">Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1158%2F1535-7163.MCT-05-0128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=15767544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Kgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=351-360&author=J.+D.+Chengauthor=M.+Valianouauthor=A.+A.+Canutescuauthor=E.+K.+Jaffeauthor=H.+O.+Leeauthor=H.+Wangauthor=J.+H.+Laiauthor=W.+W.+Bachovchinauthor=L.+M.+Weiner&title=Abrogation+of+fibroblast+activation+protein+enzymatic+activity+attenuates+tumor+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth</span></div><div class="casAuthors">Cheng, Jonathan D.; Valianou, Matthildi; Canutescu, Adrian A.; Jaffe, Eileen K.; Lee, Hyung-Ok; Wang, Hao; Lai, Jack H.; Bachovchin, William W.; Weiner, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">351-360</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tumor-assocd. fibroblasts are functionally and phenotypically distinct from normal fibroblasts that are not in the tumor microenvironment.  Fibroblast activation protein is a 95 kDa cell surface glycoprotein expressed by tumor stromal fibroblasts, and has been shown to have dipeptidyl peptidase and collagenase activity.  Site-directed mutagenesis at the catalytic site of fibroblast activation protein, Ser624 Ala624, resulted in an ∼100,000-fold loss of fibroblast activation protein dipeptidyl peptidase (DPP) activity.  HEK293 cells transfected with wild-type fibroblast activation protein, enzymic mutant (S624A) fibroblast activation protein, or vector alone, were inoculated s.c. into immunodeficient mouse to assess the contribution of fibroblast activation protein enzymic activity to tumor growth.  Overexpression of wild-type fibroblast activation protein showed growth potentiation and enhanced tumorigenicity compared with both fibroblast activation protein S624A and vector-transfected HEK293 xenografts.  HEK293 cells transfected with fibroblast activation protein S624A showed tumor growth rates and tumorigenicity potential similar only to vector-transfected HEK293.  In vivo assessment of fibroblast activation protein DPP activity of these tumors showed enhanced enzymic activity of wild-type fibroblast activation protein, with only baseline levels of fibroblast activation protein DPP activity in either fibroblast activation protein S624A or vector-only xenografts.  These results indicate that the enzymic activity of fibroblast activation protein is necessary for fibroblast activation protein-driven tumor growth in the HEK293 xenograft model system.  This establishes the proof-of-principle that the enzymic activity of fibroblast activation protein plays an important role in the promotion of tumor growth, and provides an attractive target for therapeutics designed to alter fibroblast activation protein-induced tumor growth by targeting its enzymic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJQ7ekEjT-O7Vg90H21EOLACvtfcHk0lgZPZsEXEDaqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Kgu7g%253D&md5=9ef5725b966bd47692ad130aecf56ba9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0128%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DValianou%26aufirst%3DM.%26aulast%3DCanutescu%26aufirst%3DA.%2BA.%26aulast%3DJaffe%26aufirst%3DE.%2BK.%26aulast%3DLee%26aufirst%3DH.%2BO.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26atitle%3DAbrogation%2520of%2520fibroblast%2520activation%2520protein%2520enzymatic%2520activity%2520attenuates%2520tumor%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D351%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kraman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambrough, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magiera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopinathan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fearon, D. T.</span><span> </span><span class="NLM_article-title">Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=827-830&author=M.+Kramanauthor=P.+J.+Bambroughauthor=J.+N.+Arnoldauthor=E.+W.+Robertsauthor=L.+Magieraauthor=J.+O.+Jonesauthor=A.+Gopinathanauthor=D.+A.+Tuvesonauthor=D.+T.+Fearon&title=Suppression+of+antitumor+immunity+by+stromal+cells+expressing+fibroblast+activation+protein-alpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKraman%26aufirst%3DM.%26aulast%3DBambrough%26aufirst%3DP.%2BJ.%26aulast%3DArnold%26aufirst%3DJ.%2BN.%26aulast%3DRoberts%26aufirst%3DE.%2BW.%26aulast%3DMagiera%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DJ.%2BO.%26aulast%3DGopinathan%26aufirst%3DA.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DFearon%26aufirst%3DD.%2BT.%26atitle%3DSuppression%2520of%2520antitumor%2520immunity%2520by%2520stromal%2520cells%2520expressing%2520fibroblast%2520activation%2520protein-alpha%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D827%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aziz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions</span> <span class="citation_source-journal">Clin. Exp. Metastasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">579</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1007%2Fs10585-011-9392-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=21604185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFCnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=567-579&author=Y.+Huangauthor=A.+E.+Simmsauthor=A.+Mazurauthor=S.+Wangauthor=N.+R.+Le%C3%B3nauthor=B.+Jonesauthor=N.+Azizauthor=T.+Kelly&title=Fibroblast+activation+protein-%CE%B1+promotes+tumor+growth+and+invasion+of+breast+cancer+cells+through+non-enzymatic+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions</span></div><div class="casAuthors">Huang, Yan; Simms, Avis E.; Mazur, Anna; Wang, Sophie; Leon, Noel R.; Jones, Barry; Aziz, Nazneen; Kelly, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Metastasis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">567-579</span>CODEN:
                <span class="NLM_cas:coden">CEXMD2</span>;
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Fibroblast activation protein-α (FAP) is a cell surface, serine protease of the post-prolyl peptidase family that is expressed in human breast cancer but not in normal tissues.  Previously, we showed that FAP expression increased tumor growth rates in a mouse model of human breast cancer.  Here the role of the proteolytic activities of FAP in promoting tumor growth, matrix degrdn. and invasion was investigated.  Mammary fat pads of female SCID mice were inoculated with breast cancer cells that express FAP and the mice treated with normal saline or Val-boroPro (talabostat); Glu-boroPro (PT-630); or 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine (LAF-237) that inhibit prolyl peptidases.  Other mice were injected with breast cancer cells expressing a catalytically inactive mutant of FAP and did not receive inhibitor treatment.  PT-630 and LAF-237 did not slow growth of tumors produced by any of the three cell lines expressing FAP.  Talabostat slightly decreased the growth rates of the FAP-expressing tumors but because PT-630 and LAF-237 did not, the growth retardation was likely not related to the inhibition of FAP or the related post-prolyl peptidase dipeptidyl peptidase IV.  Breast cancer cells expressing a catalytically inactive mutant of FAP (FAPS624A) also produced tumors that grew rapidly.  In vitro studies revealed that cells expressing wild type FAP or FAPS624A degrade extracellular matrix (ECM) more extensively, accumulate higher levels of matrix metalloproteinase-9 (MMP-9) in conditioned medium, are more invasive in type I collagen gels, and have altered signaling compared to control transfectants that do not express FAP and form slow growing tumors.  We conclude that the proteolytic activity of FAP participates in matrix degrdn., but other functions of the protein stimulate increased tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofYFS39K1wf7Vg90H21EOLACvtfcHk0ljlvLfRJliEBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFCnurw%253D&md5=fe86072a63578490a9eadcacf0d979aa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs10585-011-9392-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10585-011-9392-x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSimms%26aufirst%3DA.%2BE.%26aulast%3DMazur%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLe%25C3%25B3n%26aufirst%3DN.%2BR.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DAziz%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DT.%26atitle%3DFibroblast%2520activation%2520protein-%25CE%25B1%2520promotes%2520tumor%2520growth%2520and%2520invasion%2520of%2520breast%2520cancer%2520cells%2520through%2520non-enzymatic%2520functions%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D2011%26volume%3D28%26spage%3D567%26epage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallner, B. P.</span><span> </span><span class="NLM_article-title">PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">5471</span><span class="NLM_x">–</span> <span class="NLM_lpage">5480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=5471-5480&author=S.+Adamsauthor=G.+T.+Millerauthor=M.+I.+Jessonauthor=T.+Watanabeauthor=B.+Jonesauthor=B.+P.+Wallner&title=PT-100%2C+a+small+molecule+dipeptidyl+peptidase+inhibitor%2C+has+potent+antitumor+effects+and+augments+antibody-mediated+cytotoxicity+via+a+novel+immune+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DG.%2BT.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DWallner%26aufirst%3DB.%2BP.%26atitle%3DPT-100%252C%2520a%2520small%2520molecule%2520dipeptidyl%2520peptidase%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520effects%2520and%2520augments%2520antibody-mediated%2520cytotoxicity%2520via%2520a%2520novel%2520immune%2520mechanism%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D5471%26epage%3D5480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Selective inhibition of fibroblast activation protein based on dipeptide substrate specificity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7437</span><span class="NLM_x">–</span> <span class="NLM_lpage">7444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7437-7444&author=C.+Y.+Edosadaauthor=C.+Quanauthor=C.+Wiesmannauthor=T.+Tranauthor=D.+Sutherlinauthor=M.+Reynoldsauthor=J.+M.+Elliottauthor=H.+Raabauthor=W.+Fairbrotherauthor=B.+B.+Wolf&title=Selective+inhibition+of+fibroblast+activation+protein+based+on+dipeptide+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DReynolds%26aufirst%3DM.%26aulast%3DElliott%26aufirst%3DJ.%2BM.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DFairbrother%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DSelective%2520inhibition%2520of%2520fibroblast%2520activation%2520protein%2520based%2520on%2520dipeptide%2520substrate%2520specificity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7437%26epage%3D7444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4 and POP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1438</span><span class="NLM_x">–</span> <span class="NLM_lpage">1442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1438-1442&author=T.+Tranauthor=C.+Quanauthor=C.+Y.+Edosadaauthor=M.+Mayedaauthor=C.+Wiesmannauthor=D.+Sutherlinauthor=B.+B.+Wolf&title=Synthesis+and+structure%E2%80%93activity+relationship+of+N-acyl-Gly-%2C+N-acyl-Sar-+and+N-blocked-boroPro+inhibitors+of+FAP%2C+DPP4+and+POP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DMayeda%26aufirst%3DM.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520N-acyl-Gly-%252C%2520N-acyl-Sar-%2520and%2520N-blocked-boroPro%2520inhibitors%2520of%2520FAP%252C%2520DPP4%2520and%2520POP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1438%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Tsai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiaang, W.</span><span> </span><span class="NLM_article-title">Substituted 4-caboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6572</span><span class="NLM_x">–</span> <span class="NLM_lpage">6583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1002556" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6572-6583&author=T.+Tsaiauthor=T.+Yehauthor=X.+Chenauthor=T.+Hsuauthor=Y.+Jaoauthor=C.+Huangauthor=J.+Songauthor=Y.+Huangauthor=C.+Chienauthor=J.+Chiuauthor=S.+Yenauthor=H.+Tangauthor=Y.+Chaoauthor=W.+Jiaang&title=Substituted+4-caboxymethylpyroglutamic+acid+diamides+as+potent+and+selective+inhibitors+of+fibroblast+activation+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm1002556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1002556%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DT.%26aulast%3DYeh%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DJao%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DChiu%26aufirst%3DJ.%26aulast%3DYen%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DChao%26aufirst%3DY.%26aulast%3DJiaang%26aufirst%3DW.%26atitle%3DSubstituted%25204-caboxymethylpyroglutamic%2520acid%2520diamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6572%26epage%3D6583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ryabtsova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issues of FAP/prolyl oligopeptidase (PREP)-selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3412</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3412-3417&author=O.+Ryabtsovaauthor=K.+Jansenauthor=S.+Van+Goethemauthor=J.+Joossensauthor=J.+D.+Chengauthor=A.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Acylated+Gly-%282-cyano%29pyrrolidines+as+inhibitors+of+fibroblast+activation+protein+%28FAP%29+and+the+issues+of+FAP%2Fprolyl+oligopeptidase+%28PREP%29-selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyabtsova%26aufirst%3DO.%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DLambeir%26aufirst%3DA.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DAcylated%2520Gly-%25282-cyano%2529pyrrolidines%2520as%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520and%2520the%2520issues%2520of%2520FAP%252Fprolyl%2520oligopeptidase%2520%2528PREP%2529-selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3412%26epage%3D3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=1397-1404&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=V.+J.+Christiansenauthor=C.+S.+Leeauthor=J.+G.+Chunauthor=P.+A.+McKee&title=Antiplasmin-cleaving+enzyme+is+a+soluble+form+of+fibroblast+activation+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DChun%26aufirst%3DJ.%2BG.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DAntiplasmin-cleaving%2520enzyme%2520is%2520a%2520soluble%2520form%2520of%2520fibroblast%2520activation%2520protein%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D1397%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Tenorio-Laranga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venäläinen, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Horsman, J. A.</span><span> </span><span class="NLM_article-title">Characterization of membrane-bound prolyl endopeptidase from brain</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">4415</span><span class="NLM_x">–</span> <span class="NLM_lpage">4427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2008&pages=4415-4427&author=J.+Tenorio-Larangaauthor=J.+I.+Ven%C3%A4l%C3%A4inenauthor=P.+T.+M%C3%A4nnist%C3%B6author=J.+A.+Garc%C3%ADa-Horsman&title=Characterization+of+membrane-bound+prolyl+endopeptidase+from+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTenorio-Laranga%26aufirst%3DJ.%26aulast%3DVen%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%2BI.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DGarc%25C3%25ADa-Horsman%26aufirst%3DJ.%2BA.%26atitle%3DCharacterization%2520of%2520membrane-bound%2520prolyl%2520endopeptidase%2520from%2520brain%26jtitle%3DFEBS%2520J.%26date%3D2008%26volume%3D275%26spage%3D4415%26epage%3D4427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Irazusta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrinaga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Maeso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meana, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casis, L.</span><span> </span><span class="NLM_article-title">Distribution of prolyl endopeptidase activities in rat and human brain</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1016%2FS0197-0186%2801%2900078-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=11792464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVOjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2002&pages=337-345&author=J.+Irazustaauthor=G.+Larrinagaauthor=J.+Gonz%C3%A1lez-Maesoauthor=J.+Gilauthor=J.+J.+Meanaauthor=L.+Casis&title=Distribution+of+prolyl+endopeptidase+activities+in+rat+and+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of prolyl endopeptidase activities in rat and human brain</span></div><div class="casAuthors">Irazusta, Jon; Larrinaga, Gorka; Gonzalez-Maeso, Javier; Gil, Javier; Meana, J. Javier; Casis, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-345</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Prolyl endopeptidase (I) is a proteolytic enzyme which could play a neuropeptide-catabolizing role in the central nervous system.  Although I has been described as a cytosolic enzyme, it has become clear that it can also be found in particulate form.  Here, the regional and subcellular distribution of I was evaluated in rat and human brain.  I activity was higher in the human than in the rat brain.  In the human brain, the activity levels of both sol. and particulate I were highest in the frontal, parietal, and occipital cortexes and lowest in the cerebellum.  In the rat brain, the regional distribution of I was more homogeneous.  I activity in all of the areas of the central nervous system was higher than in peripheral tissues.  The subcellular distribution of the enzyme in the brain indicated that I is higher in the cytosolic fraction than in the particulate fractions.  The particulate form was enriched in synaptosomal and myelin membranes.  The high activity of I in the human cortex suggests that it may play a role in the functions of this brain area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoULD-VZP08a7Vg90H21EOLACvtfcHk0liC6eOFTx_Wcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVOjtg%253D%253D&md5=36ade534063e5d762c2243f5c6572d6d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0197-0186%2801%2900078-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-0186%252801%252900078-X%26sid%3Dliteratum%253Aachs%26aulast%3DIrazusta%26aufirst%3DJ.%26aulast%3DLarrinaga%26aufirst%3DG.%26aulast%3DGonz%25C3%25A1lez-Maeso%26aufirst%3DJ.%26aulast%3DGil%26aufirst%3DJ.%26aulast%3DMeana%26aufirst%3DJ.%2BJ.%26aulast%3DCasis%26aufirst%3DL.%26atitle%3DDistribution%2520of%2520prolyl%2520endopeptidase%2520activities%2520in%2520rat%2520and%2520human%2520brain%26jtitle%3DNeurochem.%2520Int.%26date%3D2002%26volume%3D40%26spage%3D337%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Myöhänen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyykkö, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpen, O.</span><span> </span><span class="NLM_article-title">Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1369%2F0022155412453051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=22740343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A280%3ADC%252BC38jlsFSltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=706-715&author=T.+T.+My%C3%B6h%C3%A4nenauthor=E.+Pyykk%C3%B6author=P.+T.+M%C3%A4nnist%C3%B6author=O.+Carpen&title=Distribution+of+prolyl+oligopeptidase+in+human+peripheral+tissues+and+in+ovarian+and+colorectal+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors</span></div><div class="casAuthors">Myohanen Timo T; Pyykko Elisa; Mannisto Pekka T; Carpen Olli</div><div class="citationInfo"><span class="NLM_cas:title">The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">706-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Prolyl oligopeptidase (PREP) is a serine protease that hydrolyzes peptides shorter than 30-mer, and it has been connected with multiple physiological and pathological conditions.  PREP has been mostly studied in the brain, but significant PREP activities have been measured in peripheral tissues.  Moreover, increased PREP activities have been found in tumors.  In this study, the authors studied the immunohistochemical distribution of PREP protein in human peripheral tissues and in ovarian and colorectal tumors.  PREP was found to be widely distributed in human peripheral tissues and specifically in certain cells.  The most intense PREP expression was seen in the testis, ovaries, liver, and some parts of the skin.  At the cellular level, high PREP levels were seen as a rule in secreting epithelial cells and cells involved in reproduction.  Increased PREP expression was seen in most of the tumors studied.  PREP expression was higher in malignant than benign tumors, and in ovarian epithelial cancers, there was a trend for increased PREP staining with increased malignancy grade.  Results suggest that PREP may be associated with secretory processes as well as in reproduction.  A more abundant expression of PREP in malignant than benign tumors suggests that PREP may be associated with expansion and metastasis of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaIn2AZnomMEcLvDNbOD4DfW6udTcc2ebagQHIr87ew7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jlsFSltg%253D%253D&md5=39f1d2b6f803c150ca501148da7439ef</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1369%2F0022155412453051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252F0022155412453051%26sid%3Dliteratum%253Aachs%26aulast%3DMy%25C3%25B6h%25C3%25A4nen%26aufirst%3DT.%2BT.%26aulast%3DPyykk%25C3%25B6%26aufirst%3DE.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DCarpen%26aufirst%3DO.%26atitle%3DDistribution%2520of%2520prolyl%2520oligopeptidase%2520in%2520human%2520peripheral%2520tissues%2520and%2520in%2520ovarian%2520and%2520colorectal%2520tumors%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2012%26volume%3D60%26spage%3D706%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Targeting proteases: successes, failures and future prospects</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1038%2Fnrd2092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=16955069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=785-799&author=B.+Turk&title=Targeting+proteases%3A+successes%2C+failures+and+future+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting proteases: successes, failures and future prospects</span></div><div class="casAuthors">Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">785-799</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Until fairly recently, proteases were considered primarily to be protein-degrading enzymes.  However, this view has dramatically changed and proteases are now seen as extremely important signalling mols. that are involved in numerous vital processes.  Protease signalling pathways are strictly regulated, and the dysregulation of protease activity can lead to pathologies such as cardiovascular and inflammatory diseases, cancer, osteoporosis and neurol. disorders.  Several small-mol. drugs targeting proteases are already on the market and many more are in development.  The status of human protease research and prospects for future protease-targeted drugs are reviewed here, with ref. to some key examples where protease drugs have succeeded or failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa_X9u2oqlzrVg90H21EOLACvtfcHk0lghb-AC3hPN6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltrs%253D&md5=00111ddbeafb283cbe88f7b0ee7bb404</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnrd2092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2092%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DTargeting%2520proteases%253A%2520successes%252C%2520failures%2520and%2520future%2520prospects%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D785%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DDrug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Strategies for discovering and derisking covalent, irreversible enzyme inhibitors</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">964</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.4155%2Ffmc.10.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=20640225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=949-964&author=D.+S.+Johnsonauthor=E.+Weerapanaauthor=B.+F.+Cravatt&title=Strategies+for+discovering+and+derisking+covalent%2C+irreversible+enzyme+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for discovering and derisking covalent, irreversible enzyme inhibitors</span></div><div class="casAuthors">Johnson, Douglas S.; Weerapana, Eranthie; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">949-964</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  This article presents several covalent inhibitors, including examples of successful drugs, as well as highly selective, irreversible inhibitors of emerging therapeutic targets, such as fatty acid amide hydolase.  Covalent inhibitors have many desirable features, including increased biochem. efficiency of target disruption, less sensitivity toward pharmacokinetic parameters and increased duration of action that outlasts the pharmacokinetics of the compd.  Safety concerns that must be mitigated include lack of specificity and the potential immunogenicity of protein-inhibitor adduct(s).  Particular attention will be given to recent technologies, such as activity-based protein profiling, which allow one to define the proteome-wide selectivity patterns for covalent inhibitors in vitro and in vivo.  For instance, any covalent inhibitor can, in principle, be modified with a 'clickable' tag to generate an activity probe that is almost indistinguishable from the original agent.  These probes can be applied to any living system across a broad dose range to fully inventory their on and off targets.  The substantial no. of drugs on the market today that act by a covalent mechanism belies historical prejudices against the development of irreversibly acting therapeutic small mols.  Emerging proteomic technologies offer a means to systematically discriminate safe (selective) vs. deleterious (nonselective) covalent inhibitors and thus should inspire their future design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqm0whEybB-LVg90H21EOLACvtfcHk0lghb-AC3hPN6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D&md5=07e1f89418b168798ae5c1a9fa43e9c1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.21%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStrategies%2520for%2520discovering%2520and%2520derisking%2520covalent%252C%2520irreversible%2520enzyme%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D949%26epage%3D964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Sanderson, P. E.</span><span> </span><span class="NLM_article-title">Small, noncovalent serine protease inhibitors</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1002%2F%28SICI%291098-1128%28199903%2919%3A2%3C179%3A%3AAID-MED4%3E3.0.CO%3B2-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=10189177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADyaK1MXhvF2htrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=179-197&author=P.+E.+Sanderson&title=Small%2C+noncovalent+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Small, noncovalent serine protease inhibitors</span></div><div class="casAuthors">Sanderson, Philip E. J.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-197</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 103 refs.  Thrombin and factor Xa (fXa) are the only serine proteases for which small, potent, selective, noncovalent inhibitors have been developed, which are ultimately intended as drug development candidates (in this case as anticoagulants).  Noncovalent inhibitors may be more selective and chem. and metabolically less reactive than covalent inhibitors.  In addn., noncovalent inhibitors are more likely to have fast-binding kinetics which is particularly important in the development of thrombin inhibitors.  TAME derived noncovalent thrombin inhibitors argatroban, napsagatran, and UK 156,406 have entered clin. trials as anticoagulants, the latter as an orally active agent.  Serine trap deletion from substrate-like peptides led to the development of inogatran and melagatran, both of which have entered clin. trials as i.v. agents.  The use of 3-aminopyridinone and pyrazinone acetamide peptidomimetic templates has resulted in the development of L-375,378 which has been chosen for clin. development as an orally active anticoagulant.  Recently, compds. which do not have the conventional hydrogen bonding capabilities of peptides have begun to appear in the thrombin literature.  Publications on noncovalent fXa inhibitors cover this type of peptidomimetic almost exclusively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1uE-zC5_v97Vg90H21EOLACvtfcHk0lghb-AC3hPN6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvF2htrw%253D&md5=b090ed0593d910f5fedeaae1d82e5634</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199903%2919%3A2%3C179%3A%3AAID-MED4%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199903%252919%253A2%253C179%253A%253AAID-MED4%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26atitle%3DSmall%252C%2520noncovalent%2520serine%2520protease%2520inhibitors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1999%26volume%3D19%26spage%3D179%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Bachovchin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">The pharmacological landscape and therapeutic potential of serine hydrolases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm400351a&amp;key=10.1038%2Fnrd3620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=22212679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=52-68&author=D.+A.+Bachovchinauthor=B.+F.+Cravatt&title=The+pharmacological+landscape+and+therapeutic+potential+of+serine+hydrolases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacological landscape and therapeutic potential of serine hydrolases</span></div><div class="casAuthors">Bachovchin, Daniel A.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-68</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Serine hydrolases perform crucial roles in many biol. processes, and several of these enzymes are targets of approved drugs for indications such as type 2 diabetes, Alzheimer's disease and infectious diseases.  Despite this, most of the human serine hydrolases (of which there are more than 200) remain poorly characterized with respect to their physiol. substrates and functions, and the vast majority lack selective, in vivo-active inhibitors.  Here, we review the current state of pharmacol. for mammalian serine hydrolases, including marketed drugs, compds. that are under clin. investigation and selective inhibitors emerging from academic probe development efforts.  We also highlight recent methodol. advances that have accelerated the rate of inhibitor discovery and optimization for serine hydrolases, which we anticipate will aid in their biol. characterization and, in some cases, therapeutic validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsWC4iV3Xc57Vg90H21EOLACvtfcHk0lgww6Qv1aoUtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOktA%253D%253D&md5=4fde1e23117ad11848a9c2eef85376b7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrd3620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3620%26sid%3Dliteratum%253Aachs%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DThe%2520pharmacological%2520landscape%2520and%2520therapeutic%2520potential%2520of%2520serine%2520hydrolases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D52%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">580</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=580&publication_year=2006&pages=1581-1586&author=C.+Y.+Edosadaauthor=C.+Quanauthor=T.+Tranauthor=V.+Phamauthor=C.+Wiesmannauthor=W.+Fairbrotherauthor=B.+B.+Wolf&title=Peptide+substrate+profiling+defines+fibroblast+activation+protein+as+an+endopeptidase+of+strict+Gly%282%29-Pro%281%29-cleaving+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DPham%26aufirst%3DV.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DFairbrother%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DPeptide%2520substrate%2520profiling%2520defines%2520fibroblast%2520activation%2520protein%2520as%2520an%2520endopeptidase%2520of%2520strict%2520Gly%25282%2529-Pro%25281%2529-cleaving%2520specificity%26jtitle%3DFEBS%2520Lett.%26date%3D2006%26volume%3D580%26spage%3D1581%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Aggarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennen, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kole, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topaloglu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi701921b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1076-1086&author=S.+Aggarwalauthor=W.+N.+Brennenauthor=T.+P.+Koleauthor=E.+Schneiderauthor=O.+Topalogluauthor=M.+Yatesauthor=R.+J.+Cotterauthor=S.+R.+Denmeade&title=Fibroblast+activation+protein+peptide+substrates+identified+from+human+collagen+I+derived+gelatin+cleavage+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi701921b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi701921b%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DS.%26aulast%3DBrennen%26aufirst%3DW.%2BN.%26aulast%3DKole%26aufirst%3DT.%2BP.%26aulast%3DSchneider%26aufirst%3DE.%26aulast%3DTopaloglu%26aufirst%3DO.%26aulast%3DYates%26aufirst%3DM.%26aulast%3DCotter%26aufirst%3DR.%2BJ.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DFibroblast%2520activation%2520protein%2520peptide%2520substrates%2520identified%2520from%2520human%2520collagen%2520I%2520derived%2520gelatin%2520cleavage%2520sites%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D1076%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Wolf, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D.</span><span> </span><span class="NLM_article-title">On the edge of validation—cancer protease fibroblast activation protein</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=719-727&author=B.+B.+Wolfauthor=C.+Quanauthor=T.+Tranauthor=C.+Wiesmannauthor=D.+Sutherlin&title=On+the+edge+of+validation%E2%80%94cancer+protease+fibroblast+activation+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DB.%2BB.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DSutherlin%26aufirst%3DD.%26atitle%3DOn%2520the%2520edge%2520of%2520validation%25E2%2580%2594cancer%2520protease%2520fibroblast%2520activation%2520protein%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D719%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Fülöp, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böcskei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgár, L.</span><span> </span><span class="NLM_article-title">Prolyl oligopeptidase; an unusual beta-propeller domain regulates proteolysis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1998&pages=161-170&author=V.+F%C3%BCl%C3%B6pauthor=Z.+B%C3%B6cskeiauthor=L.+Polg%C3%A1r&title=Prolyl+oligopeptidase%3B+an+unusual+beta-propeller+domain+regulates+proteolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DV.%26aulast%3DB%25C3%25B6cskei%26aufirst%3DZ.%26aulast%3DPolg%25C3%25A1r%26aufirst%3DL.%26atitle%3DProlyl%2520oligopeptidase%253B%2520an%2520unusual%2520beta-propeller%2520domain%2520regulates%2520proteolysis%26jtitle%3DCell%26date%3D1998%26volume%3D94%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Wang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D. M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=935-945&author=X.+M.+Wangauthor=D.+M.+T.+Yuauthor=W.+McCaughanauthor=M.+D.+Gorrell&title=Fibroblast+activation+protein+increases+apoptosis%2C+cell+adhesion%2C+and+migration+by+the+LX-2+human+stellate+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BM.%26aulast%3DYu%26aufirst%3DD.%2BM.%2BT.%26aulast%3DMcCaughan%26aufirst%3DW.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DFibroblast%2520activation%2520protein%2520increases%2520apoptosis%252C%2520cell%2520adhesion%252C%2520and%2520migration%2520by%2520the%2520LX-2%2520human%2520stellate%2520cell%2520line%26jtitle%3DHepatology%26date%3D2005%26volume%3D42%26spage%3D935%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Sunwoo, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bancroft, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Waes, C.</span><span> </span><span class="NLM_article-title">Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κB cell survival, tumor growth, and angiogenesis in squamous cell carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400351a&amp;key=11350913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400351a&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlels7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=1419-1428&author=J.+B.+Sunwooauthor=Z.+Chenauthor=G.+Dongauthor=N.+Yehauthor=C.+C.+Bancroftauthor=E.+Sausvilleauthor=J.+Adamsauthor=P.+Elliotauthor=C.+Van+Waes&title=Novel+proteasome+inhibitor+PS-341+inhibits+activation+of+nuclear+factor-%CE%BAB+cell+survival%2C+tumor+growth%2C+and+angiogenesis+in+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma</span></div><div class="casAuthors">Sunwoo, John B.; Chen, Zhong; Dong, Gang; Yeh, Ning; Bancroft, Caren Crowl; Sausville, Edward; Adams, Julian; Elliott, Peter; Van Waes, Carter</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1419-1428</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have shown that activation of nuclear factor-κB (NF-κB) promotes cell survival and expression of cytokines such as growth-regulated oncogene-α, which can modulate angiogenesis, growth, and metastasis of squamous cell carcinoma (SCC).  Activation of NF-κB and cytoprotective genes in cancer may result from signal-induced phosphorylation and proteasome-dependent degrdn. of inhibitor-κB.  In this study, we examd. the effects of the novel proteasome inhibitor PS-341 on activation of NF-κB and cell survival, growth, and angiogenesis in murine and human SCC cell lines.  PS-341 inhibited activation of NF-κB DNA binding and functional reporter activity at concns. between 10-8 and 10-7 M.  Cytotoxicity was obsd. at 10-7 M in four murine and two human SCC lines, and followed early cleavage of poly(ADP-ribose) polymerase, a marker of caspase-mediated apoptosis.  In vivo, PS-341 inhibited growth of murine and human SCC in mice at doses of 1-2 mg/kg given three times weekly, and dose-limiting toxicity was encountered at 2 mg/kg.  Tumor growth inhibition was assocd. with a marked decrease in vessel d.  PS-341 inhibited expression of the proangiogenic cytokines growth-regulated oncogene-α and vascular endothelial growth factor by SCC in the range at which PS-341 inhibits NF-κB.  We conclude that PS-341 inhibits activation of NF-κB pathway components related to cell survival, tumor growth, and angiogenesis in SCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEXkVYUm_8OrVg90H21EOLACvtfcHk0lgww6Qv1aoUtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlels7k%253D&md5=f7299b6521b3d0a02437158154f52e89</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSunwoo%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DYeh%26aufirst%3DN.%26aulast%3DBancroft%26aufirst%3DC.%2BC.%26aulast%3DSausville%26aufirst%3DE.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DElliot%26aufirst%3DP.%26aulast%3DVan%2BWaes%26aufirst%3DC.%26atitle%3DNovel%2520proteasome%2520inhibitor%2520PS-341%2520inhibits%2520activation%2520of%2520nuclear%2520factor-%25CE%25BAB%2520cell%2520survival%252C%2520tumor%2520growth%252C%2520and%2520angiogenesis%2520in%2520squamous%2520cell%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D1419%26epage%3D1428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Coutts, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krolikowski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ksiazek, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2087</span><span class="NLM_x">–</span> <span class="NLM_lpage">2094</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950732f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=2087-2094&author=S.+J.+Couttsauthor=T.+A.+Kellyauthor=R.+J.+Snowauthor=C.+A.+Kennedyauthor=R.+W.+Bartonauthor=J.+Adamsauthor=D.+A.+Krolikowskiauthor=D.+M.+Freemanauthor=S.+J.+Campbellauthor=J.+F.+Ksiazekauthor=W.+W.+Bachovchin&title=Structure%E2%80%93activity+relationships+of+boronic+acid+inhibitors+of+dipeptidyl+peptidase+IV.+1.+Variation+of+the+P2+position+of+Xaa-boroPro+dipeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm950732f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950732f%26sid%3Dliteratum%253Aachs%26aulast%3DCoutts%26aufirst%3DS.%2BJ.%26aulast%3DKelly%26aufirst%3DT.%2BA.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DKennedy%26aufirst%3DC.%2BA.%26aulast%3DBarton%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DKrolikowski%26aufirst%3DD.%2BA.%26aulast%3DFreeman%26aufirst%3DD.%2BM.%26aulast%3DCampbell%26aufirst%3DS.%2BJ.%26aulast%3DKsiazek%26aufirst%3DJ.%2BF.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520boronic%2520acid%2520inhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV.%25201.%2520Variation%2520of%2520the%2520P2%2520position%2520of%2520Xaa-boroPro%2520dipeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D2087%26epage%3D2094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Milo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maw, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poplawski, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanford, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudmeier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span> </span><span class="NLM_article-title">Chemical and biological evaluation of dipeptidyl boronic acid proteasome inhibitors for use in prodrugs and pro-soft drugs targeting solid tumors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4365</span><span class="NLM_x">–</span> <span class="NLM_lpage">4377</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200460q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4365-4377&author=L.+J.+Miloauthor=J.+H.+Laiauthor=W.+Wuauthor=Y.+Liuauthor=H.+Mawauthor=Y.+Liauthor=Z.+Jinauthor=Y.+Shuauthor=S.+E.+Poplawskiauthor=Y.+Wuauthor=D.+G.+Sanfordauthor=J.+L.+Sudmeierauthor=W.+W.+Bachovchin&title=Chemical+and+biological+evaluation+of+dipeptidyl+boronic+acid+proteasome+inhibitors+for+use+in+prodrugs+and+pro-soft+drugs+targeting+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm200460q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200460q%26sid%3Dliteratum%253Aachs%26aulast%3DMilo%26aufirst%3DL.%2BJ.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMaw%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DPoplawski%26aufirst%3DS.%2BE.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSanford%26aufirst%3DD.%2BG.%26aulast%3DSudmeier%26aufirst%3DJ.%2BL.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DChemical%2520and%2520biological%2520evaluation%2520of%2520dipeptidyl%2520boronic%2520acid%2520proteasome%2520inhibitors%2520for%2520use%2520in%2520prodrugs%2520and%2520pro-soft%2520drugs%2520targeting%2520solid%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4365%26epage%3D4377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Poplawski, S. E.; Li, Y.; Shu, Y.; Zhang, M.; DiMare, M. T.; Sanford, D. G.; Lai, J. H.; Cheng, J. D.; Gorrell, M. D.; Bachovchin, W. W.</span> Unpublished data.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Poplawski%2C+S.+E.%3B+Li%2C+Y.%3B+Shu%2C+Y.%3B+Zhang%2C+M.%3B+DiMare%2C+M.+T.%3B+Sanford%2C+D.+G.%3B+Lai%2C+J.+H.%3B+Cheng%2C+J.+D.%3B+Gorrell%2C+M.+D.%3B+Bachovchin%2C+W.+W.+Unpublished+data."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPoplawski%26aufirst%3DS.%2BE." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NU8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NU8','PDB','1NU8'); return false;">PDB: 1NU8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z68" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z68','PDB','1Z68'); return false;">PDB: 1Z68</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400351a&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-9%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm400351a%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400351a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990cc8fa383d4e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
